mistral-7b.json

[{"PMCID":1174877,"edit_id":"9238a12ff9fe708749e740e2d2bcd2d0","category":"omission","question":"What other health conditions are often found with metabolic syndrome?","answer":"Hypertension and diabetes mellitus are often found with metabolic syndrome.","input_idx":[[133,194]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1174877,"edit_id":"040341b93f8e0b40dfb865871f20ef7d","category":"omission","question":"What is the main function of Telmisartan?","answer":"Telmisartan is a medication taken to lower high blood pressure.","input_idx":[[269,407]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":1174877,"edit_id":"f96cd0b8e605c1b4556709f8afb2fb1f","category":"concept","question":"What is the term used to describe a group of health conditions that can increase the risk of heart disease?","answer":"The term used to describe a group of health conditions that can increase the risk of heart disease is \"metabolic syndrome\".","input_idx":null,"output_idx":[[34,103]],"annotator":"mistral-7b","prediction_errors":["invalid_input_localization"]},{"PMCID":1291385,"edit_id":"1a219a242fee3133717c21c01f273a30","category":"omission","question":"What was the goal of this study?","answer":"The goal of this study was to compare the effects of co-administered dexamethasone and diclofenac potassium (diclofenac K) with diclofenac K alone on the postoperative pain, swelling and trismus after surgical removal of third molars.","input_idx":[[242,473]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1291385,"edit_id":"13a8452aa0e962dee08c486a33ffca56","category":"omission","question":"How was the study conducted?","answer":"The study was conducted at the Department of Oral and Maxillofacial Surgery, Lagos University Teaching Hospital, Nigeria, using a prospective, randomized, double-blind design.","input_idx":[[497,652]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1291385,"edit_id":"2e41e6ef7a9a7114267313027e9e3e98","category":"omission","question":"How many patients were included in the study and what were the criteria for selection?","answer":"A total of 100 patients were included in the study. The inclusion criteria were not specified, but it is likely that patients were selected based on their need for surgery and their eligibility for the medications being tested.","input_idx":[[653,889]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1291385,"edit_id":"4e3a68d76b6fbb2ed5e1fe7c9d8bcc7a","category":"concept","question":"What does \"significantly superior\" mean in this context?","answer":"\"Significantly superior\" means that the combination of dexamethasone and diclofenac K was able to provide better relief from pain and reduce facial swelling compared to using diclofenac alone.","input_idx":[[1272,1579]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":1291385,"edit_id":"7cada3d2d0e248d79ca3417b9c89adac","category":"concept","question":"How was facial swelling and mouth-opening ability measured in the study?","answer":"Facial swelling was measured using a tape measure placed from the tragus to the gonion to the tragus, while interincisal mouth-opening of patients was measured using a vernier calibrated caliper before and after the operation.","input_idx":[[1041,1261]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":1618957,"edit_id":"b00c02d3a2bc54a7bc05caab7f92d601","category":"omission","question":"Who were the participants in the study?","answer":"The participants were people who had been using lanreotide microparticles 30 mg for at least 2 months and had responded to treatment.","input_idx":[[404,581]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1618957,"edit_id":"38573cc51241f175f67262207b81a61e","category":"omission","question":"How many shots of lanreotide Autogel\u00ae were given to the participants?","answer":"The participants received 3 to 5 shots of lanreotide Autogel\u00ae 120 mg.","input_idx":[[582,655]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1618957,"edit_id":"863578ecf54b4a3d477fe4ab35c54cf8","category":"omission","question":"When were the injections of lanreotide Autogel\u00ae given?","answer":"The injections of lanreotide Autogel\u00ae were given every 4, 6 or 8 weeks, depending on the timing of the previous injections of lanreotide microparticles.","input_idx":[[656,814]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1618957,"edit_id":"599b43fb0d69b9c82b9b524d86939c1b","category":"concept","question":"What was the specific measure used to compare the efficacy of the two formulations?","answer":"The specific measure used to compare the efficacy of the two formulations was the steady-state GH concentrations.","input_idx":[[990,1075]],"output_idx":[[965,1057]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1618957,"edit_id":"75f990fc0055538f63a86ff8168f6dfa","category":"concept","question":"Was the difference in GH levels between the two formulations statistically significant?","answer":"Yes, the difference in GH levels between the two formulations was statistically significant (P < 0\u00b7001).","input_idx":[[1132,1265]],"output_idx":[[1059,1158]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1618957,"edit_id":"6f95036205174128b06389a94076638c","category":"concept","question":"What was the specific measure used to assess the control of symptoms and the acceptance of the treatment?","answer":"The specific measure used to assess the control of symptoms and the acceptance of the treatment was the percentage of patients who had GH levels < 2\u00b75 ng\/ml and normalized IGF-1 with lanreotide Autogel\u00ae and microparticles, respectively.","input_idx":[[1267,1444]],"output_idx":[[1160,1227]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":165418,"edit_id":"490906f771e8aa339c1f19f400dd9201","category":"omission","question":"What is the relationship between depression and type 2 diabetes?","answer":"Depression is a common comorbidity in people with type 2 diabetes and can negatively impact their glycemic control and overall quality of life.","input_idx":[[12,129]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":165418,"edit_id":"6e17a4d07d74d38e7a13ece79f8b0291","category":"omission","question":"What was the specific goal of this study?","answer":"The study aimed to evaluate the effect of paroxetine on metabolic control, quality of life and mental well-being in mildly depressed women with type 2 diabetes.","input_idx":[[130,319]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":165418,"edit_id":"506d64cb9272b322df4f3a8fc405c06e","category":"concept","question":"How were the participants selected for this study?","answer":"The participants were selected based on their diagnosis of type 2 diabetes and depression, and their inability to control their blood sugar levels. The study was a single-blind study, meaning that neither the participants nor the researchers knew which treatment each participant received.","input_idx":[[330,500]],"output_idx":[[376,505]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":165418,"edit_id":"78db1e7d20d821c2d8939c9a007ca965","category":"concept","question":"What specific techniques were used to measure glycemic control, quality of life and mental state?","answer":"The specific techniques used to measure glycemic control, quality of life and mental state were glycosylated hemoglobin A1c (GHbA1c) for glycemic control, RAND-36 for quality of life and mental state was assessed using two clinician-rated scoring instruments, Hamilton's Anxiety Scale (HAM-A) and Montgomery-A\u030asberg's Depression Rating Scale (MADRS), and a patient-rated scoring instrument, Beck's Depression Inventory (BDI).","input_idx":[[568,930]],"output_idx":[[585,793]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1774569,"edit_id":"84e38a5a435feb92026ad389827a31d8","category":"omission","question":"Who is the study focused on?","answer":"The study is focused on drug users who present to primary care requesting detoxification from illicit opiates.","input_idx":[[12,98]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1774569,"edit_id":"d9cfa1d3cea4646db3bc78e95a17e01d","category":"omission","question":"What are the current options for detoxification agents and why is there no recommended drug of choice?","answer":"There are various detoxification agents available, but there is no recommended drug of choice for detoxification from illicit opiates.","input_idx":[[100,177]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1774569,"edit_id":"5d29886fc4ced8678ae7982e577015de","category":"omission","question":"What is the purpose of this study?","answer":"The purpose of this study is to compare buprenorphine with dihydrocodeine for detoxification from illicit opiates in primary care.","input_idx":[[179,308]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1774569,"edit_id":"3e9d759a3d2b96557b7c514a95067274","category":"concept","question":"How was the study designed?","answer":"The study was an open label randomized controlled trial conducted in NHS Primary Care (General Practices) in Leeds, UK.","input_idx":[[320,409]],"output_idx":[[335,426]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1774569,"edit_id":"557596d6d7b33a1a95118d543095cc39","category":"concept","question":"What were the reducing regimens for both interventions and what was the standard regimen?","answer":"The reducing regimens for both interventions were at the discretion of the prescribing doctor, within a standard regimen of not more than 15 days.","input_idx":[[534,670]],"output_idx":[[505,651]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1774569,"edit_id":"70b753631cfaa38b4e2062e5606c8683","category":"concept","question":"What was the primary outcome of the study?","answer":"The primary outcome of the study was abstinence from illicit opiates at final prescription as indicated by a urine sample.","input_idx":[[672,776]],"output_idx":[[653,782]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1868720,"edit_id":"d454dbb4839a1cddf915c49420dcf913","category":"omission","question":"How many employees were approached in the trial?","answer":"8603 employees were approached in the trial.","input_idx":[[1051,1175]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":1868720,"edit_id":"20bcdd701ad7fb38806aee3d757dda02","category":"concept","question":"What was the screening instrument and what does \"response rate\" mean?","answer":"The screening instrument was likely a questionnaire or survey that was used to gather information about the employees' health and eligibility for the intervention program. \"Response rate\" refers to the percentage of people who completed the survey.","input_idx":[[749,808]],"output_idx":[[836,880]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2253708,"edit_id":"938935410f1bb9bbd20f66f1d5222368","category":"omission","question":"What was the sample size of the study?","answer":"The study had a total of 1499 participants.","input_idx":[[917,965]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2253708,"edit_id":"938935410f1bb9bbd20f66f1d5222368","category":"omission","question":"What was the sample size of the study?","answer":"The study had a total of 1499 participants.","input_idx":[[1143,1189]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2253708,"edit_id":"83a28e6605c6df906e02be4c9bbcc683","category":"concept","question":"What is the Transtheoretical Model of behaviour change?","answer":"The Transtheoretical Model of behaviour change is a psychological theory that describes the stages that people go through when trying to change a behaviour, such as smoking. It is a widely used model in the field of health psychology and behaviour change.","input_idx":[[713,785]],"output_idx":[[781,857]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2427034,"edit_id":"49dc601b2ed83d5fbf2faa1de45fdd8d","category":"omission","question":"What methods were used to confirm H. pylori infection in the study?","answer":"The study used H. pylori-specific 23S rRNA PCR, ELISA, and13C-urea breath test assays to confirm H. pylori infection.","input_idx":[[593,663]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2427034,"edit_id":"5fd83a58ee339869f2c8bdb380f385ba","category":"omission","question":"What method was used to detect the A2143G mutation in the study?","answer":"The study used RFLP assays to detect the A2143G mutation.","input_idx":[[713,724]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2427034,"edit_id":"46a9892a0df0f20f8b8e19f7ff12ef6c","category":"concept","question":"How was H. pylori infection measured in the study and what was the time frame for the measurement?","answer":"H. pylori infection was measured by 23S rRNA detection and the time frame for the measurement was 7.3 years after treatment.","input_idx":[[736,874]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":2427034,"edit_id":"200c2612a59a7c1992179f6e6fda3418","category":"concept","question":"What was the specific value of the A2143G mutation rate in each group and how was the difference between them determined?","answer":"The A2143G mutation rate in the OAC group was 31.7%, in the OA group it was 10.2% and in the placebo group it was 13.8%. The difference between the OAC group and the OA group was statistically significant (p<0.05) and the difference between the OAC group and the placebo group was also statistically significant (p<0.05).","input_idx":[[1022,1224]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":2430614,"edit_id":"5f14856086959b53987657c9cd23d3da","category":"omission","question":"What was the third drug combination that was compared in the study?","answer":"The third drug combination that was compared in the study was Artesunate+chlorproguanil-dapsone (AS+CD).","input_idx":[[175,216]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2430614,"edit_id":"e15f7f9dc1adf94e98bd50e3e40a9324","category":"omission","question":"What is the trial registration number for this study?","answer":"The trial registration number for this study is ClinicalTrials.gov NCT00119145.","input_idx":[[1862,1892]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2500257,"edit_id":"3700f558ada5dd10727b086c7a49dbcc","category":"omission","question":"What is the name of the test used in this study?","answer":"The test used in this study is called PNA-FISH, which stands for Fluorescence in situ hybridization using peptide nucleic acid probes.","input_idx":[[0,79]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2500257,"edit_id":"8a22e01c1aa4c50496d58f07d9d14198","category":"omission","question":"How many patients were included in the study?","answer":"The study included 202 patients with positive blood cultures.","input_idx":[[168,210]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2500257,"edit_id":"ed8e5073921dd722a8a3e030c7a8ba8b","category":"concept","question":"What are clusters (GPCC)?","answer":"Clusters (GPCC) refer to a group of Gram-positive-cocci bacteria, which are a type of bacteria that are commonly found in the skin and respiratory tract.","input_idx":[[151,166]],"output_idx":[[130,152]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2500257,"edit_id":"566a9f391f10efd6d19f9275692bf90d","category":"concept","question":"What is the statistical significance of the results?","answer":"The results of the study were statistically significant, as indicated by the p-values. The p-value for mortality was 0.05, which is considered statistically significant. The p-value for antibiotic use was 0.01, which is also considered statistically significant. The trend for reduced hospital stay and charges was also statistically significant.","input_idx":[[281,461]],"output_idx":[[300,517]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2556743,"edit_id":"bca6585d0e807ccab5eca705f618b1c6","category":"omission","question":"What method was used to achieve the goal of maximizing stroke volume?","answer":"The method used was to monitor and minimize the variation in arterial pulse pressure (\u0394PP) induced by mechanical ventilation by volume loading.","input_idx":[[1514,1586]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2556743,"edit_id":"87417a3c0b5372487d53a69d5f6e954e","category":"omission","question":"What was the specific goal of the study?","answer":"The specific goal of the study was to find out if the method of monitoring and minimizing the variation in arterial pulse pressure (\u0394PP) induced by mechanical ventilation by volume loading during high-risk surgery could shorten the length of a patient's stay in the hospital after surgery.","input_idx":[[404,473]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2556743,"edit_id":"59a39bd93e3e0873c21abea621f25a6c","category":"concept","question":"How much did the blood pressure changes decrease?","answer":"The blood pressure changes decreased from 22 \u00b1 75 to 9 \u00b1 1%, which is a decrease of 23%.","input_idx":[[1050,1097]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":2556743,"edit_id":"f353874c57271014848ccd985af6b46e","category":"concept","question":"How much shorter was the length of hospital stay in the intervention group?","answer":"The length of hospital stay was shorter by 10 days in the intervention group.","input_idx":[[1110,1192]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":2639329,"edit_id":"bac9a0778771477cec5fb74afb28189a","category":"omission","question":"What was the purpose of the \u0152DIPE study?","answer":"The purpose of the \u0152DIPE study was to examine the safety and efficacy of an abbreviated hospitalization after implantation or replacement of dual-chamber pacemakers using a telecardiology-based ambulatory surveillance programme.","input_idx":[[6,218]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2639329,"edit_id":"4cdb06c831be8230f20489f4fab98d73","category":"omission","question":"How were patients assigned to the active and control groups?","answer":"Patients were randomly assigned to the active or control group. The active group was discharged from the hospital 24 hours after a first PM implant or 4\u20136 hours after a replacement, and followed for 4 weeks with Home-Monitoring (HM), while the control group was monitored for 4 weeks following standard medical practices.","input_idx":[[241,518]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2639329,"edit_id":"7e75f30821a4c2369f69caf170fc4d4e","category":"omission","question":"What was the main goal of the study?","answer":"The main goal of the study was to confirm that the proportion of patients who experienced one or more major adverse events (MAE) was not higher in the active than in the control group.","input_idx":[[519,698]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2639329,"edit_id":"bb2b4c79b4675d71272b91345aa0690c","category":"concept","question":"How many patients were included in the study?","answer":"The study included 379 patients.","input_idx":[[699,731]],"output_idx":[[761,788]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2639329,"edit_id":"d3f1096188d14210bb53573beada907c","category":"concept","question":"What was the percentage of patients in the active group who experienced treatment-related MAE?","answer":"About 9% of patients in the active group experienced some negative events related to their treatment.","input_idx":[[732,965]],"output_idx":[[789,1044]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2639329,"edit_id":"770935df91312622ae76eeb44ac53fe1","category":"concept","question":"What was the statistical significance of the difference in hospitalization duration between the active and control groups?","answer":"The mean hospitalization duration was 34% shorter in the active than in the control group (P < 0.001).","input_idx":[[966,1179]],"output_idx":[[1051,1215]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2639329,"edit_id":"bb2b4c79b4675d71272b91345aa0690c","category":"concept","question":"How many patients were included in the study?","answer":"The study included 379 patients.","input_idx":[[699,731]],"output_idx":[[761,788]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2652457,"edit_id":"cc9bc85bb6fffa24b5be5b9c4eb67525","category":"omission","question":"Who was the target population of the study?","answer":"The target population of the study was people who work with children.","input_idx":[[12,79]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2652457,"edit_id":"4475f77713fe340b6daae1c0efce0469","category":"omission","question":"What software was used to develop the package and what does it mean by \"educationally appropriate knowledge about autism\"?","answer":"The package was developed using Xerte and Flash Macromedia software. \"Educationally appropriate knowledge about autism\" means that the information provided in the package is accurate, age-appropriate, and easy to understand.","input_idx":[[148,265]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2652457,"edit_id":"5715127638a125fa86fc3478090eb5cb","category":"concept","question":"How was the effectiveness of the package evaluated?","answer":"The effectiveness of the package was evaluated by randomly assigning 32 childcare students in the UK to either watch the CAL package or read the information leaflet containing the same information.","input_idx":[[421,642]],"output_idx":[[401,609]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2652457,"edit_id":"809beb84e8d68bb4322f124a6e94007f","category":"concept","question":"What specific measures were used to evaluate the effectiveness of the package?","answer":"The effectiveness of the package was evaluated by measuring the retention performance, level of enjoyment, and level of confidence of the students to identify a child with autism after the interventions.","input_idx":[[644,784]],"output_idx":[[640,788]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2699080,"edit_id":"806a18a7b8479e674f71f5aafd4fd717","category":"omission","question":"What were the perioperative parameters that were compared between the two groups?","answer":"The perioperative parameters that were compared between the two groups were operative time, analgesic use, hospital stay, and complication and success rates.","input_idx":[[739,869]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2699080,"edit_id":"98c3bea0a84963c67df6753adf81155a","category":"omission","question":"How long after the surgery were patients followed up with scans?","answer":"Patients were followed up with scans at three months and six months after the surgery.","input_idx":[[662,738]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2699080,"edit_id":"e8ef7b2657e7e43c592862d915d7d549","category":"concept","question":"What specific techniques were used in the traditional surgeries?","answer":"The traditional surgeries used either standard open Anderson Hynes pyeloplasty, spiral flap or VY plasty, depending on the patient's specific anatomic considerations.","input_idx":[[549,661]],"output_idx":[[469,543]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2699714,"edit_id":"92e17d2d8f17a2334a82943cf9cdf8c5","category":"omission","question":"What was the average A1C level at week 24 for the etanercept group and the placebo group?","answer":"The average A1C level at week 24 for the etanercept group was 5.91 \u00b1 0.5% and for the placebo group was 6.98 \u00b1 1.2%.","input_idx":[[770,1025]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2699714,"edit_id":"e2c2ae9861e23e2120af97665e3af940","category":"omission","question":"What was the percent change in C-peptide area under the curve from baseline to week 24 for the etanercept group and the placebo group?","answer":"The percent change in C-peptide area under the curve from baseline to week 24 for the etanercept group was 39% and for the placebo group was 20%.","input_idx":[[1027,1201]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2699714,"edit_id":"e494138ccb8147c576277e8a4bf53522","category":"omission","question":"What was the percent change in insulin dose from baseline to week 24 for the etanercept group and the placebo group?","answer":"The percent change in insulin dose from baseline to week 24 for the etanercept group was 18% and for the placebo group was 23%.","input_idx":[[1203,1339]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2699714,"edit_id":"d1e243db3847ce51af51752518ac155e","category":"concept","question":"What was the specific value of the percent change in C-peptide area under the curve from baseline to week 24 for the etanercept group and the placebo group?","answer":"The specific value of the percent change in C-peptide area under the curve from baseline to week 24 for the etanercept group was 39% and for the placebo group was 20%.","input_idx":[[1027,1201]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":2699714,"edit_id":"153800de6bc3231be819cfa773534213","category":"concept","question":"What was the statistical significance of the difference in percent change in C-peptide area under the curve from baseline to week 24 between the etanercept group and the placebo group?","answer":"The statistical significance of the difference in percent change in C-peptide area under the curve from baseline to week 24 between the etanercept group and the placebo group was P < 0.05.","input_idx":[[1027,1201]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":2703617,"edit_id":"de41006424577a012767406e4ab345f8","category":"omission","question":"What were the specific measures used to evaluate the impact of the FTA?","answer":"The study evaluated the impact of the FTA on waiting times, length of stay, rate of patients leaving without being seen, and mortality rates in non-urgent patients.","input_idx":[[229,468]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2703617,"edit_id":"146593ed3a1cd14356376e75e233c894","category":"omission","question":"What type of hospital was the study conducted at?","answer":"The study was conducted at a 500-bed, urban, tertiary care hospital in Abu Dhabi, United Arab Emirates.","input_idx":[[582,682]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2703617,"edit_id":"98dd2894daf08f866bc1db471cc88bef","category":"concept","question":"How was the study designed?","answer":"The study was a quasi-experimental, which compared the waiting times, length of stay, rate of patients leaving without being seen, and mortality rates of a pre-intervention control group (January 2005) with a post-intervention study group (January 2006).","input_idx":[[683,870]],"output_idx":[[498,579]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2703617,"edit_id":"d74e6c842c160f8992b2bf066dd7851c","category":"concept","question":"What specific measures were used to evaluate the impact of the FTA?","answer":"The study evaluated the impact of the FTA on waiting times, length of stay, rate of patients leaving without being seen, and mortality rates in non-urgent patients. The specific measures used to evaluate the impact of the FTA were the mean waiting times of patients rated as less urgent in the Canadian Triage Acuity Scale (CTAS) 4 and 5.","input_idx":[[894,1111]],"output_idx":[[747,826]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2710065,"edit_id":"b6ed515444bc4b0375265f30a6394fe4","category":"omission","question":"What was the age range of the patients in the study?","answer":"The patients in the study were between 19 and 84 years old, with a mean age of 47.3 years.","input_idx":[[301,354]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2710065,"edit_id":"8cf61a8e51c6ec4726ed0a5d91f6365c","category":"omission","question":"What type of antibiotic was given to the patients in the study?","answer":"The patients received a single intravenous dose of cefoperazone, an antibiotic used to treat bacterial infections.","input_idx":[[633,674]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2710065,"edit_id":"fcf1884b6ae0e915cad7299fc480a7f7","category":"omission","question":"What percentage of the patients underwent additional procedures?","answer":"15% of the patients underwent additional procedures such as punch biopsy or TUR of a small bladder tumor. These procedures were similarly distributed in both groups.","input_idx":[[844,1019]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2710065,"edit_id":"6c0aa5364e1e0b48caf3b2d1e087abd0","category":"concept","question":"What was the exact procedure that was performed on the patients?","answer":"The patients underwent a diagnostic cystoscopy, which is a procedure where a thin, flexible tube with a camera and a light is inserted into the bladder to examine it for any abnormalities.","input_idx":[[431,454]],"output_idx":[[259,287]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2710065,"edit_id":"d66b2b6cf3f853e14596c87b747021ad","category":"concept","question":"What specific tests were done on the urine samples?","answer":"Urine analysis and urine cultures were done on the second day after the procedure. These tests help to detect any bacteria or other substances in the urine that may indicate an infection.","input_idx":[[694,765]],"output_idx":[[494,535]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2742700,"edit_id":"dbd9453c12fd552984ab4d48312483d3","category":"omission","question":"How did the study compare the results of the interventions with the usual care?","answer":"The study found that the interventions did not result in better blood pressure control compared to the usual care.","input_idx":[[944,1094]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2742700,"edit_id":"58b072f953c416b4d60f57529bccbd34","category":"concept","question":"Who conducted the class for group A and what was the content of the class?","answer":"The class was conducted by a nurse educator and the content was about diabetes and high blood pressure.","input_idx":[[493,571]],"output_idx":[[382,459]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2742700,"edit_id":"fef3072773dae4e264b55400ad1444eb","category":"concept","question":"What type of device was provided to group B for monitoring their blood pressure?","answer":"Group B was provided with a device to track their blood pressure at home.","input_idx":[[573,677]],"output_idx":[[461,552]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2774638,"edit_id":"71973b13cb3927c0cbfec0c7d4c6d1d2","category":"omission","question":"What was the main objective of the study?","answer":"The main objective of the study was to design and test a calcium-focused food frequency questionnaire (CFFFQ) including foods naturally rich in calcium and calcium-fortified foods.","input_idx":[[274,457]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2774638,"edit_id":"fb0e42f69d39a24cf774aaf9725d1c5a","category":"omission","question":"What were the secondary objectives of the study?","answer":"The secondary objectives of the study were to review calcium sources and adequacy of intake in black and white postmenopausal women.","input_idx":[[458,576]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2774638,"edit_id":"ed267aa24f7f46e58714454130b75f4b","category":"concept","question":"Who were the participants in the study?","answer":"The participants in the study were a convenience sample of 46 black and 139 white postmenopausal women, whose ages averaged around 69.4 years.","input_idx":[[587,699]],"output_idx":[[693,812]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2774638,"edit_id":"30fdc3f43a1c8bc1d2ab023e6252106c","category":"concept","question":"How was the dietary data collected in the study?","answer":"The dietary data was collected in the study through a multiple-pass interview for 24-hour recall.","input_idx":[[700,801]],"output_idx":[[813,943]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2774638,"edit_id":"41c10fd1dcc6b91c449b1849ac2b246e","category":"concept","question":"How strong was the correlation between the two methods?","answer":"The correlation between the two methods was moderately strong (r = 0.53, P <.001).","input_idx":[[816,919]],"output_idx":[[955,1070]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2784391,"edit_id":"c19a705f8a3cc3652f76e5fe2ffbf693","category":"omission","question":"Who were the participants in the study?","answer":"The study was conducted on critically ill patients.","input_idx":[[14,88]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2784391,"edit_id":"37e0ddfc9378f0b80c87704aa1cfee19","category":"omission","question":"Why were the patients immobile?","answer":"The patients were immobile due to their critical illness.","input_idx":[[160,174]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2784391,"edit_id":"e01151e1795616ebdecb4e75b5a3ef0f","category":"omission","question":"What diseases or conditions were the EMS used as an alternative to active exercise for?","answer":"EMS may be an alternative to active exercise for patients with chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) who also suffer from muscle weakness.","input_idx":[[176,386]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2784391,"edit_id":"d2abc2135ca9bb759d162b80a72d16a9","category":"concept","question":"How was muscle mass measured in the study?","answer":"Muscle mass was measured using ultrasound by measuring the thickness of two muscles in the thigh.","input_idx":[[388,535]],"output_idx":[[469,606]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2784391,"edit_id":"ce2d0fc941d9060b821d41f074371a8a","category":"concept","question":"Why were only 26 patients evaluated in the study?","answer":"Only 26 patients were evaluated because that was the number of patients that were fully evaluated.","input_idx":[[977,1020]],"output_idx":[[1040,1085]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2864284,"edit_id":"9ef35c573cf4654f6ac37a7d53ff6a8e","category":"omission","question":"When was the study conducted?","answer":"The study was conducted between July 2007 and February 2009.","input_idx":[[324,359]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2864284,"edit_id":"c61faed3faa6141077dbced5320261c7","category":"omission","question":"Why was primaquine not given to the patients in the study?","answer":"Primaquine was not given to the patients in the study because it is not recommended in the current national guidelines for the treatment of P. vivax infection.","input_idx":[[554,630]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2864284,"edit_id":"43523c4d7b8a6ab672b46d5857525475","category":"omission","question":"How often were the patients followed up during the study?","answer":"The patients were followed up daily during the acute phase of illness (days 0-3) and weekly until day 56.","input_idx":[[632,732]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2864284,"edit_id":"0b55e44719779c07422cf0902afe3e42","category":"concept","question":"At what point in the study were all participants cured?","answer":"All participants were cured after four weeks.","input_idx":[[1104,1159]],"output_idx":[[753,815]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2864284,"edit_id":"089edcc2bc199e376d346da7eef5b146","category":"concept","question":"At what point in the study was parasite clearance more rapid with dihydroartemisinin-piperaquine than chloroquine?","answer":"Parasite clearance was more rapid with dihydroartemisinin-piperaquine than chloroquine.","input_idx":[[1160,1247]],"output_idx":[[832,888]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2864284,"edit_id":"23ce15770ca002a7a3f6c9014fc2da5c","category":"concept","question":"At what point in the study were recurrent infections more common in the chloroquine arm compared to the dihydroartemisinin-piperaquine arm?","answer":"At day 56, there were more recurrent infections in the chloroquine arm compared to the dihydroartemisinin-piperaquine arm.","input_idx":[[1248,1494]],"output_idx":[[889,980]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2882922,"edit_id":"38f2a050900abe98492e34f02344de3c","category":"omission","question":"Who were the participants in the study?","answer":"The study looked at breast cancer patients who did not receive adjuvant post-operative tamoxifen (TAM) for various reasons.","input_idx":[[12,138]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2882922,"edit_id":"2dc1cc293adfb6331b907ae1d46dd7cd","category":"omission","question":"What was the goal of this study?","answer":"The goal of this study was to evaluate the role of late Tamoxifen in breast cancer patients who did not receive adjuvant post-operative tamoxifen (TAM) for various reasons.","input_idx":[[140,212]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2882922,"edit_id":"0899bb6475e75073a5fa227af1a28fa5","category":"omission","question":"What were the characteristics of the patients in the study?","answer":"The patients in the study were similar in age, time from surgery, and cancer type, and about half of them were ER positive.","input_idx":[[975,1225]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2882922,"edit_id":"b434a3ad7e7a6792e4f3d39d9a9b992a","category":"concept","question":"Who were the participants in the study?","answer":"The study looked at breast cancer patients who had surgery more than 2 years before and did not receive adjuvant TAM. These patients were healthy enough to take Tamoxifen and did not have any signs of cancer spreading.","input_idx":[[223,492]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":2882922,"edit_id":"4e41aaac8d66fd15b61d867d13ab4b6d","category":"concept","question":"What were the outcomes that were tracked in the study?","answer":"The study tracked various outcomes including local and distant cancer recurrence, new breast cancers, other types of cancer, and death.","input_idx":[[493,675]],"output_idx":[[617,745]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2900076,"edit_id":"5931c1db45792b232626b7964c732362","category":"omission","question":"What is tranexamic acid and how does it work?","answer":"Tranexamic acid is a medication that slows down the body's natural process of clotting blood. It works by preventing the breakdown of clots, which can help to reduce blood loss.","input_idx":[[147,228]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2900076,"edit_id":"166b00d7d0765345b377fed848b00816","category":"omission","question":"What type of surgery was performed on the patients and what type of anesthesia was used?","answer":"The patients underwent a total knee arthroplasty (TKA) surgery, which is a knee replacement procedure. The anesthesia used was a combination of spinal and epidural anesthesia.","input_idx":[[230,325]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2900076,"edit_id":"7abbb04308d4564b32c3cc6694e25fe8","category":"omission","question":"How was the study designed and what was the dosage and timing of the medication given to the patients?","answer":"The study was designed as a double-blind, randomized controlled trial. The patients were randomly assigned to either receive a placebo or tranexamic acid. The tranexamic acid was given as an intravenous injection, 10 mg\/kg just before the tourniquet was inflated, and then 1 mg\/kg\/hour until the wound closed.","input_idx":[[327,523]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2900076,"edit_id":"b8c84e145cf0807b91d556f6b427f9a1","category":"concept","question":"What was the mean volume of drainage fluid in the placebo group and how did it compare to the tranexamic acid group?","answer":"The mean volume of drainage fluid in the placebo group was 270 ml and 620 ml for unilateral and bilateral TKR patients respectively. In contrast, the mean volume of drainage fluid in the tranexamic acid group was 160 ml and 286 ml respectively for unilateral and bilateral TKR patients.","input_idx":[[668,792]],"output_idx":[[817,908]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2900076,"edit_id":"f1bebb9e6bfef7d6cb59a047294dc73f","category":"concept","question":"By how much did tranexamic acid reduce total blood loss and blood transfusion requirements?","answer":"Tranexamic acid decreased total blood loss by nearly 54% in bilateral TKR and 40% in unilateral TKR. It also drastically reduced (more than 80%) blood transfusion requirements.","input_idx":[[1192,1328]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":2967098,"edit_id":"948abc9f8beda68a1ea8370d86f82ea0","category":"omission","question":"What was the purpose of this study?","answer":"The purpose of this study was to compare the efficacy of high and low oral doses of haloperidol in the treatment of acute and transient psychotic disorders.","input_idx":[[218,390]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2967098,"edit_id":"ca47bb98c7c1cf1a78830e39f222e5b7","category":"omission","question":"What were the patients diagnosed with? How were they selected for the study? How were they divided into the two groups?","answer":"The patients were diagnosed with acute and transient psychotic disorders. They were selected based on their experience of a brief bout of mental illness. They were divided into two groups randomly, with one group receiving a high dose (20 mg\/day) and the other receiving a low dose (5 mg\/day) of haloperidol.","input_idx":[[391,644]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2967098,"edit_id":"90de14e2bd53b0df979b1f1271025b1a","category":"omission","question":"What tools were used to assess the patients' progress and what were the specific time points of assessment?","answer":"The patients' progress was assessed using the Brief Psychiatric Rating Scale and the Haloperidol Side-effects Check List. The specific time points of assessment were day 7, 14, 21, 28, 35, and 42.","input_idx":[[645,775]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":2967098,"edit_id":"2551a2cbf998be1254e1ede0d1c6f973","category":"concept","question":"What was the rationale for this study?","answer":"The rationale for this study was to compare the efficacy of high and low oral doses of haloperidol in the treatment of acute and transient psychotic disorders.","input_idx":[[218,390]],"output_idx":[[146,283]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":2967098,"edit_id":"09037fd4dfb95cc111c96691271a5230","category":"concept","question":"What was the specific measure used to assess improvement and what does \"recovery\" mean?","answer":"The specific measure used to assess improvement was the Brief Psychiatric Rating Scale (BPRS) and \"recovery\" means that the patients showed significant improvement in their symptoms at every check-up.","input_idx":[[776,867]],"output_idx":[[732,830]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3118076,"edit_id":"eb362d7a1f752f274f9fb56504a44acf","category":"omission","question":"What specific measurements were taken to assess the soft tissue profile?","answer":"The study measured the modified plaque index (mPI), modified bleeding index (mBI), papillary index (PPI), marginal level of soft tissue (ML) and width of keratinized mucosa (WKM) to assess the soft tissue profile.","input_idx":[[724,879]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3118076,"edit_id":"0e8064f1cd548a498f559bce6a3b1d94","category":"concept","question":"What type of implants were used in the IL group and the DL group?","answer":"Single-piece implants were used for the IL group and two-piece implants were used for the DL group.","input_idx":[[591,690]],"output_idx":[[763,791]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3136370,"edit_id":"fa574b4c811fd7c67e7ff07a477c6e0a","category":"omission","question":"Why are controlled trials important to assess the effectiveness of CAM practices?","answer":"Controlled trials are important to assess the effectiveness of CAM practices because they help to determine whether a particular treatment is effective or not. They do this by comparing the outcomes of a group of people who receive a particular treatment with a group of people who receive a placebo or no treatment.","input_idx":[[82,178]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3136370,"edit_id":"5d30998028f0f28176048f94a1680926","category":"omission","question":"How was the study designed?","answer":"The study was designed as a randomized, double-blind, placebo-controlled, early phase trial. This means that participants were randomly assigned to either a group that received a soy shake or a group that received a placebo shake, and neither the participants nor the researchers knew which group each participant was in.","input_idx":[[180,261]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3136370,"edit_id":"82183194632bb30be2b0b5e514395754","category":"omission","question":"What were the specific outcome measures used in the study?","answer":"The specific outcome measures used in the study were scores of the Fibromyalgia Impact Questionnaire (FIQ) and the Center for Epidemiologic Studies Depression Scale (CES-D) at baseline and after 6 weeks of intervention. These measures were used to assess the impact of the intervention on the participants' fibromyalgia symptoms and depression levels.","input_idx":[[394,581]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3136370,"edit_id":"c18dcf568e4ed2d3bb1abf6087becc15","category":"concept","question":"How was the statistical analysis done in the study?","answer":"The statistical analysis used in the study was done with standard statistics and intent-to-treat analysis. The results showed that total FIQ scores decreased by 14% in the soy group (P =.02) and by 18% in the placebo group (P <.001). The difference in change in scores between the groups was not significant (P =.16). With the same analysis, CES-D scores decreased in the soy group by 16% (P =.004) and in the placebo group by 15% (P =.05). The change in scores was similar in the groups (P =.83).","input_idx":[[754,927]],"output_idx":[[501,574]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3136370,"edit_id":"f7dab5e150e4774ca7933faf40fbf947","category":"concept","question":"What was the main result of the statistical analysis?","answer":"The main result of the statistical analysis was that there was no benefit of soy compared with placebo. The results of statistical analysis using the separation test and intent-to-treat analysis revealed no benefit of soy compared with placebo.","input_idx":[[1196,1331]],"output_idx":[[501,574]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3137438,"edit_id":"1771230d6480858f88dc4c9fcc0c81c4","category":"omission","question":"How was the effectiveness of the seal evaluated?","answer":"The amount of microleakage was evaluated after one week and three months.","input_idx":[[704,792]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3137438,"edit_id":"7cb5413df6a732882e7ad00518c6e3cc","category":"concept","question":"What statistical method was used to analyze the results?","answer":"The data was analyzed using two-way ANOVA.","input_idx":[[793,850]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3172326,"edit_id":"7ac7de15d6d1b2a4bef396b0151ceaed","category":"omission","question":"How was the pain intensity measured in the study?","answer":"The pain intensity was measured using a 10-point visual analogue scale (VAS) at specific times after the surgery.","input_idx":[[684,841]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3172326,"edit_id":"b6a9804b4b99ebbe50eb741ee27bdd47","category":"omission","question":"How long did it take for patients in the ketamine group to request pain relief?","answer":"On average, it took 23.1 minutes for patients in the ketamine group to request pain relief, compared to 18.1 minutes for patients in the control group.","input_idx":[[1036,1177]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3172326,"edit_id":"3bc1db6b2e25f89e849c9854685e0350","category":"omission","question":"How many pethidine injections did patients in the ketamine group receive in the first 24 hours after surgery?","answer":"On average, patients in the ketamine group received 0.6 pethidine injections in the first 24 hours after surgery, compared to 2.0 pethidine injections for patients in the control group.","input_idx":[[1179,1333]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3172326,"edit_id":"552e19911aff6ecd9c6c96dfc77341ca","category":"concept","question":"How were the patients randomly assigned to the two groups?","answer":"The patients were randomly assigned to the two groups using a randomization method.","input_idx":[[445,490]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3172326,"edit_id":"bfd83c8db1771863ef63343be0eb07fd","category":"concept","question":"How were the ketamine and saltwater injections administered to the patients?","answer":"The ketamine and saltwater injections were administered to the patients through an IV (intravenous) drip.","input_idx":null,"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_input_localization","invalid_output_localization"]},{"PMCID":3172326,"edit_id":"7ac7de15d6d1b2a4bef396b0151ceaed","category":"concept","question":"How was the pain intensity measured in the study?","answer":"The pain intensity was measured using a 10-point visual analogue scale (VAS) at specific times after the surgery.","input_idx":[[684,841]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3214395,"edit_id":"9e7f6de9c9a21e7c8031c7553141ae71","category":"omission","question":"What is the Bispectral index (BIS)?","answer":"The Bispectral index (BIS) is a measure of the effects of anesthesia on brain activity. It is used to determine the depth of anesthesia.","input_idx":[[426,448]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3214395,"edit_id":"cbd9fa50705da1ceb90179400f84c5bd","category":"omission","question":"What is tracheal intubation?","answer":"Tracheal intubation is a medical procedure where a breathing tube is inserted through the windpipe (trachea) into the lungs to help a person breathe during surgery or other medical procedures.","input_idx":[[170,189]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3214395,"edit_id":"c4d0a7bfa35ab931c3fc2a1593394658","category":"concept","question":"How is the depth of anesthesia typically judged?","answer":"The depth of anesthesia is typically judged by observing changes in brain activity, such as the Bispectral index (BIS) used in this study.","input_idx":[[248,303]],"output_idx":[[238,290]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3214395,"edit_id":"d1d4fd2db79559cf31a0d8f7c18275a6","category":"concept","question":"What does \"appropriate level of anesthesia\" mean in this context?","answer":"In this context, \"appropriate level of anesthesia\" means the level of anesthesia that is safe and effective for tracheal intubation.","input_idx":[[1243,1339]],"output_idx":[[1042,1125]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3214395,"edit_id":"2eae46d8a9d06370507f30600a430b06","category":"concept","question":"What were the specific measures used to evaluate the success of tracheal intubation in this study?","answer":"The specific measures used to evaluate the success of tracheal intubation in this study were laryngoscopy duration, the occurrence of laryngospasm, bronchospasm, laryngoscopy failure, extremity movement and awakening time.","input_idx":[[1340,1519]],"output_idx":[[1127,1268]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3215316,"edit_id":"cb1443f329d7f24a36a572653a7b79d0","category":"omission","question":"How common is Thalassemia in India?","answer":"Thalassemia is the most common genetic disease in India, with around 10,000 babies born each year with severe Thalassemia.","input_idx":[[0,58]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3215316,"edit_id":"5e155e299d40e7c25fd3a874cd1e4260","category":"omission","question":"What specific conditions does Dhatri Avaleha treat?","answer":"Dhatri Avaleha is known to treat conditions like anemia, jaundice, and liver disease.","input_idx":[[318,396]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3215316,"edit_id":"fc8db8dd5d26c0e51062ca3da93e632e","category":"omission","question":"How were the children divided into the two groups?","answer":"The children were randomly divided into two groups.","input_idx":[[398,532]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3215316,"edit_id":"374837edc2d5359009809d28624412be","category":"omission","question":"What specific parameters were assessed during the study?","answer":"The children were monitored on subjective and objective parameters after 30 days and 60 days of treatment, and for two months after the treatment.","input_idx":[[537,657]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3215316,"edit_id":"813657392ed771676a7eb9ccf1bf7ac0","category":"concept","question":"Why was a randomized controlled trial conducted for this study?","answer":"The randomized controlled trial was conducted to test the effectiveness of Dhatri Avaleha in improving the quality of life of Thalassemia patients.","input_idx":[[234,312]],"output_idx":[[214,262]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3215316,"edit_id":"842793b056533c674766f19ff21c591e","category":"concept","question":"What are the potential benefits of using Dhatri Avaleha as a supportive therapy for Thalassemia?","answer":"The potential benefits of using Dhatri Avaleha as a supportive therapy for Thalassemia are to increase blood transfusion interval and decrease secondary infection.","input_idx":[[785,970]],"output_idx":[[924,1161]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3232074,"edit_id":"64acc253d996f73e5873a0973f1aa07e","category":"omission","question":"What is diabetic neuropathy?","answer":"Diabetic neuropathy is a complication of diabetes that affects the nerves in the body, leading to various symptoms such as pain, numbness, and tingling.","input_idx":[[41,184]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3232074,"edit_id":"3524760e0e0a758a9428a300fe248568","category":"omission","question":"What was the purpose of the study?","answer":"The purpose of the study was to evaluate the effectiveness of Semelil (ANGIPARSTM) in treating diabetic foot ulcers and peripheral neuropathy.","input_idx":[[185,351]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3232074,"edit_id":"753ccca6a9b738529255f16eae1db2a4","category":"concept","question":"What was the nature of the study?","answer":"The study was a double-blind clinical trial, where 49 people with type 2 diabetes and varying degrees of foot ulcers were divided into two groups, one group received the new medicine and the other received a placebo.","input_idx":[[362,525]],"output_idx":[[314,423]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3232074,"edit_id":"ea5888dc4f87e82c3ee9a6f196340129","category":"concept","question":"What tests were conducted before and after the study?","answer":"The patients underwent a series of tests before and after the study, including laboratory tests, United Kingdom screening test, Michigan neuropathy screening score, Michigan diabetic neuropathy score, vibration perception thresholds, nerve conduction study, monofilament test and visual analog scale. The study lasted for 12 weeks.","input_idx":[[526,822]],"output_idx":[[536,646]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3233513,"edit_id":"d16152e292b8455e04f28603c27c2372","category":"omission","question":"What is the disease that the study was conducted on?","answer":"The study was conducted on patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD), a lung disease that makes it hard for a person to breathe.","input_idx":[[0,133]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3233513,"edit_id":"f2b2fadf68676b3f7dd46b181a4da0bc","category":"omission","question":"How was the study designed?","answer":"The study was a double-blind, placebo-controlled, parallel-group, multinational phase III study. Patients were randomized to receive either formoterol 4.5 or 9 \u03bcg twice daily via Turbuhaler\u00ae or placebo for 12 weeks. They were also allowed to use Salbutamol for relief if needed.","input_idx":[[134,394]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3233513,"edit_id":"29c6118c7fa5c3ad8ecd1e8091cbc7e8","category":"omission","question":"What was the primary outcome measure used in the study?","answer":"The primary outcome measure used in the study was change (ratio) from baseline to treatment period in FEV1 60-min post-dose. FEV1 is a measure of lung function and the ratio from baseline to treatment period indicates the improvement in lung function after taking the drug.","input_idx":[[470,577]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3233513,"edit_id":"57f459de3ad29482204c38d17a4ca4bf","category":"concept","question":"What type of asthma drug was used in the study?","answer":"The type of asthma drug used in the study was Salbutamol.","input_idx":[[395,469]],"output_idx":[[419,502]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3233513,"edit_id":"dc5b7d8318bc809fa4db9d394a56f947","category":"concept","question":"What specific measure of lung function was used in the study?","answer":"The specific measure of lung function used in the study was FEV1, which is a measure of lung function and the ratio from baseline to treatment period indicates the improvement in lung function after taking the drug.","input_idx":[[470,577]],"output_idx":[[503,588]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3269796,"edit_id":"04049e3b4f0c49f4eeb659a306415e8c","category":"omission","question":"What was the purpose of this research?","answer":"The purpose of this research was to compare a newly developed bone marrow device with the regular bone marrow needle.","input_idx":[[0,194]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3269796,"edit_id":"cdd5f07a743cc657766e4948bcc0d4e9","category":"omission","question":"How does the OnControl device work?","answer":"The OnControl device is a bone marrow biopsy system that uses a battery-powered drill to insert its needle.","input_idx":[[195,312]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3269796,"edit_id":"36ceef7add76a5a25950b6229ff12448","category":"omission","question":"How many bone marrow tests were performed in the study?","answer":"The research carried out 54 bone marrow tests, half done with the standard needle and half done with the new OnControl device.","input_idx":[[313,486]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3269796,"edit_id":"52992dc9618561574403d367e3d75d22","category":"omission","question":"What was the primary endpoint of the study?","answer":"The primary endpoint of the study was the mean length of the marrow biopsy specimens, which was determined by a pathologist in a blinded manner.","input_idx":[[487,654]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3269796,"edit_id":"cdd5f07a743cc657766e4948bcc0d4e9","category":"concept","question":"How does the OnControl device work?","answer":"The OnControl device is a bone marrow biopsy system that uses a battery-powered drill to insert its needle.","input_idx":[[195,312]],"output_idx":[[311,376]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3269796,"edit_id":"71285230243453d3e187ef48630fda5c","category":"concept","question":"What was the statistical significance of the difference in mean length between the two groups?","answer":"The mean length of the marrow biopsy specimens was significantly longer (56%) for the OBM group (15.3 mm) than for the standard bone marrow (SBM) group (9.8 mm), P<0.003.","input_idx":[[655,825]],"output_idx":[[631,762]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3269796,"edit_id":"190976ae0ea00608a7e7b711a90af09c","category":"concept","question":"What was the statistical significance of the difference in procedure time between the two groups?","answer":"The OnControl device completed its tests significantly faster than the regular needle did.","input_idx":null,"output_idx":[[821,911]],"annotator":"mistral-7b","prediction_errors":["invalid_input_localization"]},{"PMCID":3269796,"edit_id":"464a3dc1f0db267f183b9cd94912c8f1","category":"concept","question":"What were the specific subjective secondary endpoints that favored the OBM group?","answer":"Several subjective secondary endpoints also favored the OBM group.","input_idx":[[981,1047]],"output_idx":[[912,961]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3357231,"edit_id":"769f90ea3edb03b1d0411ab43a6579e9","category":"omission","question":"Besides HbA1c, what other parameters were measured in the study?","answer":"The study also measured triglyceride levels.","input_idx":[[702,727]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3357231,"edit_id":"c6431181d7a8f79c36aedc40ad22da46","category":"concept","question":"How were the participants randomized in the study?","answer":"The participants were randomly assigned to receive either isomaltulose or sucrose in their sweet foods and beverages.","input_idx":[[200,409]],"output_idx":[[201,338]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3357231,"edit_id":"f4de0914226cdc6367076aff8fa3ec3a","category":"concept","question":"What was the main goal of the study?","answer":"The main goal of the study was to test the hypothesis that replacement of sucrose with isomaltulose in sweet foods and beverages improves metabolic control in patients with type 2 diabetes. The primary outcome parameter was HbA1c levels at 12 weeks.","input_idx":[[410,462]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3425422,"edit_id":"396cadf6747021552fcf999257183f8c","category":"omission","question":"What is the relationship between postprandial hyperglycemia and platelet activation?","answer":"Postprandial hyperglycemia is associated with platelet activation.","input_idx":[[0,65]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3425422,"edit_id":"45b6f4a9685a37d20ac49804cee79a3d","category":"omission","question":"How was the study designed and what were the specific doses of insulin used?","answer":"The study was a randomized, double-blind, cross-over study where the order of insulin and placebo treatments were randomly assigned and then swapped. The specific doses of insulin used were 0.1 and 0.2 units\/kg.","input_idx":[[161,392]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3425422,"edit_id":"4b8b59e2bd01eba0683d6e3e0184e0fd","category":"omission","question":"What technology was used to measure platelet activation?","answer":"The process used a technology called flow cytometry to measure platelet activation.","input_idx":[[394,514]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3425422,"edit_id":"14d2be5527793f1bf5d1f9660cd72926","category":"concept","question":"How did pre-meal insulin affect postmeal insulin levels?","answer":"Pre-meal insulin infusion was also associated with platelet activation.","input_idx":[[754,848]],"output_idx":[[989,1068]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3425422,"edit_id":"692b5c09d95705c409aaf904559d5246","category":"concept","question":"How did postprandial insulin levels and glucose levels affect postprandial platelet activation?","answer":"Postprandial platelet activation correlated positively to postprandial insulin levels and inversely to glucose levels.","input_idx":[[1149,1266]],"output_idx":[[844,978]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3441250,"edit_id":"9254410e4d4a4e7453458a71c197585d","category":"omission","question":"Why was this study conducted?","answer":"The study was conducted to determine if administration of equivolumes of a colloid (hydroxyethyl starch 130\/0.4) reduced post operative nausea and vomiting in healthy volunteers undergoing ambulatory gynecologic laparoscopy surgery compared to a crystalloid solution (Hartmann's Solution).","input_idx":[[12,150]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3441250,"edit_id":"c5a91a5d11e167fb541c705887425543","category":"omission","question":"How was the volume of fluid administered to the patients determined?","answer":"The volume of fluid administered was calculated based on the patient's weight and how many hours they had gone without food.","input_idx":[[648,731]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3441250,"edit_id":"b78eb25f01d1b7ad4c33e49f88165fa6","category":"omission","question":"What specific measures were used to assess the patients' symptoms?","answer":"Patients were interviewed to assess their symptoms of nausea, vomiting, anti-emetic use, dizziness, sore throat, headache and general well-being at 30 minutes and 2, 24 and 48 hours post-surgery.","input_idx":[[732,924]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3441250,"edit_id":"660cb3fbf63a53eaba53a82988e42723","category":"concept","question":"How many patients experienced vomiting or used anti-emetic medication in both groups?","answer":"The incidence of vomiting and anti-emetic usage was low in both groups, but the exact number of patients who experienced vomiting or used anti-emetic medication is not provided.","input_idx":[[1215,1309]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3441250,"edit_id":"5ff424dc88b6d7b4f1450f8cca90cd1c","category":"concept","question":"Were there any differences in the incidence of sore throat, dizziness, headache or general well-being between the two groups?","answer":"Sore throat, dizziness, headache and general well-being were not different between the two groups, meaning that the incidence of these symptoms was the same in both groups.","input_idx":[[1310,1404]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3482439,"edit_id":"343e37d08b9503160987b478ba3d61c3","category":"omission","question":"How long did the researchers follow up with the patients after the surgery?","answer":"The researchers followed up with the patients for an average of 36 months, ranging from 24 to 56 months.","input_idx":[[808,855]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3482439,"edit_id":"2e3de99396c0ec453ccb184b7aae836d","category":"omission","question":"What were the results of the study in terms of functional recovery, reoperation, and mortality rates?","answer":"There was no statistically significant difference in the functional recovery score, reoperation, and mortality rates between the two groups.","input_idx":[[1017,1154]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3482439,"edit_id":"507bf98b2bfd59b2c77a93ec928e3040","category":"concept","question":"Why was surgery faster for group B?","answer":"The difference in surgical time was due to the fact that the cephalomedullary nails required more time to insert and secure, but the sliding hip screws were easier to insert and secure. The difference in fluoroscopy time was due to the fact that the cephalomedullary nails required more x-ray imaging to ensure proper placement and fixation.","input_idx":[[857,963]],"output_idx":[[671,733]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3482439,"edit_id":"36596db1820d75de6f739c7a68b1c07b","category":"concept","question":"What is the Z-effect phenomenon?","answer":"The Z-effect phenomenon is a complication that can occur when using cephalomedullary nails to fix a broken thigh bone. It is caused by the nail bending and breaking in a specific way, which can lead to a loss of fixation and a need for additional surgery.","input_idx":[[1156,1265]],"output_idx":[[871,972]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3483284,"edit_id":"7007dd8d02375184d7334a0e3e66fc4f","category":"omission","question":"What was the purpose of the study?","answer":"The study aimed to determine if supplemental ATP would improve muscle torque, power, work, or fatigue during repeated bouts of high intensity resistance exercise.","input_idx":[[697,713]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3483284,"edit_id":"93ff08b9effeb5cdbdf5aa449c09ad4f","category":"omission","question":"How much ATP supplementation did the participants receive?","answer":"The participants received 400 mg of ATP supplementation, divided into two daily doses.","input_idx":[[1037,1072]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3483284,"edit_id":"7844ecb0e627017cc246a70256224da1","category":"concept","question":"Was the ATP in the supplements naturally occurring or synthetically produced?","answer":"The ATP in the supplements was synthetically produced.","input_idx":[[697,713]],"output_idx":[[853,868]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3483284,"edit_id":"49b337fa201057f5fae44f842730b721","category":"concept","question":"What was the design of the study?","answer":"The study was a double-blinded, placebo-controlled study using a crossover design. This means that the participants were randomly assigned to either receive the ATP supplements or a placebo, and the study was repeated with the participants switching roles in the second phase.","input_idx":[[919,984]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3511949,"edit_id":"513046d59c63115904d60fe75db9763a","category":"omission","question":"What was the age range of the participants in the study?","answer":"The participants were between 50 and 80 years old.","input_idx":[[336,410]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3511949,"edit_id":"be4d2e2c7d3d1037250c8c6749daf3bd","category":"omission","question":"What was the other component of the injections in Groups M and T?","answer":"The other component of the injections in Groups M and T was bupivacaine.","input_idx":[[411,603]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3511949,"edit_id":"5d0f50d5b342c8839ee11233fad3724f","category":"omission","question":"When were the patients evaluated during the study?","answer":"The patients were evaluated before the injection and at 2, 4, 6, and 12 weeks after the injection.","input_idx":[[604,698]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3511949,"edit_id":"7136b6b458bf23d35adb6fc02abf1e0c","category":"omission","question":"What was the first-line supplementary analgesic in the study?","answer":"The first-line supplementary analgesic in the study was oral paracetamol 1500 mg\/day.","input_idx":[[699,767]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3511949,"edit_id":"513bd12c3baa07964208126d24f040e2","category":"omission","question":"What was the second-line supplementary analgesic in the study?","answer":"If analgesia was insufficient with paracetamol, oral dexketoprofen trometamol 50 mg\/day was recommended to patients.","input_idx":[[768,884]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3511949,"edit_id":"5d0f50d5b342c8839ee11233fad3724f","category":"concept","question":"When were the patients evaluated during the study?","answer":"The patients were evaluated before the injection and at 2, 4, 6, and 12 weeks after the injection.","input_idx":[[604,698]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3511949,"edit_id":"684aea519794c61cb8471aeed0a78f39","category":"concept","question":"How were the participants divided into the three groups?","answer":"The participants were randomly divided into three groups.","input_idx":[[372,410]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3511949,"edit_id":"be4d2e2c7d3d1037250c8c6749daf3bd","category":"concept","question":"What was the other component of the injections in Groups M and T?","answer":"The other component of the injections in Groups M and T was bupivacaine.","input_idx":[[411,603]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3511949,"edit_id":"5d0f50d5b342c8839ee11233fad3724f","category":"concept","question":"When were the patients evaluated during the study?","answer":"The patients were evaluated before the injection and at 2, 4, 6, and 12 weeks after the injection.","input_idx":[[604,698]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3511949,"edit_id":"684aea519794c61cb8471aeed0a78f39","category":"concept","question":"How were the participants divided into the three groups?","answer":"The participants were randomly divided into three groups.","input_idx":[[372,410]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3511949,"edit_id":"be4d2e2c7d3d1037250c8c6749daf3bd","category":"concept","question":"What was the other component of the injections in Groups M and T?","answer":"The other component of the injections in Groups M and T was bupivacaine.","input_idx":[[411,603]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3511949,"edit_id":"5d0f50d5b342c8839ee11233fad3724f","category":"concept","question":"When were the patients evaluated during the study?","answer":"The patients were evaluated before the injection and at 2, 4, 6, and 12 weeks after the injection.","input_idx":[[604,698]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3511949,"edit_id":"684aea519794c61cb8471aeed0a78f39","category":"concept","question":"How were the participants divided into the three groups?","answer":"The participants were randomly divided into three groups.","input_idx":[[372,410]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3511949,"edit_id":"be4d2e2c7d3d1037250c8c6749daf3bd","category":"concept","question":"What was the other component of the injections in Groups M and T?","answer":"The other component of the injections in Groups M and T was bupivacaine.","input_idx":[[411,603]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3511949,"edit_id":"5d0f50d5b342c8839ee11233fad3724f","category":"concept","question":"When were the patients evaluated during the study?","answer":"The patients were evaluated before the injection and at 2, 4, 6, and 12 weeks after the injection.","input_idx":[[604,698]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3511949,"edit_id":"684aea519794c61cb8471aeed0a78f39","category":"concept","question":"How were the participants divided into the three groups?","answer":"The participants were randomly divided into three groups.","input_idx":[[372,410]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3511949,"edit_id":"be4d2e2c7d3d1037250c8c6749daf3bd","category":"concept","question":"What was the other component of the injections in Groups M and T?","answer":"The other component of the injections in Groups M and T was bupivacaine.","input_idx":[[411,603]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3515338,"edit_id":"8d21b5c7932f5c5c3ec3c0647f8031e7","category":"omission","question":"How common are mental health problems and what impact do they have on disability and healthcare costs?","answer":"Mental health problems are quite common and can lead to increased disability and healthcare costs.","input_idx":[[12,112]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3515338,"edit_id":"294e4e1a80533d47c7170a1e47fc5f99","category":"omission","question":"What type of evaluation was performed in the study?","answer":"An economic evaluation from a societal perspective was performed alongside a randomized clinical trial.","input_idx":[[435,537]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3515338,"edit_id":"0ab5eaba106a91048bef93ef0df62706","category":"concept","question":"What were the specific criteria for eligibility in the study?","answer":"Patients were eligible if they had a positive General Health Questionnaire score (score \u2265 4) and visited their general practitioner at least three times during the past 6 months.","input_idx":[[539,713]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3515338,"edit_id":"e02bb6ab18556dd9b9b51ce22c4bf36b","category":"concept","question":"What specific outcome measures were used in the study?","answer":"The study measured the improvement in mental health and quality of life using the Hospital Anxiety and Depression Scale and QALYs based on the EQ-5D.","input_idx":[[715,822]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3564932,"edit_id":"8d29395e01a93feb7b0df577bf4804bb","category":"omission","question":"What are the potential benefits of outpatient IOL?","answer":"Outpatient IOL can potentially reduce the impact on both the individual woman and health service delivery.","input_idx":[[169,231]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3564932,"edit_id":"0002d92d05a21c78256d53e3add1edfe","category":"omission","question":"What are the potential safety concerns of using prostaglandins in the outpatient setting?","answer":"The potential safety concern of using prostaglandins in the outpatient setting is hyperstimulation.","input_idx":[[314,452]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3564932,"edit_id":"9245c5120c2df08ce0363422f0734dd2","category":"omission","question":"What was the purpose of this study?","answer":"The purpose of this study was to assess the feasibility, clinical effectiveness, and patient acceptability of outpatient Foley catheter (OPC) vs. inpatient vaginal PGE2 (IP) for induction of labour (IOL) at term.","input_idx":[[454,661]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3564932,"edit_id":"9c261fddb751424e6f32feef40b83907","category":"concept","question":"What was the condition of the cervix that required IOL?","answer":"The condition of the cervix that required IOL was unfavourable.","input_idx":[[672,737]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3564932,"edit_id":"cd77e0f6a6edb6364416a3a251a1d188","category":"concept","question":"What was done to the women in the outpatient group?","answer":"The women in the outpatient group received a Foley catheter and were sent home after a reassuring cardiotocograph.","input_idx":[[859,966]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3564932,"edit_id":"d2eb042925df8dbb92f3acacd35863e3","category":"concept","question":"What medication did the women in the inpatient group receive?","answer":"The women in the inpatient group received vaginal PGE2.","input_idx":[[967,1051]],"output_idx":[[1042,1083]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3570228,"edit_id":"cfac5f11fdcf3a000b676de0b37dc2d5","category":"omission","question":"What was the specific metric used to measure hemodynamic fluctuations?","answer":"The specific metric used to measure hemodynamic fluctuations was not mentioned in the simplification.","input_idx":[[1044,1104]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3570228,"edit_id":"8108b1466c80bf3e52fb056f1ffe6fe3","category":"omission","question":"What was the specific metric used to measure postoperative eye-opening and extubation time?","answer":"The specific metric used to measure postoperative eye-opening and extubation time was not mentioned in the simplification.","input_idx":[[1106,1151]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3570228,"edit_id":"be54f7ef5a277c0c3988b54e9d326607","category":"omission","question":"What was the specific metric used to measure post-extubation restlessness and pain scores?","answer":"The specific metric used to measure post-extubation restlessness and pain scores was not mentioned in the simplification.","input_idx":[[1157,1201]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3570228,"edit_id":"605031d144f19542f50e9df605951a2e","category":"concept","question":"What is target-controlled infusion (TCI)?","answer":"Target-controlled infusion (TCI) is a method of administering drugs during surgery, where the drug levels in the body are monitored and adjusted to a specific target concentration.","input_idx":[[104,136]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3570228,"edit_id":"54b310d6fa82cc92c8f18832d93b98c0","category":"concept","question":"What are the specific hormones that were measured and how are they related to stress?","answer":"The specific hormones that were measured are norepinephrine (NE), epinephrine (E) and angiotensin II (Ang II). These hormones are released during stress and play a role in regulating blood flow and blood pressure.","input_idx":[[847,928]],"output_idx":[[808,829]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3570228,"edit_id":"08525b62306b059f5f7fa741fbeba1d0","category":"concept","question":"How does the drug combination stabilize blood flow and reduce stress hormones?","answer":"The drug combination stabilizes blood flow by controlling the levels of norepinephrine (NE), epinephrine (E) and angiotensin II (Ang II) in the body. It reduces stress hormone levels by blocking the action of these hormones.","input_idx":[[1544,1664]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3575357,"edit_id":"30bbc0100551d8719c60b7c2a89c88d1","category":"omission","question":"What specific health questionnaires were used to measure the effectiveness of the intervention?","answer":"The Short Form 12 health survey questionnaire was used to measure the general state of health and the EuroQoL-5D questionnaire was used to determine the quality of life.","input_idx":[[572,770]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3575357,"edit_id":"16381b83f79a6af1c89d8e61afc367c1","category":"omission","question":"What specific tests were used to measure cardiopulmonary function?","answer":"Spirometry and a walking test according to the Bruce protocol were used to measure cardiopulmonary function.","input_idx":[[771,878]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3575357,"edit_id":"0b7b91d407aacbc1b47af88ff4731e3c","category":"concept","question":"How statistically significant was the improvement in quality of life in men?","answer":"The improvement in quality of life in men was statistically significant at a p-value of 0.05.","input_idx":[[889,989]],"output_idx":[[608,671]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3575357,"edit_id":"300c170ef464597c8e7d719b4be07cc0","category":"concept","question":"What specific changes in lung and cardiovascular function were measured and what was the significance of those changes?","answer":"The average changes in lung and cardiovascular function were not significant between groups. The specific changes that were measured were not mentioned in the simplification.","input_idx":[[1045,1140]],"output_idx":[[672,750]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3580299,"edit_id":"d94c8d46b8f0e55c18e5df47ec1af490","category":"omission","question":"What was the effect of alfuzosin on the overall success rate of removing kidney stones?","answer":"The use of alfuzosin in combination with ESWL did not affect the overall success rate of removing kidney stones.","input_idx":[[1364,1526]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3580299,"edit_id":"a5f3707c89333403957a600887acbe0f","category":"concept","question":"How was the trial designed and conducted?","answer":"The trial was a controlled, single-blind medical trial, meaning that the participants were randomly assigned to one of two groups and were not aware of which group they were in. The trial was conducted by one physician between June 2010 and August 2011.","input_idx":[[190,311]],"output_idx":[[196,274]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3580299,"edit_id":"813f5e4717de7f3fd1c12ffbc7d09a74","category":"concept","question":"What was the statistical significance of the results?","answer":"The results were not statistically significant, as indicated by the p-value of 0.96.","input_idx":[[758,879]],"output_idx":[[712,864]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3608893,"edit_id":"9aba29841e2684f8eac876a032c6f8e0","category":"omission","question":"What type of diet was used in the study?","answer":"The diet used in the study was a commercially available, portion-controlled diet.","input_idx":[[47,102]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3608893,"edit_id":"82ea392d4e5f1308a592a203f3307392","category":"omission","question":"What type of program was the intervention?","answer":"The intervention was a nine-session program.","input_idx":[[354,394]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3608893,"edit_id":"08f6940c53bf8fc56aa855b082266e6c","category":"omission","question":"What were the specific goals for energy intake and physical activity?","answer":"Participants in both groups were prescribed the same goals for energy intake (1250-1550 kcal per day) and physical activity (200 minutes per week).","input_idx":[[493,638]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3608893,"edit_id":"c9261c44403fed31d3e441d30605f7fc","category":"concept","question":"What does \"commercially available\" mean in this context?","answer":"\"Commercially available\" means that the diet is something that can be bought or purchased from a store or other commercial source.","input_idx":[[47,102]],"output_idx":[[1274,1312]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3608893,"edit_id":"5eee005f8202957584393ac123cc9f78","category":"concept","question":"What does \"group lifestyle intervention\" mean in this context?","answer":"\"Group lifestyle intervention\" means a program that is designed to help people make changes to their lifestyle, such as their diet and physical activity, in a group setting.","input_idx":[[354,394]],"output_idx":[[500,522]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3608893,"edit_id":"08f6940c53bf8fc56aa855b082266e6c","category":"concept","question":"What were the specific goals for energy intake and physical activity?","answer":"Participants in both groups were prescribed the same goals for energy intake (1250-1550 kcal per day) and physical activity (200 minutes per week).","input_idx":[[493,638]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["missing_output_localization"]},{"PMCID":3620559,"edit_id":"872bafd5a52140ae2a69f8d485060e64","category":"omission","question":"What was the main conclusion of the study?","answer":"The main conclusion of the study was that the size of the needle used to collect a woman's eggs during in vitro fertilization (IVF) does not affect the number of eggs that can be obtained.","input_idx":[[1196,1240]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3620559,"edit_id":"2ae362e0710047d5ead24099b83aa40f","category":"omission","question":"How did the use of thinner needles affect the duration of the procedure?","answer":"The use of thinner needles made the procedure take about 3.3 minutes longer per ovary.","input_idx":[[1316,1378]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3620559,"edit_id":"090345143f6f28f3f14174677fb49cec","category":"concept","question":"What was the purpose of this study?","answer":"The purpose of this study was to determine whether the size of the needle used to collect a woman's eggs during in vitro fertilization (IVF) affects the number of eggs that can be obtained.","input_idx":[[208,293]],"output_idx":[[174,205]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3620559,"edit_id":"2b6eb42cc70830545bcb0cd2143af612","category":"concept","question":"What was the ovarian reserve of the participants in the study?","answer":"The ovarian reserve of the participants was not specified in the simplification.","input_idx":[[921,1054]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["missing_output_localization"]},{"PMCID":3628658,"edit_id":"61ed5ca2ab1afa30b85282a2b48bdcf8","category":"omission","question":"How many patients were included in the study?","answer":"There were 120 patients included in the study.","input_idx":[[246,271]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3628658,"edit_id":"d0f84faf256e5da8a314f4ec6cbc374b","category":"omission","question":"Which specific measures were compared between the two groups?","answer":"The specific measures that were compared between the two groups were hospital stay, surgery time, blood loss, surgical cut size, X-ray use, and out-of-bed time.","input_idx":[[360,600]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3628658,"edit_id":"4cba60b698e7853f922fca9edfa723c9","category":"omission","question":"What was the specific measure of union time and Harris values?","answer":"The specific measure of union time and Harris values was not mentioned in the simplification, but it was mentioned in the original text that there was no statistical significance on union time and Harris values in the two position groups.","input_idx":[[601,699]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3628658,"edit_id":"d0f84faf256e5da8a314f4ec6cbc374b","category":"concept","question":"Which specific measures were compared between the two groups?","answer":"The specific measures that were compared between the two groups were hospital stay, surgery time, blood loss, surgical cut size, X-ray use, and out-of-bed time.","input_idx":[[360,600]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3628658,"edit_id":"4cba60b698e7853f922fca9edfa723c9","category":"concept","question":"What was the specific measure of union time and Harris values?","answer":"The specific measure of union time and Harris values was not mentioned in the simplification, but it was mentioned in the original text that there was no statistical significance on union time and Harris values in the two position groups.","input_idx":[[601,699]],"output_idx":[[836,978]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3628658,"edit_id":"5e40728bc2dc662a863e7c00d8904660","category":"concept","question":"What specific type of complications were observed in each group?","answer":"The specific type of complications that were observed in each group were superficial wound infections in the lateral decubitus position group and deep venous thrombosis and wound deep infection in the supine position group.","input_idx":[[710,928]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3630066,"edit_id":"45fa53b13dbd6ea14eeefaa94f61fe9b","category":"omission","question":"What kind of pain was studied in the animal models?","answer":"The study used animal models to investigate the effects of nasal insufflation of CO2 on pain caused by activation of TRPV1-receptor positive nociceptive neurons.","input_idx":[[12,225]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3630066,"edit_id":"ef165e61fcda128f4eb7c49d4b830200","category":"omission","question":"What kind of pain was studied in the clinical setting?","answer":"The study looked at the effects of nasal insufflation of CO2 on craniofacial pain caused by activation of TRPV1 receptor positive trigeminal neurons.","input_idx":[[226,399]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3630066,"edit_id":"b1e78627615188a175eaf0365ee5f9fb","category":"omission","question":"What was the human model used in the study?","answer":"The study used a human model of craniofacial pain elicited by nasal application of capsaicin.","input_idx":[[593,739]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3630066,"edit_id":"698a434d6145f1ae3e56373a4b98bbec","category":"concept","question":"What was the purpose of the first experiment?","answer":"The first experiment aimed to examine the effects of intranasal CO2 on a human model of craniofacial pain elicited by nasal application of capsaicin, which activates TRVP1 positive nociceptive neurons.","input_idx":[[753,948]],"output_idx":[[504,659]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3630066,"edit_id":"8ded3047056fb7bf59a1f84c15d58fab","category":"concept","question":"How was the CO2 or air insufflated in the experiment?","answer":"In the experiment, CO2 or air was insufflated into the nasal cavity at a flow rate of 1 l\/min for 60 seconds each.","input_idx":[[949,1060]],"output_idx":[[665,751]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3630066,"edit_id":"f4ab4b7eedfa162782b0f1608ee02072","category":"concept","question":"How were the participants divided into the two groups?","answer":"In the second experiment, participants were randomly divided into two groups of 24 each and received either continuous nasal insufflation of CO2 or placebo for 18:40 minutes after nociceptive stimulation with intranasal capsaicin.","input_idx":[[1061,1287]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3656551,"edit_id":"a24cf10a253e009e483bbcdbbdcafcf4","category":"omission","question":"Why is it important to improve influenza vaccine strategies for infants and preschool children?","answer":"Improving influenza vaccine strategies for infants and preschool children is important because they are at a higher risk of severe complications from the flu and are more vulnerable to the virus.","input_idx":[[12,105]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3656551,"edit_id":"bdb0d60d8a3df652b2c542977ff17cdd","category":"omission","question":"How was the study designed and conducted?","answer":"The study was designed and conducted carefully, with the researcher not knowing who received what amount of the vaccine, and it was conducted at multiple centers. The children were divided into two age groups (6-23 months and 24-35 months) and their prior influenza immunization status was taken into account.","input_idx":[[301,467]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3656551,"edit_id":"8c8c0a518010cfc204d712349b837e07","category":"concept","question":"What were the specific criteria that were met for immunogenicity in adults?","answer":"The vaccine met the regulatory criteria for immunogenicity in adults, which means it was able to boost the immune system effectively.","input_idx":[[640,772]],"output_idx":[[610,655]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3656551,"edit_id":"7f763bc18b88565409866c35e066654f","category":"concept","question":"What is reactogenicity and safety, and how were they measured in this study?","answer":"Reactogenicity refers to the side effects of the vaccine, such as fever or soreness at the injection site. Safety refers to the overall safety of the vaccine. In this study, the reactogenicity and safety of both doses were not significantly different, meaning that the larger dose did not cause more side effects or have a higher risk of adverse events.","input_idx":[[773,960]],"output_idx":[[987,1040]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3658388,"edit_id":"d201f846defc8760236bca36fcafd597","category":"omission","question":"What previous studies have been done on LLLT and hearing loss\/tinnitus?","answer":"Previous studies have looked at the effects of LLLT on hearing loss and tinnitus, but the results have been mixed or inconclusive.","input_idx":[[92,199]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3658388,"edit_id":"d927887eacb2e92d457ec9915ffb7927","category":"omission","question":"How was LLLT applied to the treatment group?","answer":"LLLT was applied to the treatment group by shining low-level lasers onto their outer ear, head, and neck.","input_idx":[[472,587]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3658388,"edit_id":"67fc952e87b56c64cf71e9a6a7cad862","category":"omission","question":"How often and for how long were the laser treatments given?","answer":"The laser treatments were given three times in a week, each lasting approximately five minutes.","input_idx":[[644,704]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3658388,"edit_id":"2dee69959bf4e0a2cbd14c18891514c9","category":"concept","question":"What specific outcomes did the study aim to measure?","answer":"The study aimed to measure hearing, understanding of speech, and general ear function in adults with hearing loss.","input_idx":[[200,344]],"output_idx":[[250,408]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3658388,"edit_id":"43c012dc0ff9f92211ad5e9ae9e27235","category":"concept","question":"What specific tests were administered to the participants?","answer":"A battery of auditory tests was administered, including pure-tone audiometry, the Connected Speech Test, and transient-evoked otoacoustic emissions.","input_idx":[[705,831]],"output_idx":[[779,891]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3659039,"edit_id":"2a91b82672a97dcbe8f7c18d98fee29f","category":"omission","question":"What happens to the levels of omega-6 PUFAs when we take omega-3 PUFAs?","answer":"When we take omega-3 PUFAs, the levels of omega-6 PUFAs, such as arachidonic acid and linoleic acid, often decrease.","input_idx":[[152,321]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3659039,"edit_id":"888fc7dca28ddc50d78cee0776cbdb08","category":"omission","question":"How do omega-3 PUFAs change the production of lipid mediators?","answer":"Omega-3 PUFAs change the pattern of lipid mediator production, resulting in a less pro-inflammatory response.","input_idx":[[322,424]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3659039,"edit_id":"3d8c7e279a6b4c29ff5d586acbdb0b9a","category":"concept","question":"How long was the treatment of omega-3 PUFAs given to the patients?","answer":"The patients received a 3-day intravenous treatment of omega-3 PUFAs.","input_idx":[[449,495]],"output_idx":[[274,332]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3659039,"edit_id":"082df1b5899bdafec0b91e362ad051a8","category":"concept","question":"Which specific components of the blood were measured in the study?","answer":"The study measured the levels of EPA and linoleic acid in plasma phosphatidylcholine (PC) and erythrocytes.","input_idx":[[1210,1257]],"output_idx":[[696,728]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3671234,"edit_id":"7c3395a928e673fa189a62f20dfe66f6","category":"omission","question":"Besides the local anesthetic, what other drugs were tried to prolong the duration of analgesia?","answer":"Several drugs were tried along with the local anesthetic to prolong the duration of analgesia.","input_idx":[[158,260]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3671234,"edit_id":"0ead8bfd675effd1e9ba0788b012fd50","category":"omission","question":"How was the study designed?","answer":"The study was designed as a prospective, randomized, double-blinded, and parallel group and open label study of 90 adult patients aged 18\u201360 years, of American Society of Anaesthesiologists (ASA) status I and II, scheduled for elective infraumbilical surgery, who were randomly allocated in two groups.","input_idx":[[380,658]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3671234,"edit_id":"1597d2a080504bc2d8b6adf4202ffae3","category":"concept","question":"What survey was used to measure participants' quality of life?","answer":"The Short Inflammatory Bowel Disease Questionnaire (SIBDQ) was used which gives insights about the physical, social, and emotional status of patients with bowel diseases.","input_idx":null,"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_input_localization","invalid_output_localization"]},{"PMCID":3681405,"edit_id":"aba438e24b11acc7f195e2ec685b46b0","category":"omission","question":"What were the specific measures used to evaluate the success of the treatment?","answer":"The study evaluated overall survival (OS), progression-free survival (PFS), and survival rate associated with clinical remission.","input_idx":[[544,652]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3681405,"edit_id":"5ad4eb3243a68add81a8b0113f2274b7","category":"omission","question":"Was the difference in survival rates between the two groups statistically significant?","answer":"Yes, the difference in survival rates between the two groups was statistically significant.","input_idx":[[664,786]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3681405,"edit_id":"2612f8f0ce0d72e30eaf34a19b5ac0bb","category":"concept","question":"What happened after the preoperative chemotherapy in the treatment group?","answer":"After the preoperative chemotherapy, patients in the treatment group had surgery, followed by additional chemotherapy.","input_idx":[[350,392]],"output_idx":[[33,60]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3681405,"edit_id":"b772416597667ff736dd2e257a6ef6d0","category":"concept","question":"What happened after the primary surgery in the control group?","answer":"After the primary surgery, patients in the control group had additional chemotherapy.","input_idx":[[415,434]],"output_idx":[[1075,1087]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3681405,"edit_id":"5ad4eb3243a68add81a8b0113f2274b7","category":"concept","question":"Was the difference in survival rates between the two groups statistically significant?","answer":"Yes, the difference in survival rates between the two groups was statistically significant.","input_idx":[[664,786]],"output_idx":[[809,936]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3687098,"edit_id":"bdffb7c645c55ffdccb7131b8ab803aa","category":"omission","question":"What was the purpose of the previous analysis?","answer":"The previous analysis was to evaluate the safety and tolerability of sitagliptin compared to other treatments for type 2 diabetes.","input_idx":[[14,306]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3687098,"edit_id":"f68e36b082637c0bd21ace7c5db07660","category":"omission","question":"What were the specific studies included in the analysis?","answer":"The analysis included 25 studies with type 2 diabetes patients who received either sitagliptin 100mg\/day or a comparator agent.","input_idx":[[580,787]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3687098,"edit_id":"632e07c06b93dbef250128a8894c6f6c","category":"omission","question":"How were the safety of sitagliptin evaluated in the analysis?","answer":"The analysis used patient-level data from each study to evaluate the incidence rates of adverse events (AEs) in the sitagliptin group and the non-exposed group, and adjusted for exposure to compare the rates.","input_idx":[[1382,1530]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3687098,"edit_id":"93a852cbabca843c369232efe4325d9d","category":"concept","question":"What specific types of adverse events (AEs) were evaluated in the analysis?","answer":"The analysis evaluated the incidence rates of adverse events (AEs) and drug-related AEs in the sitagliptin group and the non-exposed group. The specific types of AEs were not mentioned in the simplification.","input_idx":[[1541,1666]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3687098,"edit_id":"85eea7d6f7b46419d43ebc5cc6d0f622","category":"concept","question":"What specific types of adverse events (AEs) were compared between the two groups?","answer":"The analysis compared the incidence rates of specific adverse events (AEs) between the sitagliptin group and the non-exposed group. The specific types of AEs were not mentioned in the simplification.","input_idx":[[1667,1965]],"output_idx":[[1489,1733]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3691658,"edit_id":"e9b7f7675b1a4a86983ec91ca3ae7100","category":"omission","question":"How were the flu-like symptoms assessed in the study?","answer":"The flu-like symptoms were assessed monthly through telephonic interviews.","input_idx":[[522,572]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3691658,"edit_id":"11616651d047e17c0e6bd405ab350782","category":"omission","question":"Which specific proteins were measured in the blood?","answer":"The serum levels of 25-hydroxy-D (25-OH-D), IL-17, IL-10, and IFN-\u03b3 were measured periodically.","input_idx":[[574,677]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3691658,"edit_id":"9e96caa22b59d93a09aa429bd24ac467","category":"omission","question":"Which specific factors were documented in the study?","answer":"The Expanded Disability Status Scale (EDSS), relapses, adverse events, and quality of life (QoL) were documented.","input_idx":[[679,751]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3691658,"edit_id":"245023f3f855ca05c70ef902ae31abf6","category":"concept","question":"What is the nature of the spike in cytokines that is associated with flu-like symptoms?","answer":"The spike in cytokines is thought to be a result of the body's immune response to the interferon beta treatment.","input_idx":null,"output_idx":[[148,232]],"annotator":"mistral-7b","prediction_errors":["invalid_input_localization"]},{"PMCID":3691658,"edit_id":"2dc39c19f7d3619e9b58e1563fa8fb19","category":"concept","question":"How does vitamin D3 help reduce flu-like symptoms?","answer":"Vitamin D3 is thought to help reduce flu-like symptoms by lowering the levels of certain proteins in the blood, which are associated with the immune response to the interferon beta treatment.","input_idx":null,"output_idx":[[234,350]],"annotator":"mistral-7b","prediction_errors":["invalid_input_localization"]},{"PMCID":3730064,"edit_id":"fd1dd35ef44878db63c1ea5f96e36950","category":"omission","question":"How were the patients injected?","answer":"The patients received the injections through subconjunctival and intrastromal routes.","input_idx":[[149,365]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3730064,"edit_id":"d5bd8d99e4fe39e369f523c586193f2c","category":"omission","question":"What was the purpose of the follow-up?","answer":"The purpose of the follow-up was to measure the change in the size of the abnormal blood vessels in the cornea.","input_idx":[[366,445]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3730064,"edit_id":"06a09f799b284c33f081c5513bd7aa7d","category":"concept","question":"How were the size of the abnormal blood vessels measured?","answer":"The size of the abnormal blood vessels was measured using corneal slit-lamp photographs stored in JPEG format and calculated using Image J software.","input_idx":[[446,654]],"output_idx":[[399,501]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3751568,"edit_id":"c6ab67ed13259d51dadc049dbb9e62e4","category":"omission","question":"What condition is the study looking at?","answer":"The study is looking at knee pain in children with Joint Hypermobility Syndrome (JHS).","input_idx":[[12,73]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3751568,"edit_id":"fbbc414dd568b04b8d2a307bd6074797","category":"omission","question":"How was the study conducted?","answer":"The study was conducted as a prospective, parallel-group, randomised controlled trial.","input_idx":[[581,639]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3751568,"edit_id":"981b79ce946ef4ff8ddb9d2aa6592fcd","category":"omission","question":"What was the baseline period of the study?","answer":"The baseline period of the study was a minimum of 2 weeks without any treatment.","input_idx":[[826,876]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3751568,"edit_id":"c9ea4105eb9b692594ab8d00fd70b1d8","category":"concept","question":"Who designed the exercise program?","answer":"The exercise program was designed by a physiotherapist.","input_idx":[[314,404]],"output_idx":[[250,282]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3751568,"edit_id":"2b18604c11769d73c590af6c27d2e464","category":"concept","question":"When were the measurements taken during the study?","answer":"The measurements were taken after the baseline period and after the exercise program ended.","input_idx":[[1131,1186]],"output_idx":[[1073,1105]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3751568,"edit_id":"3bff009c7362f341d1cf3b9114cb342e","category":"concept","question":"How were the assessors and participants kept blinded during the study?","answer":"The assessors and participants were kept blinded during the study by using a computer program to randomly assign the children to the two groups and by not telling the children which group they were in.","input_idx":[[1187,1312]],"output_idx":[[1107,1253]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3780629,"edit_id":"fc466b95af536b3b2699d7ea0d449c42","category":"omission","question":"What type of therapy is being combined with the computerized exercises?","answer":"The specific type of therapy being combined with the computerized exercises is not mentioned in the simplification.","input_idx":[[11,67]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3780629,"edit_id":"713ebfeef21028735f10fa44912e82f3","category":"omission","question":"What type of therapy is being used in the online therapy component?","answer":"The specific type of therapy being used in the online therapy component is not mentioned in the simplification.","input_idx":[[146,196]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3780629,"edit_id":"0aa18d9b74e4f55f73ab848079b98750","category":"omission","question":"What type of CBM is being used in the computerized exercises?","answer":"The specific type of CBM being used in the computerized exercises is not mentioned in the simplification.","input_idx":[[417,422]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3780629,"edit_id":"62a9d7f3c879d81a533e85798e302546","category":"concept","question":"What is CBM-I?","answer":"CBM-I stands for computerized cognitive-bias modification, which is a type of therapy that uses computer programs to help individuals identify and change negative thought patterns.","input_idx":[[417,422]],"output_idx":[[53,75]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3780629,"edit_id":"780a16571a7cf43610a0d08da335a5b7","category":"concept","question":"What is the goal of CBM-I?","answer":"The goal of CBM-I is to help individuals identify and change negative thought patterns.","input_idx":[[417,422]],"output_idx":[[53,75]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3781573,"edit_id":"27c67ee0ec97ee7cba93d634f79ccb92","category":"omission","question":"What is diabetic peripheral neuropathy?","answer":"Diabetic peripheral neuropathy (DPN) is a condition that affects the nerves, causing numbness and pain, mostly in your hands and feet.","input_idx":[[496,590]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3781573,"edit_id":"8f022d1cd3387a4bc0cd02e6188f41b0","category":"omission","question":"How did the researchers compare the prevalence and incidence of DPN between the two treatment groups?","answer":"The researchers used advanced statistical methods such as intention-to-treat modeling, logistic generalized estimating equation models, Kaplan-Meier estimates, and Cox regression models to compare the prevalence and incidence of DPN between the two treatment groups.","input_idx":[[640,853]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3781573,"edit_id":"a57cb15e27f0ca51907e7f6b18d676bf","category":"concept","question":"What specific statistical methods did the researchers use to compare the prevalence and incidence of DPN between the two treatment groups?","answer":"The researchers used intention-to-treat modeling, logistic generalized estimating equation models, Kaplan-Meier estimates, and Cox regression models to compare the prevalence and incidence of DPN between the two treatment groups.","input_idx":[[640,853]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3798949,"edit_id":"02adb3b677b68452215ba4f1410138f1","category":"omission","question":"What were the costs of clinical trials compared to standard of care?","answer":"Clinical trials cost more than standard of care.","input_idx":[[95,184]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3798949,"edit_id":"6b3f4b381ec30d422876432b70abb4ff","category":"omission","question":"How was the difference between the cost of experimental treatment and standard of care calculated?","answer":"The difference between the cost of experimental treatment and standard of care was calculated by subtracting the experimental treatment cost from the standard of care cost.","input_idx":[[792,897]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3798949,"edit_id":"be82fb7330cd76b82b181e5a6c167ba5","category":"omission","question":"How was the average treatment cost estimated for randomised trials?","answer":"The average treatment cost for randomised trials was estimated by taking into account the number of arms and randomisation ratio.","input_idx":[[899,1027]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3798949,"edit_id":"c03a39ef218dbe748894d7d5f28ac0da","category":"concept","question":"When and where were the clinical trials conducted?","answer":"The clinical trials were conducted in 2009 and 2010 in a single UK institution.","input_idx":[[413,586]],"output_idx":[[123,173]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3798949,"edit_id":"3a69c1f43f1a4047d68f2e61dce2c7cf","category":"concept","question":"How were the treatment costs identified?","answer":"The treatment costs were identified by analysing the trial protocols and comparing the cost of the treatments in the trials with the usual treatments the patients could have received.","input_idx":[[588,790]],"output_idx":[[352,462]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3798949,"edit_id":"2693065394f12fc7881e8b45c2f3f0cb","category":"concept","question":"What was the range of values for the treatment cost difference?","answer":"The range of values for the treatment cost difference was \u00a36393 excess to \u00a36005 for non-commercial trials and \u00a30 to \u00a371 480 for commercial trials.","input_idx":[[1349,1564]],"output_idx":[[859,1006]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3814649,"edit_id":"d8690a7254dafcd4d618be20c5d6ec36","category":"omission","question":"Did the cleavage and blastocyst rates differ between the control, VS1 and VS1 + VS2 groups?","answer":"No, the cleavage and blastocyst rates were the same in the control, VS1 and VS1 + VS2 groups.","input_idx":[[1240,1346]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3814649,"edit_id":"ebf25a94ba9d0ef83ce2bb49392d2dcd","category":"omission","question":"Did the time in the warming solution affect the cleavage and blastocyst rates in Experiment 2?","answer":"No, the time in the warming solution did not affect the cleavage and blastocyst rates in Experiment 2.","input_idx":[[1347,1416]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3814649,"edit_id":"756399020c885b72f094084de357f6f6","category":"concept","question":"How much lower were the cleavage and blastocyst rates in the vitrified group compared to the other groups?","answer":"The cleavage and blastocyst rates were 40.9% and 1.6% lower in the vitrified group compared to the control, VS1 and VS1 + VS2 groups.","input_idx":[[1432,1553]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3814649,"edit_id":"cacb515fbc0e1b6f9f41709ccc5e8073","category":"concept","question":"Why did the time in the warming solution not affect the cleavage and blastocyst rates in Experiment 2?","answer":"The time in the warming solution was not long enough to affect the cleavage and blastocyst rates in Experiment 2.","input_idx":[[1347,1416]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3816909,"edit_id":"d5878ed537ca81679addc847d3c31754","category":"omission","question":"What is the relationship between genetic variants near IRS1 and MetS?","answer":"Genetic variants near IRS1 are associated with features of the metabolic syndrome (MetS).","input_idx":[[11,99]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3816909,"edit_id":"76579b93bea7f0dd2b99d150befce9c4","category":"omission","question":"Which specific genetic variants were examined in the study?","answer":"Two genetic variants near IRS1, rs1522813 and rs2943641, were genotyped in 738 overweight\/obese adults.","input_idx":[[287,381]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3816909,"edit_id":"15832ba63d6660b301dfce32bcd7a819","category":"omission","question":"Which specific diet groups and genotype groups were compared in the study?","answer":"We compared MetS status of high-fat (40% of caloric intake; n = 370) and low-fat (20% caloric intake; n = 368) diet groups differentiated by genotypes (rs1522813 A-allele carriers and noncarriers and rs2943641T-allele carriers and noncarriers).","input_idx":[[581,824]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3816909,"edit_id":"ab6a03b9e7486f16aeeb214f424dff01","category":"concept","question":"What was the difference between the high-fat and low-fat diet groups in terms of caloric intake?","answer":"The high-fat diet group had 40% of caloric intake and the low-fat diet group had 20% of caloric intake.","input_idx":[[581,824]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3816909,"edit_id":"63f82a557f86b1b8005513c547c61cfb","category":"concept","question":"Which specific genetic variants were used to differentiate the high-fat and low-fat diet groups?","answer":"Two genetic variants near IRS1, rs1522813 and rs2943641, were used to differentiate the high-fat and low-fat diet groups.","input_idx":[[581,824]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3821103,"edit_id":"b2d37bbdb248e6f64583ed1b44c4973c","category":"omission","question":"What was the goal of this study?","answer":"The goal of this study was to compare the effectiveness of morphine and tramadol in reducing pain after minor knee surgery.","input_idx":[[139,303]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3821103,"edit_id":"0b82df2d05575081cb68348463378370","category":"omission","question":"What treatments were the patients randomly assigned to receive?","answer":"The patients were randomly assigned to receive either 5 mg morphine or 50 mg tramadol intra-articularly.","input_idx":[[327,526]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3821103,"edit_id":"7a9f6301754f92ccdab446276d9bb090","category":"omission","question":"How was pain evaluated in the study?","answer":"Pain was evaluated using the verbal pain rating score (VRS) both before and after surgery.","input_idx":[[527,709]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3821103,"edit_id":"b4b22a193254880db81b64946da0bf3f","category":"concept","question":"What type of surgery did the patients undergo?","answer":"The patients underwent minor arthroscopic knee surgery.","input_idx":null,"output_idx":[[280,348]],"annotator":"mistral-7b","prediction_errors":["invalid_input_localization"]},{"PMCID":3821103,"edit_id":"a32a1e091f5c09501221f04738715b1d","category":"concept","question":"Which pain relievers were used in the study and which groups were assigned to them?","answer":"The study used morphine and tramadol as pain relievers and the patients were randomly assigned to receive either morphine or tramadol.","input_idx":null,"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_input_localization","invalid_output_localization"]},{"PMCID":3877023,"edit_id":"e0368958672daca983b30a1f4cc821a4","category":"omission","question":"Who were the participants in the study?","answer":"The participants were 93 patients, 80% of whom were women, with an average age of 53.","input_idx":[[243,453]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3877023,"edit_id":"2263c88bbe705a9b457874b1f55677b2","category":"omission","question":"How was the image quality assessed in the study?","answer":"The image quality was assessed by looking at the level of detail and brightness, and how sharp the outline of the images appeared. Additionally, the study also looked at the signal-to-noise (SNR) and contrast-to-noise ratios (CNR) and quantitative contour sharpness.","input_idx":[[503,662]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3892495,"edit_id":"0a9390fbc81d975dbc1f9c99c7aa13d1","category":"omission","question":"How much higher were the growth hormone levels in the CHO group compared to the CON group?","answer":"The growth hormone levels in the CHO group were significantly higher than the CON group by 15 and 30 minutes.","input_idx":[[385,518]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3892495,"edit_id":"fb1ba16eb306f1eb3b874a76fcee481a","category":"omission","question":"By how much was the fat oxidation rate lower in the CHO group compared to the CON group?","answer":"The fat oxidation rate was significantly lower in the CHO group compared to the CON group during certain time intervals (5-15 minutes, 25-35 minutes, and 45-55 minutes into their walk).","input_idx":[[519,634]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3892495,"edit_id":"a493fceb6a6b0cb27be788ac26f05688","category":"omission","question":"By how much were the FFA levels lower in the CHO group compared to the CON group?","answer":"The plasma FFA levels were significantly lower in the CHO group compared to the CON group after 30, 45, and 60 minutes of walking.","input_idx":[[635,735]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3892495,"edit_id":"20f159b37a023dfec9765a5ff112d22e","category":"omission","question":"By how much were the glucose levels lower in the CHO group compared to the CON group?","answer":"The plasma glucose levels in the CHO group were significantly lower compared to the CON group after 15 and 30 minutes.","input_idx":[[736,881]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3892495,"edit_id":"a493fceb6a6b0cb27be788ac26f05688","category":"omission","question":"By how much were the FFA levels lower in the CHO group compared to the CON group?","answer":"The plasma FFA levels were significantly lower in the CHO group compared to the CON group after 30, 45, and 60 minutes of walking.","input_idx":[[635,735]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3892495,"edit_id":"0a9390fbc81d975dbc1f9c99c7aa13d1","category":"concept","question":"How much higher were the growth hormone levels in the CHO group compared to the CON group?","answer":"The growth hormone levels in the CHO group were significantly higher than the CON group by 15 and 30 minutes.","input_idx":[[385,518]],"output_idx":[[352,505]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3892495,"edit_id":"fb1ba16eb306f1eb3b874a76fcee481a","category":"concept","question":"By how much was the fat oxidation rate lower in the CHO group compared to the CON group?","answer":"The fat oxidation rate was significantly lower in the CHO group compared to the CON group during certain time intervals (5-15 minutes, 25-35 minutes, and 45-55 minutes into their walk).","input_idx":[[519,634]],"output_idx":[[515,670]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3892495,"edit_id":"a493fceb6a6b0cb27be788ac26f05688","category":"concept","question":"By how much were the FFA levels lower in the CHO group compared to the CON group?","answer":"The plasma FFA levels were significantly lower in the CHO group compared to the CON group after 30, 45, and 60 minutes of walking.","input_idx":[[635,735]],"output_idx":[[671,771]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3892495,"edit_id":"20f159b37a023dfec9765a5ff112d22e","category":"concept","question":"By how much were the glucose levels lower in the CHO group compared to the CON group?","answer":"The plasma glucose levels in the CHO group were significantly lower compared to the CON group after 15 and 30 minutes.","input_idx":[[736,881]],"output_idx":[[772,872]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3892495,"edit_id":"a493fceb6a6b0cb27be788ac26f05688","category":"concept","question":"By how much were the FFA levels lower in the CHO group compared to the CON group?","answer":"The plasma FFA levels were significantly lower in the CHO group compared to the CON group after 30, 45, and 60 minutes of walking.","input_idx":[[635,735]],"output_idx":[[671,771]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3893439,"edit_id":"9efc10d6076d64984f7d569149bebdb3","category":"omission","question":"What is the condition that the study is investigating?","answer":"The study is investigating the effects of environment enrichment (EE) on reducing inflammation and restoring energy balance in the brain after a minor brain injury.","input_idx":[[12,132]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3893439,"edit_id":"12c5c33a97c746db3fa1dbd0c106c260","category":"omission","question":"Why did the researchers focus on using EE in this study?","answer":"The researchers focused on using EE in this study because of the lack of success of most TBI interventions and the documented benefits of EE in enhancing brain plasticity.","input_idx":[[134,282]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3893439,"edit_id":"c7a2d02b7eb86ad6ebde91248660ef0c","category":"omission","question":"What type of rats were used in the study and how were they assigned to the groups?","answer":"Adult male Wistar rats were used in the study and randomly assigned to receive either mild TBI (mTBI) using the controlled cortical injury model or sham surgery.","input_idx":[[448,610]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3893439,"edit_id":"980e52fec1c0e32d8a8b97a394dbff8e","category":"concept","question":"What method was used to induce the brain injury in the rats?","answer":"The rats received a mild TBI using the controlled cortical injury model.","input_idx":[[535,593]],"output_idx":[[427,447]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3893439,"edit_id":"f1135e420fec87005b7fb6a5d912fa73","category":"concept","question":"What were the specific living conditions that the rats were placed in after surgery?","answer":"The rats were placed in either an EE or standard laboratory housing (CON) after surgery.","input_idx":[[611,733]],"output_idx":[[570,620]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3893439,"edit_id":"27987bf6d581e91f10a91347215365fa","category":"concept","question":"What specific proteins were measured after behavioral testing?","answer":"The levels of pro-inflammatory cytokines IL-1\u03b2 and TNF-\u03b1 and the anti-inflammatory cytokine IL-10 were measured after behavioral testing.","input_idx":[[869,1021]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3917487,"edit_id":"343d17cabd498c3d81456731df5c7611","category":"omission","question":"What was the test used to measure the participants' physical performance?","answer":"The HarvardStep test was used to measure the participants' physical performance.","input_idx":[[596,602]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3917487,"edit_id":"d4d833cf56089c091a281a8f20f711f8","category":"concept","question":"How long did the probiotic yogurt group experience less difficulty breathing and ear pain?","answer":"The duration of the probiotic yogurt group experiencing less difficulty breathing and ear pain was not specified in the original text.","input_idx":[[1236,1371]],"output_idx":[[866,971]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3921228,"edit_id":"5d0e6849710ca674c41cb811faa84bf0","category":"omission","question":"What is the relationship between amygdala hemodynamic responses and major depressive disorder?","answer":"Amygdala hemodynamic responses are less active in people with major depressive disorder, but this can improve with remission.","input_idx":[[12,112]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3921228,"edit_id":"ed0b1f341e5c4b44987c5784330908f1","category":"omission","question":"What is the purpose of rtfMRI-nf?","answer":"rtfMRI-nf is a non-invasive method to modulate the activity in the amygdala.","input_idx":[[144,258]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3921228,"edit_id":"63d889d79a9885402d7158cce556dd9a","category":"concept","question":"What was the specific goal of the study?","answer":"The specific goal of the study was to examine whether depressed participants can use rtfMRI-nf to enhance amygdala responses to positive autobiographical memories and whether this ability alters symptom severity.","input_idx":[[260,439]],"output_idx":[[335,509]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3921228,"edit_id":"07d6fd6930b677eb9b7b00b17e56c7f0","category":"concept","question":"How did the participants in the experimental group increase their amygdala responses?","answer":"The participants in the experimental group were asked to think about happy personal memories to increase the level of a certain signal in the targeted brain area.","input_idx":[[989,1091]],"output_idx":[[1041,1159]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3926947,"edit_id":"53f6fe1b078384dbb3883aab859c619d","category":"omission","question":"What was the aim of this paper?","answer":"The aim of this paper was to study whether Interactive Voice Response (IVR) is a more effective method than a questionnaire sent by post when following up outpatient treatment in child and adolescent psychiatry.","input_idx":[[0,78]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3926947,"edit_id":"284401413cb35a1865d6a9be1e70b103","category":"omission","question":"Where was the study conducted?","answer":"The study was conducted in a child and adolescent psychiatric outpatient unit in Sweden.","input_idx":[[324,420]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3926947,"edit_id":"7cd45f560a199576517bf304f5f0fd4d","category":"concept","question":"How statistically significant was the difference between the response rates?","answer":"The difference between the response rates was statistically significant (p = 0.014).","input_idx":[[589,699]],"output_idx":[[457,593]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3926947,"edit_id":"d5e83f7833fc7a5b53f1e4b4136a97ad","category":"concept","question":"What kind of treatment was being evaluated in the study?","answer":"The study evaluated evidence-based treatment in child and adolescent psychiatric care.","input_idx":[[765,891]],"output_idx":[[659,815]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3932017,"edit_id":"bdaa09ad751bf134a898b3f3bd27a074","category":"omission","question":"What is the relationship between type 2 diabetes and cardiovascular disease?","answer":"Type 2 diabetes is a risk factor for cardiovascular disease, as it can cause arterial stiffness changes.","input_idx":[[12,127]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3932017,"edit_id":"6e487327d823b636d143ee8d16d7e66c","category":"omission","question":"What techniques were used to investigate the changes in the carotid artery?","answer":"The study used radio frequency and X-strain ultrasound techniques to investigate the changes in the carotid artery.","input_idx":[[128,297]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3932017,"edit_id":"607a74928480ab30e03a146149cbedfe","category":"concept","question":"What specific measurements were used to investigate the changes in the carotid artery wall?","answer":"The study used quality intima-media thickness (QIMT), quality arterial stiffness (QAS), and X-strain analysis with a Mylab Twice ultrasound instrument to investigate the changes in the carotid artery wall.","input_idx":[[397,624]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3932017,"edit_id":"d846a9905200e65b6e650b4e44a275e6","category":"concept","question":"What specific analysis was performed to compare the findings of the two groups?","answer":"The study analyzed the relationships among variables between the two groups.","input_idx":[[625,710]],"output_idx":[[540,577]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3943081,"edit_id":"b366cde637c942190ffc6789ad2024e3","category":"omission","question":"Besides chest physiotherapy, what else was done to prevent lung collapse in the control group?","answer":"In addition to chest physiotherapy, the control group was also monitored and their underlying disease was treated if a lung collapse occurred.","input_idx":[[1161,1203]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3943081,"edit_id":"04ce2ad8523d36d2219f419e1810457c","category":"concept","question":"What specific types of neuromuscular diseases were included in the study?","answer":"The study included patients with spinal muscular atrophy, Guillain-Barre syndrome, critical illness polyneuropathy\/myopathy, and cerebral palsy. These are all neuromuscular diseases that can affect a person's ability to breathe and increase the risk of lung collapse.","input_idx":[[505,646]],"output_idx":[[532,558]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3953523,"edit_id":"438df6597926b831952f2875d8229076","category":"omission","question":"What specific tool was used to measure the knee health of the participants?","answer":"The Knee injury and Osteoarthritis Outcome Score (KOOS) was used to measure the knee health of the participants.","input_idx":[[441,492]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3953523,"edit_id":"306b45b59f5fe6e590a56841fb69d640","category":"omission","question":"What specific tool was used to measure the range of motion of the knee?","answer":"The range of motion of the knee was measured using a specific tool.","input_idx":[[497,518]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3953523,"edit_id":"88f68fa35f18e34bb47eb10d487e938a","category":"concept","question":"What condition did the participants in the study have?","answer":"The participants in the study had chronic knee osteoarthritis (OA).","input_idx":[[177,259]],"output_idx":[[201,267]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3953523,"edit_id":"1de45d7cf559e20aea88b0c0da054289","category":"concept","question":"What specific tool was used to measure the pain levels of the participants?","answer":"A 100-mm visual analogue scale (VAS) was used to measure the pain levels of the participants.","input_idx":[[403,439]],"output_idx":[[489,508]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3953523,"edit_id":"438df6597926b831952f2875d8229076","category":"concept","question":"What specific tool was used to measure the knee health of the participants?","answer":"The Knee injury and Osteoarthritis Outcome Score (KOOS) was used to measure the knee health of the participants.","input_idx":[[441,492]],"output_idx":[[510,529]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3984795,"edit_id":"ca25c8e89755c80f0c6591d167b4fb95","category":"omission","question":"When were the blood and fecal samples collected?","answer":"The blood and fecal samples were collected at the beginning and end of the study.","input_idx":[[436,504]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3984795,"edit_id":"583732dfbecbcd58bc0d11faef663bb5","category":"omission","question":"What specific changes in cholesterol levels were seen in the group that took the probiotic VSL#3?","answer":"The group that took the probiotic VSL#3 showed a significant reduction in total cholesterol, triglyceride, LDL, and VLDL and had increased HDL.","input_idx":[[506,655]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3984795,"edit_id":"eac452ee247fe46d8d0318559f6a351c","category":"omission","question":"What specific changes in hsCRP and gut microbiota composition were seen in the group that took the probiotic VSL#3?","answer":"VSL#3 improved insulin sensitivity (P < 0.01), decreased hsCRP, and favorably affected the composition of gut microbiota.","input_idx":[[663,784]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":3984795,"edit_id":"506a71636a2a7c69d089276f20a67568","category":"concept","question":"How were the participants assigned to the groups?","answer":"The participants were randomly assigned to the groups.","input_idx":[[306,435]],"output_idx":[[291,542]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3984795,"edit_id":"583732dfbecbcd58bc0d11faef663bb5","category":"concept","question":"What specific changes in cholesterol levels were seen in the group that took the probiotic VSL#3?","answer":"The group that took the probiotic VSL#3 showed a significant reduction in total cholesterol, triglyceride, LDL, and VLDL and had increased HDL.","input_idx":[[506,655]],"output_idx":[[616,768]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3984795,"edit_id":"7caa7507ceb18ba634e56440e4f799ac","category":"concept","question":"What specific effect on hsCRP was seen with omega-3?","answer":"Omega-3 had a significant effect on hsCRP.","input_idx":[[785,885]],"output_idx":[[934,1057]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3984795,"edit_id":"2c5f47fb8426bdf8488a8d380f8b6d3c","category":"concept","question":"What specific effect on hsCRP was seen with the addition of omega-3 fatty acid with VSL#3?","answer":"The addition of omega-3 fatty acid with VSL#3 had a more pronounced effect on hsCRP.","input_idx":[[886,993]],"output_idx":[[1067,1200]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3990364,"edit_id":"f390ffc8b29e1e8586270f777045db30","category":"omission","question":"What device was used to measure the spinal ranges of motion?","answer":"The SpinalMouse\u00ae device was used to measure the spinal ranges of motion.","input_idx":[[961,1232]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3990364,"edit_id":"e06227157a076fd311c63527a1f2db3d","category":"omission","question":"Where were the participants recruited from?","answer":"The participants were recruited from a senior center in Palermo.","input_idx":[[521,704]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":3990364,"edit_id":"205008b64418fd84d6f1ca773cf61673","category":"concept","question":"How was spinal flexibility measured before and after the training period?","answer":"Spinal flexibility was measured using a SpinalMouse\u00ae device, which measures the range of motion (ROM) of the spine from a neutral standing position to maximum bending and extension positions.","input_idx":[[961,1232]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":3990364,"edit_id":"8a3ed0a23c31264bf8eca95154f52c97","category":"concept","question":"How were the participants divided into the trained and control groups?","answer":"The participants were randomly assigned to the trained and control groups.","input_idx":[[579,704]],"output_idx":[[604,662]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4006208,"edit_id":"259743fa1d43321e50df3adbad1fb855","category":"omission","question":"What is the problem that this study is trying to address?","answer":"The study is trying to address the problem of antibiotic resistance and the increasing incidence of oral diseases.","input_idx":[[12,93]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4006208,"edit_id":"d3bf4068386f982da06d9790f1dd75b9","category":"omission","question":"How was the study conducted?","answer":"The study was conducted by randomly allocating 300 healthy volunteers into three groups, where they were tested for their gum health and plaque levels, professionally cleaned their teeth, and then given either Aloe vera mouthwash, chlorhexidine mouthwash, or saline water to use for four days without brushing or flossing.","input_idx":[[173,394]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4006208,"edit_id":"48689489749108d22bc8507ada4ddf58","category":"concept","question":"How were the participants selected for the study?","answer":"The participants were selected by randomly allocating 300 healthy volunteers into three equal groups.","input_idx":[[419,501]],"output_idx":[[456,513]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4006208,"edit_id":"d96115f558e57c3e204cda7b62fb2ac4","category":"concept","question":"What were the specific measurements used to assess the health of the participants' gums and plaque levels?","answer":"The specific measurements used to assess the health of the participants' gums and plaque levels were Gingival index and plaque index, which were recorded at the start of the study.","input_idx":[[613,683]],"output_idx":[[668,782]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4015738,"edit_id":"9507aeff1599423f919a2393edac9365","category":"omission","question":"What were the potential benefits of using balanced solutions during surgery?","answer":"The use of balanced solutions during surgery was associated with less alteration of plasmatic electrolytes, acid\u2013base equilibrium, kidney function and it might be associated with an early anti-inflammatory mechanisms triggering.","input_idx":[[1555,1767]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4015738,"edit_id":"4918e8fbeaef0f26b9fa223b573ee3e5","category":"concept","question":"What specific variables were collected during the study and what do they represent?","answer":"The study collected data on active matrix metalloproteinase 9 (MMP-9) and its tissue inhibitor (TIMP-1), IL-6, IL-8, IL-10, blood gases variables, electrolytes, albumin, total serum protein and the strong ion difference, and neutrophil gelatinase-associated lipocalin (NGAL) from urinary sample. These variables are related to inflammation, electrolyte balance, acid-base balance, kidney function and tissue damage.","input_idx":[[994,1304]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4018698,"edit_id":"67b78499e01e56622552631a1fac2576","category":"omission","question":"Why is controlling postoperative pain important in the field of surgery?","answer":"Controlling postoperative pain is important because it can prevent unnecessary suffering and complications in patients who are undergoing surgery.","input_idx":[[12,185]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4018698,"edit_id":"21ee2c163d77c38d32f9e2a1c415f3bb","category":"omission","question":"What are the consequences of inadequate pain treatment?","answer":"Inadequate pain treatment can cause unnecessary suffering and can lead to complications in patients who are undergoing surgery.","input_idx":[[186,340]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4018698,"edit_id":"a463d2e8c366d59afd2cf03f065d0421","category":"omission","question":"What are analgesic modalities and how can they help in preventing or minimizing needless suffering and complications?","answer":"Analgesic modalities are methods of pain relief, such as medication or other treatments. If properly applied, they can help prevent or minimize unnecessary suffering and complications in patients who are undergoing surgery.","input_idx":[[341,465]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4018698,"edit_id":"756ce93466f7f1843d4f307e22f1d665","category":"concept","question":"What were the two methods of giving the local anesthetic drugs?","answer":"The two methods of giving the local anesthetic drugs were by paravertebral and epidural routes.","input_idx":[[479,687]],"output_idx":[[392,534]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4018698,"edit_id":"5af05da312bb650f2770434f9b652f8f","category":"concept","question":"What specific measures were used to compare the levels of pain and other factors between the two groups?","answer":"The specific measures used to compare the levels of pain and other factors between the two groups were the visual analogue scale (VAS) score, vital statistics, rescue analgesia, and procedure time.","input_idx":[[1287,1514]],"output_idx":[[1033,1176]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4065461,"edit_id":"2f45eed36148e177620e4a71e452027b","category":"omission","question":"How was the study conducted?","answer":"The study was a double-blind, randomized controlled trial on infants (1 to 12 months) who were diagnosed in the emergency department with moderate-to-severe bronchiolitis.","input_idx":[[242,408]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4065461,"edit_id":"7dcad6db2030fe105d634590688a0906","category":"omission","question":"What were the specific outcomes that were measured in the study?","answer":"The primary outcome was the rate of hospital admission within 7 days of the first dose of treatment, and the secondary outcomes were changes in respiratory distress assessment instrument score, heart rate, respiratory rate, and oxygen saturation (O2 Sat) over a 4-hour observation period.","input_idx":[[409,697]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4065461,"edit_id":"5392771a6a4909569b90dbd33cc877da","category":"omission","question":"What specific drugs were given to the infants in the study?","answer":"The infants were given different combinations of drugs, specifically dexamethasone + epinephrine, dexamethasone + salbutamol, placebo + epinephrine, and placebo + salbutamol.","input_idx":[[698,916]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4065461,"edit_id":"2a3778b45d4db053b1ebfae4e4d0a6ae","category":"concept","question":"Were the results of the study statistically significant?","answer":"Yes, the results of the study were statistically significant. The study showed that there was no statistically significant difference in the rate of hospitalization for patients who received dexamethasone + epinephrine compared to those who received placebo + epinephrine or salbutamol (P = 0.64) and no statistically significant difference in the rate of hospitalization for patients who received dexamethasone + salbutamol compared to those who received placebo + epinephrine or salbutamol (P = 0.51).","input_idx":[[927,1301]],"output_idx":[[444,592]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4065461,"edit_id":"082b7900ab7fcb7c39335ec25bcb499b","category":"concept","question":"What specific clinical parameters were measured in the study?","answer":"The clinical parameters that were measured in the study were respiratory distress assessment instrument score, heart rate, respiratory rate, and oxygen saturation (O2 Sat) over a 4-hour observation period. The study showed that all treatment groups showed improvements in these clinical parameters at the end of the 4-hour observation period.","input_idx":[[1302,1405]],"output_idx":[[678,773]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4069047,"edit_id":"aeda003b3522ae6ac43b09eb0a67628e","category":"omission","question":"What is the link between poor sleep quality and Alzheimer's disease?","answer":"Poor sleep quality has been suggested to be linked to Alzheimer's disease.","input_idx":[[9,100]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4069047,"edit_id":"8f8c8fe44c75767948463e200af85540","category":"omission","question":"What is the relationship between melatonin levels and Alzheimer's disease?","answer":"Melatonin levels are already reduced in preclinical stages of Alzheimer's disease.","input_idx":[[101,179]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4069047,"edit_id":"683f2203b5e082d060a176310512d662","category":"omission","question":"How was the study designed?","answer":"The study was designed as a randomized, double-blind, parallel-group study.","input_idx":[[779,833]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4069047,"edit_id":"6ac4784ca757286f14960e817d961ca7","category":"concept","question":"How long were patients given melatonin and how was the treatment decided?","answer":"Patients were given melatonin for 24 weeks and then given a placebo for 2 weeks. The treatment was decided through randomization.","input_idx":[[835,992]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4069047,"edit_id":"cc717025d2243110e37ed6227f967920","category":"concept","question":"How was cognitive performance measured and what was the statistical significance of the results?","answer":"Cognitive performance was measured using the Instrumental Activities of Daily Living (IADL) and the Mini\u2013Mental State Examination (MMSE). The results were statistically significant, with a p-value of 0.004 for IADL and 0.044 for MMSE.","input_idx":[[1261,1431]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4078065,"edit_id":"7e9b0a91a333d02ab959d9dcd874a95d","category":"omission","question":"What is the name of the process that the study is investigating?","answer":"The name of the process is Reverse Cholesterol Transport (RCT).","input_idx":[[0,35]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4078065,"edit_id":"368bd7fa63f016c16905bf09e865558d","category":"omission","question":"What amino acid was studied in the study?","answer":"The amino acid that was studied is citrulline.","input_idx":[[110,120]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4078065,"edit_id":"3010fbb4591a14afb781dbff1e583fe5","category":"omission","question":"What molecule was studied in the study?","answer":"The molecule that was studied is nitric oxide.","input_idx":[[188,200]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4078065,"edit_id":"4de281a0e99a27536047eeb42296712d","category":"omission","question":"What are the names of the proteins that were studied in the study?","answer":"The names of the proteins that were studied are ABCA1 and ABCG1.","input_idx":[[542,557]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4078065,"edit_id":"8b85755772f7f79a3c688b085a6c1a7a","category":"omission","question":"What is the name of the protein that was studied in the study?","answer":"The name of the protein that was studied is apolipoprotein A-I.","input_idx":[[467,481]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4078065,"edit_id":"fec1e4b7bfc6003c33052298fe556294","category":"omission","question":"What is the name of the lipoprotein that was studied in the study?","answer":"The name of the lipoprotein that was studied is HDL.","input_idx":[[96,99]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4078065,"edit_id":"527294815c155b1f094176463b5f4368","category":"concept","question":"What specific transporters were studied in the study?","answer":"The specific transporters that were studied are ABCA1 and ABCG1.","input_idx":[[256,520]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4078065,"edit_id":"71a2088e9384b1d90c93706c0611d9a8","category":"concept","question":"How did citrulline increase the levels of ABCA1 and ABCG1?","answer":"Citrulline increased the levels of ABCA1 and ABCG1 by increasing their mRNA and protein levels in THP-1 macrophages.","input_idx":[[521,674]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4078065,"edit_id":"36927e1dde84a263d20fd0f65ac68be6","category":"concept","question":"What was the specific design of the human study?","answer":"The human study was a crossover study, where 8 healthy male volunteers consumed either 3.2 g\/day citrulline or placebo for 1 week.","input_idx":[[675,808]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4078065,"edit_id":"d46c80b65bbe4c7499053e80ef7c5daa","category":"concept","question":"How did citrulline increase the levels of ABCA1 and ABCG1 in the macrophages?","answer":"Citrulline increased the levels of ABCA1 and ABCG1 in the macrophages by increasing their mRNA and protein levels.","input_idx":null,"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_input_localization","invalid_output_localization"]},{"PMCID":4092926,"edit_id":"66c4e954f79e4c07b2c87f9260d095ad","category":"omission","question":"What kind of goats were used in the study?","answer":"The study used Boer goats, which is a breed of goat that originated in South Africa.","input_idx":[[183,314]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4092926,"edit_id":"2cde14906d825fcd7730ac0b596d592b","category":"omission","question":"What were the specific substitution levels of soybean meal by sunflower cake used in the study?","answer":"The study used four substitution levels of soybean meal by sunflower cake: 0%, 33%, 66%, and 100% DM. DM stands for dry matter.","input_idx":[[358,465]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4092926,"edit_id":"d99f05ee6c785c913fb2c93a5e6b75f5","category":"concept","question":"How were the goats evaluated at the end of the study?","answer":"The goats were evaluated based on their overall size, leg dimensions, amount of muscle, fat and bone weight, and muscle-to-fat ratios.","input_idx":[[467,535]],"output_idx":[[345,579]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4092926,"edit_id":"85d20e1c8e935665b03124649e90d4cb","category":"concept","question":"Can sunflower cake be used as a complete replacement for soybean meal in goat food?","answer":"Yes, sunflower cake can be used as a complete replacement for soybean meal in goat food without any noticeable changes in how the goats grow.","input_idx":[[1271,1414]],"output_idx":[[582,719]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4106715,"edit_id":"f7a0d27f821360a2d8997ac9ce9b7004","category":"omission","question":"How many participants were included in the study?","answer":"There were 301 smokers included in the study.","input_idx":[[347,360]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4106715,"edit_id":"4cc1a5bc7eb2be5fa2ef92ae9bf5e1ab","category":"omission","question":"What were the specific doses and frequency of administration of the vaccine?","answer":"The vaccine was given in doses of 200 or 400 \u03bcg, either 4 or 5 times over a period of 6 months.","input_idx":[[369,429]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4106715,"edit_id":"01788ff11df049c92acf50e08068067f","category":"omission","question":"What is AUC and how was it used to determine the top 30% of recipients?","answer":"AUC stands for the area under the curve of the antibody response over time. The top 30% of recipients were determined based on their AUC values.","input_idx":[[451,546]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4106715,"edit_id":"71852bd7e8cd63b67608e89f0da4fa23","category":"concept","question":"How was the study designed?","answer":"The study was a randomized, double-blinded, placebo-controlled multicenter clinical trial.","input_idx":[[272,345]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4106715,"edit_id":"9820e716ab9dd445062c7158e9584f41","category":"concept","question":"What is NicVAX\u00ae and how does it work?","answer":"NicVAX\u00ae is a nicotine vaccine that contains a synthetic nicotine compound called 3'AmNic-rEPA. It works by stimulating the body's immune system to produce antibodies to nicotine, which can help smokers quit.","input_idx":[[0,42]],"output_idx":[[35,51]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4106715,"edit_id":"dce74e01935f77678fb80565e777f6e3","category":"concept","question":"What is serum and how is it related to the antibody response?","answer":"Serum is a clear, watery liquid that is part of the blood. It contains antibodies, which are proteins that the body produces to fight off infections and other harmful substances. In this study, the researchers measured the levels of antibodies in the serum of the participants to determine their response to the vaccine.","input_idx":[[492,529]],"output_idx":[[885,904]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4115605,"edit_id":"9533badf2eeb2ace61cb09320ddd5ca9","category":"omission","question":"What conditions did the patients have that made them eligible for the study?","answer":"The patients had one of the following conditions: Parkinson's disease, multiple system atrophy, pure autonomic failure, or non-diabetic autonomic neuropathy.","input_idx":[[150,290]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4115605,"edit_id":"ac62ea10fe06dc2c524f481acd2dce4a","category":"omission","question":"How were the doses of droxidopa adjusted for each patient?","answer":"The doses of droxidopa were adjusted for each patient based on their response. The doses ranged from 100-600 mg 3 times daily.","input_idx":[[301,366]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4115605,"edit_id":"9ecf15c67563fe004dd033b977df18fd","category":"omission","question":"What was the design of the study after the dose optimization phase?","answer":"After the dose optimization phase, the responders were given a 7-day break, after which they were given either droxidopa or a placebo for 7 days. The study was double-blind, meaning that neither the researcher nor the participants knew which treatment each participant received.","input_idx":[[368,469]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4115605,"edit_id":"c8f1a1b46fefbbee9298e0778a73c167","category":"concept","question":"What was the name of the questionnaire used to measure the symptoms and how it affected daily activities?","answer":"The questionnaire used to measure the symptoms and how it affected daily activities was the Orthostatic Hypotension Questionnaire (OHQ). It is a validated, nOH-specific tool that assesses symptom severity and symptom impact on daily activities.","input_idx":[[570,670]],"output_idx":[[546,656]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4115605,"edit_id":"f690ced9698fcf49a206c8115f77c1a6","category":"concept","question":"How much did the standing blood pressure increase for the patients who received droxidopa compared to those who received a placebo?","answer":"The standing blood pressure increased by 11.2 mm Hg for the patients who received droxidopa compared to 3.9 mm Hg for those who received a placebo.","input_idx":[[1087,1233]],"output_idx":[[873,949]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4115605,"edit_id":"f6f6996d258edd7c3d315c87cc3b496a","category":"concept","question":"What was the exact percentage of patients who had supine systolic BP above 180 mm Hg at the end of the study?","answer":"At the end of the study, 4.9% of droxidopa recipients had supine systolic BP above 180 mm Hg, compared to 2.5% of placebo recipients.","input_idx":[[1235,1343]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4121500,"edit_id":"51dd4d0bba681aad44176037a52f4381","category":"omission","question":"What specific measurements were used to monitor the patients' body functions and consciousness?","answer":"The specific measurements used were the Bispectral index (BIS), systolic blood pressure, heart rate, and Ramsay score.","input_idx":[[504,581]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4121500,"edit_id":"9d51de4a7bec0a770e746c7081ea724d","category":"omission","question":"What specific outcomes were recorded during the study?","answer":"The specific outcomes that were recorded were the complications, drug use, lowest BIS and time to reach BIS 80 after termination of dexmedetomidine.","input_idx":[[691,788]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4121500,"edit_id":"5684a8c546e2ff6553a9c5e2a2e0e187","category":"concept","question":"What was the physical status of the patients included in the study?","answer":"The patients included in the study were of American Society of Anesthesiologists physical status I and II.","input_idx":[[230,292]],"output_idx":[[194,208]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4121500,"edit_id":"e9abe824a4da502592d1a59ebc64de03","category":"concept","question":"What was the specific loading dose used in the study?","answer":"The patients in group L received a loading dose of 0.5 \u03bcg\/kg for 10 minutes.","input_idx":[[429,469]],"output_idx":[[314,338]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4121500,"edit_id":"1aca2a304a398af0ecf0d5455d33bce8","category":"concept","question":"What was the specific loading dose used in the study?","answer":"The patients in group H received a loading dose of 1.0 \u03bcg\/kg.","input_idx":[[429,454]],"output_idx":[[314,339]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4140238,"edit_id":"12dca26061813753532fa665a3d9524d","category":"omission","question":"How many trials were conducted and what was the design of the study?","answer":"Two Phase III, placebo-controlled, double-masked, randomized clinical trials were conducted.","input_idx":[[222,298]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4140238,"edit_id":"8ccf3f8d0598bfffe3ea34f9d0d65729","category":"omission","question":"What were the primary and secondary end points of the study?","answer":"The primary end points were changes in ocular itching reported at 3, 5, and 7 minutes and conjunctival hyperemia assessed at 7, 15, and 20 minutes following each CAC. The secondary end points included chemosis, episcleral and ciliary hyperemia judged by investigators, and tearing (scored as either absent or present) and eyelid swelling judged by subjects.","input_idx":[[686,859]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4140238,"edit_id":"a17fc99c2d0014fcc44b05d0916fbc6e","category":"omission","question":"What were the adverse events of the study?","answer":"Adverse events were generally mild and transient.","input_idx":[[1718,1767]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4140238,"edit_id":"610a84a83f8f3fd7d7cb55ac4822c1eb","category":"concept","question":"How many centers were involved in the study and how long did it last?","answer":"The study was conducted at a total of six separate centers and lasted for the duration of the trials.","input_idx":[[397,545]],"output_idx":[[151,324]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4140238,"edit_id":"88e4ae76df876538274193ad1508a0ab","category":"concept","question":"At what time intervals were the primary end points measured?","answer":"The primary end points were measured at 3, 5, and 7 minutes for ocular itching and at 7, 15, and 20 minutes for conjunctival hyperemia following each CAC.","input_idx":[[686,859]],"output_idx":[[485,595]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4166055,"edit_id":"6c614dcbf6c87c1cf1164568b9cf8c41","category":"omission","question":"What was the purpose of this study?","answer":"The purpose of this study was to examine the effects of preoperatively administered i.v. hypertonic saline on hypotension following induction of general anesthesia.","input_idx":[[12,172]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4166055,"edit_id":"9550f4f707f5cf5f82e7a8139a10c49b","category":"omission","question":"How many patients were in each group?","answer":"Fifty-four patients were studied, 27 patients in each group, one group received hypertonic saline 5% (2.3 ml\/kg) and the other group received normal saline (13 ml\/kg).","input_idx":[[197,388]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4166055,"edit_id":"9e45b4445e95b6656e21630a33ab043b","category":"omission","question":"How long was the infusion of the salt solution?","answer":"The infusion of the salt solution was done for 30 minutes, half an hour before the patient was put to sleep for surgery.","input_idx":[[389,490]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4166055,"edit_id":"e9ecfd5d13740a34410c22c3a5fa7326","category":"concept","question":"What was the standard protocol for anesthesia?","answer":"The standard protocol for anesthesia was followed for all patients.","input_idx":[[491,556]],"output_idx":[[541,598]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4166055,"edit_id":"182794faed72d57ebd28a05eba2252bd","category":"concept","question":"What specific measurements were taken in all patients?","answer":"The specific measurements taken in all patients were age, gender, body mass index (BMI), systolic and diastolic blood pressure (SBP, DBP), heart rate (HR) and mean arterial pressure (MAP).","input_idx":[[557,719]],"output_idx":[[599,737]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4166058,"edit_id":"1d7702f6a35d90ef1b346129dea8556e","category":"omission","question":"What was the purpose of this study?","answer":"The purpose of this study was to evaluate the humidifying and heating capabilities of two systems, MR850 and PMH7000, in providing oxygen therapy to newborn babies through a nasal tube.","input_idx":[[12,195]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4166058,"edit_id":"cf0a32faf1f168ae504f1f1f11ffc9a4","category":"omission","question":"Which systems were approved by the FDA to administer heated, humidified HFNC?","answer":"The systems MR850 and PMH7000 were approved by the FDA to administer heated, humidified HFNC.","input_idx":[[392,537]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4166058,"edit_id":"c9bf9b0c9810c64ee3c12de9dd907a95","category":"concept","question":"What are the specific physical criteria that need to be met in order to administer oxygen through a nasal cannula?","answer":"The specific physical criteria that need to be met in order to administer oxygen through a nasal cannula are 100% relative humidity (RH) and a temperature of 37\u00b0C.","input_idx":[[197,391]],"output_idx":[[159,298]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4166058,"edit_id":"dd329460f005811c4431435f650e9d68","category":"concept","question":"How was the study designed?","answer":"The study was designed as a randomized controlled trial (RCT) on newborns weighing 1,000 to 1,500 grams who were recovering from respiratory distress syndrome (RDS) while nCPAP was administered at CDP = 4 cmH2O, Fio2 <30%. Patients were randomized to two groups of 35 receiving HHHFNC after treatment with nCPAP, with one group using MR850 humidifier and the other PMH7000. The patients were compared according to the duration of HHHFNC administration, repeated need for nCPAP respiratory support, the need for invasive ventilation, apnea, nasal trauma, RH, and temperature of the gases.","input_idx":[[836,986]],"output_idx":[[327,599]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4171519,"edit_id":"33f1e815a894ac73b0767e574dfe5c1c","category":"omission","question":"Which parts of the body were tested in the study?","answer":"The femora and lumbar vertebrae were harvested for imaging and mechanical testing.","input_idx":[[695,772]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4171519,"edit_id":"5fa7d5689b05d17f3269b3c8b9995244","category":"omission","question":"Which groups were the blood glucose levels of the raloxifene-treated rats compared to?","answer":"The blood glucose levels of the raloxifene-treated rats were compared to both diabetic vehicle-treated rats and vehicle-treated rats that did not become diabetic.","input_idx":[[888,1058]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4171519,"edit_id":"3a5a18619271537a9a2cdbfea92ceb02","category":"concept","question":"In what specific ways did raloxifene improve bone quality?","answer":"Raloxifene improved bone material and mechanical properties independent of bone mineral density. Specifically, it increased the toughness of the femora and improved the structural (extrinsic) mechanical properties of energy-to-failure, post-yield energy-to-failure, and post-yield displacement.","input_idx":[[139,234]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4183415,"edit_id":"e39019668ee44fe8e93618211fd57dbb","category":"omission","question":"What might have been the problem with the advice given by dispensers?","answer":"The problem was that the dispensers might not have had the correct knowledge about the drug and how to advise patients properly, which could have led to poor adherence to the medication schedule.","input_idx":[[72,141]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4183415,"edit_id":"42c1bf47f8c7160db442aa5e5475737c","category":"omission","question":"What were the interviews with the drug store staff members about?","answer":"The interviews were about the knowledge of AL dispensing practices and whether they received the malaria-related text messages.","input_idx":[[469,592]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4183415,"edit_id":"2f5c90e60f5a0d9d19a7b52e6af40694","category":"concept","question":"What does \"no significant difference\" mean in this context?","answer":"\"No significant difference\" means that the difference between the two groups (intervention and control) was not large enough to be considered statistically significant, meaning it was not likely to be due to chance.","input_idx":[[656,964]],"output_idx":[[415,655]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4183415,"edit_id":"726c8c450777bea69fcf7db7d93c5aa2","category":"concept","question":"Why are more studies needed?","answer":"More studies are needed to see if text messages can be used effectively to improve how patients adhere to their medication schedules. The current study did not find a significant difference in adherence between the intervention and control groups, so more research is needed to determine the effectiveness of text message reminders in improving adherence.","input_idx":[[966,1048]],"output_idx":[[784,917]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4202567,"edit_id":"e49d0b9ed303526f89171fe7e61bfb2d","category":"omission","question":"What type of statistical analysis was used to analyze the results?","answer":"A repeated measures, mixed design ANOVA was used to analyze the results.","input_idx":[[799,838]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4202567,"edit_id":"1271c78e630ef5bf8b6f3739eb906ac3","category":"omission","question":"What is polarity dependence in the context of this study?","answer":"Polarity dependence refers to the idea that the direction of the electrical current (positive or negative) used in tDCS can affect the outcome.","input_idx":[[1305,1360]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4202567,"edit_id":"2b5f952dd04b186fb2920e4027040da1","category":"concept","question":"What is tDCS and how does it work?","answer":"tDCS is a non-invasive brain stimulation technique that uses a small electrical current to stimulate specific areas of the brain. It is considered safe and does not require surgery.","input_idx":[[382,428]],"output_idx":[[309,390]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4202567,"edit_id":"d217ca08e8892b71873726cb5357eb78","category":"concept","question":"What is the DLFPC and why is it important for working memory?","answer":"The DLFPC is a region of the brain that is involved in working memory, which is the ability to temporarily store and manipulate information in our minds. It is important for working memory because it is responsible for organizing and processing information that we receive from our environment.","input_idx":[[223,261]],"output_idx":[[99,210]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4231047,"edit_id":"91280549d8d0c9b7fc41a57f6b2ea6b2","category":"omission","question":"What type of therapy was used in the study?","answer":"The study used targeted radiotherapy of liver malignancies.","input_idx":[[16,59]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4231047,"edit_id":"f46524184cece4789ce179c150296015","category":"omission","question":"What is the limitation of the therapy used in the study?","answer":"The limitation of the therapy used in the study is the low tolerance of the liver parenchyma to radiation.","input_idx":[[108,217]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4231047,"edit_id":"8de202095d225f181baec4ccd6ba7c3d","category":"omission","question":"Who were the participants in the study?","answer":"The participants in the study were patients with liver metastases from colorectal carcinoma.","input_idx":[[459,515]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4231047,"edit_id":"9780b1045672f1da940725e1eae4551d","category":"concept","question":"What type of liver injury was caused by radiation in the study?","answer":"The type of liver injury caused by radiation in the study was focal radiation-induced liver injury (fRILI).","input_idx":[[389,433]],"output_idx":[[372,402]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4231047,"edit_id":"b9c5c1a8082cf2f94b03d8285e74ea0e","category":"concept","question":"What type of MRI was used to assess liver injury in the study?","answer":"The type of MRI used to assess liver injury in the study was functional hepatobiliary magnetic resonance imaging (MRI).","input_idx":[[782,839]],"output_idx":[[701,704]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4231047,"edit_id":"a79fbf2698de5a2834150f8f91b2db9f","category":"concept","question":"What is the definition of the minimal dose in the study?","answer":"The minimal dose in the study is the dose to which the outer rim of the focal radiation-induced liver injury (fRILI) was formerly exposed to.","input_idx":[[841,940]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4236282,"edit_id":"4f04c0f38dba515a6f39a41fa3d5c78e","category":"omission","question":"What were the specifics of the interventions that were tested in the study?","answer":"The interventions were two web-supported methods: motivational interviewing (MIC) and nutrition psychoeducation (NPC), an attention-control intervention.","input_idx":[[98,194]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4236282,"edit_id":"4dbac196a991d0edb1edf812ebeda830","category":"omission","question":"How were the participants assessed at post-treatment and 3-month follow-up?","answer":"The participants were assessed using standardized measures such as weight, triglyceride levels, and depression scores.","input_idx":[[640,719]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4236282,"edit_id":"b94927c6feb0be0c0c11e590803586df","category":"concept","question":"What is motivational interviewing and how does it work?","answer":"Motivational interviewing is a counseling technique that helps people make positive changes in their lives by exploring and resolving ambivalence about change. It is a form of psychotherapy that aims to help people overcome the psychological barriers to change.","input_idx":[[357,388]],"output_idx":[[1269,1293]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4236282,"edit_id":"2a2d782a3dab672515b6c995827dad64","category":"concept","question":"What is nutrition psychoeducation and how does it work?","answer":"Nutrition psychoeducation is a type of intervention that combines education and counseling to help people understand the psychological and emotional aspects of eating and weight management. It aims to help people develop a healthier relationship with food and make positive changes in their eating habits.","input_idx":[[393,424]],"output_idx":[[1340,1362]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4236282,"edit_id":"fe3fd6e8a8d36d194a6c8c7c8c0b3b1d","category":"concept","question":"What is a randomized controlled trial and how is it different from other types of studies?","answer":"A randomized controlled trial is a type of study in which participants are randomly assigned to one of two or more groups, and the groups are then compared to see if there is a difference in the outcome. It is considered the gold standard for evaluating the effectiveness of a treatment or intervention.","input_idx":[[280,315]],"output_idx":[[28,33]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4260384,"edit_id":"5f9a15ffb0b7a0d88c283fd67d40a56e","category":"omission","question":"What was the purpose of this study?","answer":"The purpose of this study was to compare and evaluate the clinical outcome of two treatments for gum recession.","input_idx":[[16,307]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4260384,"edit_id":"e4b85b5a1d61a5e19649d1f8ee07c714","category":"omission","question":"How many people were involved in the study and what was their age range?","answer":"Ten people aged between 20 and 50 were involved in the study.","input_idx":[[339,435]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4260384,"edit_id":"81dfe571f74354180a8bd71a05677f09","category":"omission","question":"What were the two treatments that were compared in the study?","answer":"The two treatments that were compared in the study were the envelope type of CAF alone and the envelope type of CAF plus the Type I collagen membrane (NEOMEM).","input_idx":[[436,658]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4260384,"edit_id":"c93d99c83da50e1980863677aed58f4b","category":"concept","question":"What specific measurements were taken by the team at the start of the study and after three and six months?","answer":"The team measured the recession depth (RD), probing depth (PD), clinical attachment level (CAL), and width of the keratinized tissue (KT) at the start of the study and after three and six months.","input_idx":[[659,839]],"output_idx":[[604,746]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4260384,"edit_id":"e822fdf979559c50213935d69b271ab5","category":"concept","question":"What were the specific values for the baseline gingival recession in each group?","answer":"In Group B, the average original depth of the gum recession was 2.34 \u00b1 0.48 mm, while in Group A, the average original depth of the gum recession was 2.52 \u00b1 0.84 mm.","input_idx":[[918,1103]],"output_idx":[[903,995]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4262215,"edit_id":"8d4e40b857b10df14fd8405b8b54e079","category":"omission","question":"What was the goal of this study?","answer":"The goal of this study was to investigate the impact of mental clinical nursing pathways on suicidal ideation and life quality in patients with malignant tumors.","input_idx":[[12,172]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4262215,"edit_id":"8fc823949f6688c51d76449d021e23ec","category":"omission","question":"How many patients were included in the study?","answer":"Two hundred patients with malignant tumors were included in the study, with 100 patients in each group.","input_idx":[[183,320]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4262215,"edit_id":"7cefb97923a363ecf29c330634da6bda","category":"omission","question":"What kind of care did patients in the study group receive?","answer":"Patients in the study group received mental clinical nursing pathway care, which included timely inspection, nurse's reactions to patient's behavior, and execution of medical orders.","input_idx":[[343,586]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4262215,"edit_id":"68c669b5750443cef624965ae1c5bb90","category":"concept","question":"What is the name of the scale used to measure suicidal ideation?","answer":"The specific name of the scale used to measure suicidal ideation is not mentioned, but it is a self-rating scale.","input_idx":[[599,638]],"output_idx":[[497,535]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4262215,"edit_id":"4eef2174dbe0622a29680014b726bf1f","category":"concept","question":"What is the name of the method used to assess physical and mental abilities?","answer":"The specific name of the method used to assess physical and mental abilities is not mentioned, but it is Karnofsky Performance Status\/KPS.","input_idx":[[643,677]],"output_idx":[[540,623]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4283690,"edit_id":"1722618d0074f6d75799121e16826ee0","category":"omission","question":"What specific survey was used to measure productivity?","answer":"The arthritis-specific Work Productivity Survey (WPS) was used which gives insights about the physical, social, and emotional status of patients with bowel diseases.","input_idx":[[437,625]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4283690,"edit_id":"f7ef6014d68598cfe4898908801f6701","category":"omission","question":"Besides work productivity, what other aspects of life did CZP improve?","answer":"CZP also improved household productivity and participation in family, social and leisure activities.","input_idx":[[1196,1342]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4283690,"edit_id":"35e6202dcb312513324c13bcc9a8a3f8","category":"concept","question":"What was the name of the trial that this study was a part of?","answer":"The trial was called RAPID-PsA and its registration number is NCT01087788.","input_idx":[[230,253]],"output_idx":[[311,360]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4283690,"edit_id":"9bbb84c5671c567daa11fa3424dc7074","category":"concept","question":"What was the dosage and frequency of CZP that was given to the patients?","answer":"Patients were randomized to receive either 200 mg of CZP every 2 weeks or 400 mg of CZP every 4 weeks.","input_idx":[[371,435]],"output_idx":[[381,404]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4302388,"edit_id":"d22d1cd808b8c95363532be2d5662dea","category":"omission","question":"What is the connection between the mineral selenium and high blood pressure conditions during pregnancy?","answer":"The study found that low levels of selenium may increase the risk of developing pregnancy-induced hypertension (PIH) and pre-eclampsia (PE) in pregnant women.","input_idx":[[0,180]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4302388,"edit_id":"9798bacf30142e5df29a68d05d551866","category":"omission","question":"What specific measurements were taken to assess the women's selenium levels?","answer":"The researchers measured whole-blood selenium concentration at 12 and 35 weeks, toenail selenium concentration at 16 weeks, plasma selenoprotein P (SEPP1) concentration at 35 weeks and plasma glutathione peroxidase (GPx3) activity at 12, 20 and 35 weeks.","input_idx":[[547,777]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4302388,"edit_id":"40178bb621105801b42465f5ffd6055b","category":"omission","question":"What specific factors were found to positively impact selenium levels?","answer":"The study found that maternal age, education and social class were positively associated with Se status.","input_idx":[[1156,1239]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4302388,"edit_id":"8a87a6bd6721c8d932a5162af125f719","category":"concept","question":"How statistically significant was the relationship between toenail selenium and the risk of developing PE\/PIH?","answer":"The study found that the lower the selenium level in the toenails, the higher the chances were for a woman to develop PIH or PE, and this relationship was statistically significant (OR 0\u00b738, 95 % CI 0\u00b717, 0\u00b787, P= 0\u00b7021).","input_idx":[[1415,1598]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4302388,"edit_id":"9ced2d5a355966c6cb738dd91e3b5747","category":"concept","question":"How statistically significant was the relationship between selenium supplementation and the risk of developing PE\/PIH after excluding non-compliers?","answer":"The study found that taking the selenium supplement significantly reduced the risk of developing PE\/PIH (OR 0\u00b730, 95 % CI 0\u00b709, 1\u00b700, P= 0\u00b7049) after excluding non-compliers.","input_idx":[[1599,1749]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4313493,"edit_id":"b781d155868b94fc2e5cc5932a41f98d","category":"omission","question":"What was the specific eye condition of the participants in the study?","answer":"The participants had primary open-angle glaucoma (POAG) or ocular hypertension (OHT).","input_idx":[[263,334]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4313493,"edit_id":"2791aaa2fd3d7b87db2267edec71e503","category":"omission","question":"How long did the participants receive the eye drops?","answer":"The participants received the eye drops for a month.","input_idx":[[468,630]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4313493,"edit_id":"ae4e796a003b478d84f87302a04cc7ea","category":"omission","question":"What was the purpose of the washout period?","answer":"The washout period was to ensure that the effects of the previous treatment had worn off before starting the next treatment.","input_idx":[[631,778]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4313493,"edit_id":"053ae0e4ad72af60e0c947e53927b46b","category":"concept","question":"What statistical method was used to compare the efficacy of the two drugs?","answer":"The statistical method used was an independent samples t-test.","input_idx":[[1022,1096]],"output_idx":[[938,1015]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4313493,"edit_id":"d46c6fad117843c14ab56e5c8faef325","category":"concept","question":"How significant was the difference in eye pressure reduction between the two drugs?","answer":"The difference in eye pressure reduction was statistically significant (P < 0.0001).","input_idx":[[1107,1232]],"output_idx":[[1026,1130]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4313493,"edit_id":"1f55c6577be20ee715ddedf8ac345734","category":"concept","question":"How was the cost-effectiveness calculated?","answer":"The cost-effectiveness was calculated by dividing the daily cost of the drug by the amount of eye pressure it lowered.","input_idx":[[816,926]],"output_idx":[[785,909]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4323432,"edit_id":"ea372026b1c544ca3eaaf54627023eb5","category":"omission","question":"What is the context of this study?","answer":"The study was investigating the suppression of peristalsis during GI endoscopy.","input_idx":[[17,85]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4323432,"edit_id":"adb7c9c58a026a04731da518c8048d8b","category":"omission","question":"What were the specific goals of this study?","answer":"The study aimed to examine the efficacy of oral phloroglucin for the suppression of peristalsis, its impact on patient compliance, and any associated complications, and compare it with intravenous or intramuscular cimetropium bromide administration.","input_idx":[[201,444]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4323432,"edit_id":"ee3255f58b259ed07cb485b96d24eed7","category":"concept","question":"How was the study designed?","answer":"The study was designed as a randomized, investigator-blind, prospective comparative study.","input_idx":[[455,528]],"output_idx":[[409,496]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4323432,"edit_id":"bc2e5aa39e5ce5b88c6440fad8bbbd97","category":"concept","question":"How were the patients included in the study?","answer":"The patients were included in the study by being randomly divided into two groups according to the medications administered prior to upper endoscopy.","input_idx":[[529,738]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4323432,"edit_id":"f991d43599a2b317fa401dbad58c9a87","category":"concept","question":"What specific parts of the digestive system were assessed and how were they assessed?","answer":"The researchers assessed the number and intensity of muscle contractions in the antrum and second duodenal portion of the digestive system for 30 seconds. The antrum is the muscular sac at the bottom of the stomach and the second duodenal portion is a part of the small intestine.","input_idx":[[739,860]],"output_idx":[[643,774]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4329963,"edit_id":"3714ed40e2295db4e617972be744e233","category":"omission","question":"What specific health promotion model was used in the study?","answer":"The study used Pender's health promotion models.","input_idx":[[388,420]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4329963,"edit_id":"cf9fbe033fd205ea08a234835ffebf09","category":"concept","question":"What specific questions were asked in the study?","answer":"The study used a demographic checklist and a standard questionnaire that included questions about lifestyle, health-related quality of life, self-efficacy, perceived affect, perceived social support, and perceived barriers.","input_idx":[[1008,1210]],"output_idx":[[643,762]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4334515,"edit_id":"22da837c7e2550d083fbe2070f7cd49b","category":"omission","question":"Who is the organization that emphasizes the importance of accessible and cost-effective caregiver support?","answer":"The World Health Organization is the organization that emphasizes the importance of accessible and cost-effective caregiver support.","input_idx":[[12,117]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4334515,"edit_id":"adbcdc9dcc72a9b641c024adb39da1a8","category":"omission","question":"What type of intervention was being assessed in the study?","answer":"The study assessed the effectiveness of the Internet intervention 'Mastery over Dementia'.","input_idx":[[270,356]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4334515,"edit_id":"8b581bf1611817a2b3fa69c23c671fd1","category":"concept","question":"What was the nature of the minimal intervention received by the control group?","answer":"The control group received informational emails.","input_idx":[[456,601]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4334515,"edit_id":"3a3fda5462a936cde0f7f37d62aff45c","category":"concept","question":"What specific scales were used to measure depression and anxiety?","answer":"The study used the Center for Epidemiologic Studies Depression Scale (CES-D) to measure depression and the Hospital Anxiety and Depression Scale (HADS-A) to measure anxiety.","input_idx":[[603,758]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4354356,"edit_id":"4f6ece91d9ad271073422f5d01512d72","category":"omission","question":"What role does the striatum play in drug reward?","answer":"The striatum is a part of the brain that plays a crucial role in mediating the subjective rewarding effects of acute drug intake.","input_idx":[[0,129]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4354356,"edit_id":"97e9f8b0e8cde7d156165e2e17a40ab7","category":"omission","question":"When do the positive and negative reinforcement effects of drug addiction typically occur?","answer":"The positive reinforcement effects of drug addiction are typically more involved in the early phases of the illness, while the negative reinforcement effects may occur more in later stages.","input_idx":[[131,306]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4354356,"edit_id":"da9858d8092517a9d8ea3e44a506ce2c","category":"omission","question":"What technique was used in this study to study the brains of long-term heroin users?","answer":"The study used resting-state functional magnetic resonance imaging to study the brains of long-term heroin users.","input_idx":[[307,531]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4354356,"edit_id":"a800163dba0b2a4c96b24821495575fc","category":"concept","question":"What specific techniques were used in this study to compare the brain activity of heroin users and healthy individuals?","answer":"The study used independent component analysis and a dual regression approach to compare resting-state functional connectivity (rsFC) strengths within the basal ganglia\/limbic network across a group of heroin-dependent patients receiving both an acute infusion of heroin and placebo and 20 healthy subjects who received placebo only.","input_idx":[[532,857]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4354356,"edit_id":"5912c5509b1dc5b92c76583d16dd1b24","category":"concept","question":"How was the correlation between the rsFC strength and the plasma level of morphine determined?","answer":"The correlation between the rsFC strength and the plasma level of morphine was determined by performing subsequent correlation analyses.","input_idx":[[1085,1341]],"output_idx":[[651,865]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4355443,"edit_id":"1d16128771f91c54ce75694b4196ffd9","category":"omission","question":"When was the study conducted?","answer":"The study was conducted from April 2010 to July 2012.","input_idx":[[107,127]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4355443,"edit_id":"2b0d7a14429f63c73e26366ca368f77e","category":"omission","question":"How many people were included in the study?","answer":"24 people were included in the study.","input_idx":[[129,192]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4355443,"edit_id":"c19ceabe84136d255108941446d90e90","category":"omission","question":"What were the treatment protocols for SIRT and DEB-TACE?","answer":"SIRT could be repeated once if the cancer came back, while DEB-TACE was repeated every 6 weeks until MRI scans showed no sign of cancer, or further treatment wasn't advisable due to other health reasons.","input_idx":[[242,431]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4355443,"edit_id":"969ea5fabc0dcbf75a739e706ad4dcdf","category":"omission","question":"How often were patients followed up with MRI scans?","answer":"Patients were followed up with MRI scans every 3 months, and the final evaluation was in May 2013.","input_idx":[[432,514]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4355443,"edit_id":"0557ff851440bb08380553551c737ef0","category":"concept","question":"What are SIRT and DEB-TACE?","answer":"SIRT and DEB-TACE are two different treatments for liver cancer. SIRT stands for Selective Insulin-Like Growth Factor Receptor Tyrosine Kinase Inhibitor and DEB-TACE stands for Drug-Eluting Beads-Thermal Ablation of Hepatic Arteries.","input_idx":[[34,51]],"output_idx":[[39,83]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4355443,"edit_id":"071697348d0cdb3f6db995abdd891bb6","category":"concept","question":"What is BCLC?","answer":"BCLC is a liver cancer staging system that categorizes liver cancer into four stages based on the extent of the cancer and the patient's overall health.","input_idx":[[720,762]],"output_idx":[[816,843]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4355443,"edit_id":"57114f07130d3b58341adb82dcc7c77a","category":"concept","question":"What is PFS?","answer":"PFS is a measure of how long a treatment can delay the progression of a disease, in this case, liver cancer.","input_idx":[[793,831]],"output_idx":[[1364,1397]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4355443,"edit_id":"2cf8bf287091b70a35863129183637f1","category":"concept","question":"What is OS?","answer":"OS is a measure of how long a patient lives after being diagnosed with a disease, in this case, liver cancer.","input_idx":null,"output_idx":[[1339,1362]],"annotator":"mistral-7b","prediction_errors":["invalid_input_localization"]},{"PMCID":4358417,"edit_id":"71ab25d1288c097be29388094b04bf8d","category":"omission","question":"How did the researchers find out that rosehip extract could help with obesity?","answer":"The researchers screened various foods and found that rosehip extract showed potent anti-obesity effects.","input_idx":[[67,132]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4358417,"edit_id":"a9001844e792395570b2ae1d081b077f","category":"omission","question":"What kind of tests were done on mice to show that rosehip extract can reduce weight gain and belly fat?","answer":"The researchers conducted tests on mice and found that rosehip extract inhibited body weight gain and decreased visceral fat.","input_idx":[[204,319]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4358417,"edit_id":"23d91d9ebdf843b20e2cdab6da167829","category":"omission","question":"What were the criteria used to define preobese subjects in the study?","answer":"The study involved 32 subjects who had a body mass index of \u226525 but <30, which is the definition of preobese.","input_idx":[[326,422]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4358417,"edit_id":"8b722bb22bb354b737a8de69c8a4e994","category":"concept","question":"How were the participants divided into two groups in the study?","answer":"The participants were randomly assigned to two groups, and the study was double-blinded, meaning that neither the researchers nor the participants knew which group they were in.","input_idx":[[580,777]],"output_idx":[[382,609]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4358417,"edit_id":"3de8e2c359ceb714f7470af591b4125d","category":"concept","question":"What statistical tests were used to compare the changes in the parameters between the rosehip and placebo groups?","answer":"The study used a double-blind, randomized, placebo-controlled design, and the changes in the parameters (abdominal total fat area, abdominal visceral fat area, body weight, and body mass index) were compared between the two groups using statistical tests (P<0.01).","input_idx":[[920,1262]],"output_idx":[[768,956]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4360612,"edit_id":"225967d246a8060b52b6353f72575965","category":"omission","question":"What is the common cause of lower back pain?","answer":"Lower back pain can be caused by a variety of factors, including SI joint pain.","input_idx":[[12,95]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4360612,"edit_id":"8d825822b279d3e10f201e64cf990c7e","category":"omission","question":"What is the goal of SI joint fusion?","answer":"The goal of SI joint fusion is to relieve pain and improve quality of life in patients who have failed nonoperative care.","input_idx":[[96,203]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4360612,"edit_id":"e6cd5f83b36c8678cb80ded4d4727050","category":"omission","question":"What is the significance of this study?","answer":"This study is significant because it is the first to compare surgical and non-surgical treatments for chronic SI joint dysfunction.","input_idx":[[204,318]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4360612,"edit_id":"ec8ae1bb71822942fd0bfa8320113762","category":"concept","question":"What specific measures were used to assess pain and disability in the study?","answer":"The study used four specific measures to assess pain and disability: SI joint pain scores, Oswestry Disability Index (ODI), Short-Form 36 (SF-36) and EuroQol-5D (EQ-5D).","input_idx":[[636,735]],"output_idx":[[598,617]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4360612,"edit_id":"5727b5f90c35aa8e00b5bf9b5b50de19","category":"concept","question":"How was success defined in the study?","answer":"Success was defined as the proportion of treated subjects with a 20-mm improvement in SI joint pain in the absence of severe device-related or neurologic SI joint-related adverse events or surgical revision.","input_idx":[[818,1037]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4382580,"edit_id":"b69c8bf12b2437cb35318846dafc01e2","category":"omission","question":"What specific measurements were taken during the evaluation of the patients?","answer":"The specific measurements taken during the evaluation of the patients included trunk and hip range of motion, goniometry, trunk and hip muscle strength assessment using load cell, and surface electromyography of the iliocostalis, long dorsal (longissimus), gluteus maximus, gluteus medius and tensor fasciae latae muscles.","input_idx":[[411,653]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4382580,"edit_id":"d610e070f6b728f09678b71ca97cdafa","category":"concept","question":"How effective was the physical therapy treatment for patients with sickle cell disease?","answer":"The physical therapy treatment was effective for patients with sickle cell disease in reducing hip and lower back pain, and improving overall fitness.","input_idx":[[1500,1630]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4391192,"edit_id":"f1b6cf27212027ac0748d58cfe24df94","category":"omission","question":"What are the factors that cause sleep deprivation in ICU patients?","answer":"The factors that cause sleep deprivation in ICU patients are noise and light.","input_idx":[[14,170]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4391192,"edit_id":"7211ddeb241a3ff2276f0525e9ea6c71","category":"omission","question":"What were the results of previous studies on earplugs and eye masks for improving sleep in ICU patients?","answer":"Previous studies showed that earplugs and eye masks can improve REM sleep in healthy subjects in simulated ICU environment and improve sleep quality in ICU patients.","input_idx":[[171,346]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4391192,"edit_id":"e6e8162059af97def633eb6fe5879c10","category":"omission","question":"What were the specific goals of this study?","answer":"The specific goals of this study were to determine the effects of using earplugs and eye masks with relaxing background music on sleep, melatonin and cortisol levels in ICU patients.","input_idx":[[347,508]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4391192,"edit_id":"16112f39e74fd1b508b24c99b4f7e91f","category":"concept","question":"What were the specific criteria for patient inclusion in this study?","answer":"The specific criteria for patient inclusion were that they underwent a scheduled cardiac surgery and were expected to stay at least 2 nights in Cardiac Surgical ICU (CSICU).","input_idx":[[519,666]],"output_idx":[[381,488]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4391192,"edit_id":"1c5023194d89884c456bd9d7f2c2cb9f","category":"concept","question":"How were the patients randomly chosen for the intervention and control groups?","answer":"The patients were randomly chosen for the intervention and control groups by assigning them to either sleep with earplugs, eye masks, and 30 minutes of soothing music or without them.","input_idx":[[667,816]],"output_idx":[[489,589]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4391192,"edit_id":"47a4b53790917746c0d4258ff5f25600","category":"concept","question":"What hormones were measured in the urine?","answer":"The hormones that were measured in the urine were nocturnal melatonin and cortisol levels.","input_idx":[[817,880]],"output_idx":[[590,650]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4398332,"edit_id":"ba39b58e1f148389a19fef3849b7aa0e","category":"omission","question":"What was the purpose of this study?","answer":"The purpose of this study was to investigate the effects of THC and CBD on emotional facial affect recognition.","input_idx":[[324,451]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4398332,"edit_id":"a95b6f997b95293a61da88047699126e","category":"omission","question":"What tool was used to measure the effects of the drugs?","answer":"A visual analogue scale (VAS) was used to measure the effects of the drugs.","input_idx":[[854,923]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4398332,"edit_id":"0b498714e0fd1c56ae711d1462ba3a6b","category":"concept","question":"How does THC impair human facial affect recognition?","answer":"THC impairs human facial affect recognition by making it harder to distinguish between different emotions, particularly when the emotions are not very strong.","input_idx":[[99,146]],"output_idx":[[109,173]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4398332,"edit_id":"3932991dd839f0d6bdd6032d3ce5d1e9","category":"concept","question":"How does CBD improve emotional facial affect recognition?","answer":"CBD improves emotional facial affect recognition by making it easier to distinguish between different emotions, particularly when the emotions are not very strong.","input_idx":[[950,998]],"output_idx":[[181,268]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4398332,"edit_id":"eba76ea1c882582f0cfbc68e43c5674c","category":"concept","question":"How does THC affect the recognition of ambiguous faces?","answer":"THC affects the recognition of ambiguous faces by making it harder to distinguish between different emotions, particularly when the emotions are not very strong.","input_idx":[[1027,1101]],"output_idx":[[109,173]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4435702,"edit_id":"8b50fc846737574220ccccbd11984040","category":"omission","question":"How long did the symptomatic relief last for patients who received the lower dosage of VM202?","answer":"The symptomatic relief lasted for 3 months for patients who received the lower dosage of VM202.","input_idx":[[1516,1633]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4435702,"edit_id":"8204c169ac76f875abf1beb95e7dc6db","category":"omission","question":"Which specific pain medicines were patients not taking when they received the VM202 treatment?","answer":"Patients who were not taking pregabalin or gabapentin had the largest reductions in pain. Pregabalin and gabapentin are commonly used medications for nerve pain.","input_idx":[[1282,1358]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4435702,"edit_id":"4c53901fb94e10e9e16f000f86d2f70b","category":"concept","question":"Was the study designed to measure the change in pain score over time?","answer":"Yes, the study was designed to measure the change in pain score over time. The primary outcome was measured prospectively, meaning that the study was designed to measure this outcome.","input_idx":[[402,494]],"output_idx":[[462,575]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4435702,"edit_id":"2eb1610c3bad5db041373501254d173a","category":"concept","question":"Was the dosage of VM202 randomly assigned to patients?","answer":"Yes, the dosage of VM202 was randomly assigned to patients. The study was designed to compare the effectiveness of different dosages.","input_idx":null,"output_idx":[[847,942]],"annotator":"mistral-7b","prediction_errors":["invalid_input_localization"]},{"PMCID":4439020,"edit_id":"bb357ba4f51677a0bf689b802b98da31","category":"omission","question":"What is the condition that the study is investigating?","answer":"The study is investigating the condition where air fills up the brain cavities after a type of brain surgery in the semisitting position.","input_idx":[[12,99]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4439020,"edit_id":"4fcbe42411b420c44f78f40fb996bc73","category":"omission","question":"What type of oxygen therapy was administered and for how long?","answer":"The study administered pure oxygen through a breathing tube for 3 hours.","input_idx":[[529,600]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4439020,"edit_id":"ace51b34e722c9b445a7d4eed2ee5e79","category":"concept","question":"How was the reduction in air build-up measured?","answer":"The reduction in air build-up was measured by the change in pneumocephalus volume, which was assessed through routine cranial CT scans.","input_idx":[[846,882]],"output_idx":[[801,821]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4439020,"edit_id":"27254efa36f0b1e688f9d43c67fbd90a","category":"concept","question":"How was the rate of air build-up reduction measured?","answer":"The rate of air build-up reduction was measured by the change in pneumocephalus volume, which was assessed through routine cranial CT scans.","input_idx":[[893,924]],"output_idx":[[801,821]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4439020,"edit_id":"57e62e163534edbe38f70fb8324d1e2c","category":"concept","question":"How was the alertness level measured?","answer":"The alertness level was measured using the Stanford Sleepiness Scale, which is a standardized tool used to assess the level of alertness in individuals.","input_idx":[[973,998]],"output_idx":[[1071,1086]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4450858,"edit_id":"0bff43ed73433b55ed7e46533f3526b5","category":"omission","question":"Were the outcomes for the mother and baby the same in both groups?","answer":"Yes, the outcomes for the mother and baby were similar in both groups.","input_idx":[[1225,1269]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4450858,"edit_id":"6cca877a952cb435cfd5264f2f9c5b5f","category":"omission","question":"What kind of discomfort did most women experience with the catheter?","answer":"Most women in both groups reported discomfort with insertion and wearing the catheter.","input_idx":[[1539,1624]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4450858,"edit_id":"5427922c973a90b32e2fed5b4bd27e71","category":"concept","question":"How was the outpatient balloon catheter ripening compared to the usual inpatient care?","answer":"The outpatient balloon catheter ripening was compared to the usual inpatient care in terms of clinical pathways and acceptability to both women and clinicians.","input_idx":[[547,686]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4450858,"edit_id":"0cbb25a75b47e2c83ec5b911f2142035","category":"concept","question":"How satisfied were the women with their care and how did they feel about the safety of their baby?","answer":"Most women in both groups reported discomfort with the catheter, but were equally satisfied with their care and felt the baby was safe.","input_idx":[[1539,1695]],"output_idx":[[1411,1467]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4472927,"edit_id":"c58965d0401026fd108de36b2ea4b264","category":"omission","question":"What are the different effects of different amounts of alcohol on the human body?","answer":"Different amounts of alcohol can have different effects on the human body, such as changes in mood, coordination, and liver function.","input_idx":[[0,81]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4472927,"edit_id":"2534faf9e80de0bac9381938829be212","category":"omission","question":"What is the topic of the research?","answer":"The topic of the research is the relationship between chronic alcohol consumption and Helicobacter pylori infection.","input_idx":[[83,183]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4472927,"edit_id":"0b3db8d2ff0ea2219b9f52059094f878","category":"omission","question":"How were the groups matched and comparable?","answer":"The groups were matched and comparable based on certain criteria, such as age, serum H. pylori CagA levels, mean drinking age, and mean daily alcohol consumption.","input_idx":[[784,992]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4472927,"edit_id":"5b10af9e49d08b296dd15f29d18ea8d6","category":"omission","question":"What was the result of the comparison of BMIs among the three groups?","answer":"The result of the comparison of BMIs among the three groups was that the BMIs in groups A and B were significantly higher than the BMI in group C.","input_idx":[[993,1116]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4472927,"edit_id":"4d4ce9d91abbda2013d7fbc29d0ea546","category":"omission","question":"What was the result of the comparison of BMIs between group A and group B?","answer":"The result of the comparison of BMIs between group A and group B was that the BMIs in group A and group B were significantly higher than the BMI in group C, but the difference between group A and group B was not statistically significant.","input_idx":[[1118,1330]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4472927,"edit_id":"e9c1e0c02a795a80018863b23e491c63","category":"omission","question":"What was the result of the comparison of serum CagA levels among the three groups?","answer":"The result of the comparison of serum CagA levels among the three groups was that no differences were found in the serum CagA levels among the groups.","input_idx":[[1346,1441]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4472927,"edit_id":"10a4ff75821a5ae0ca92c641370a576f","category":"omission","question":"What was the result of the comparison of serum IL-10 and E-selectin levels between group A and group B?","answer":"The result of the comparison of serum IL-10 and E-selectin levels between group A and group B was that the serum IL-10 and E-selectin levels in group A were significantly lower than those in group B.","input_idx":[[1443,1580]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4472927,"edit_id":"5fa79d029cf64944f9a93aefe8b84f7a","category":"omission","question":"What was the result of the comparison of serum IL-10 levels between group A and group C?","answer":"The result of the comparison of serum IL-10 levels between group A and group C was that the serum IL-10 in group A was significantly higher than that in group C.","input_idx":[[1582,1663]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4472927,"edit_id":"f83e714c8a61de513e63a815ccfc9003","category":"omission","question":"What was the result of the comparison of serum E-selectin levels between group A and group C?","answer":"The result of the comparison of serum E-selectin levels between group A and group C was that the serum E-selectin levels in group A did not significantly differ compared with those in group C.","input_idx":[[1665,1772]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4472927,"edit_id":"f2ac691d6b58faad4cae37fe75e83ebf","category":"omission","question":"What was the result of the comparison of serum IL-10 and E-selectin levels between group B and group C?","answer":"The result of the comparison of serum IL-10 and E-selectin levels between group B and group C was that the serum IL-10 and E-selectin levels in group B were significantly higher than those in group C.","input_idx":[[1787,1926]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4472927,"edit_id":"d63a4d75112bd63ebc085083896e6321","category":"omission","question":"What was the result of the comparison of serum TNF-\u03b1 levels among the three groups?","answer":"The result of the comparison of serum TNF-\u03b1 levels among the three groups was that the serum TNF-\u03b1 levels did not differ among the groups.","input_idx":[[1928,2000]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4472927,"edit_id":"3bd6c10efb9534ef43e708f2f49ecbc2","category":"omission","question":"What was the result of the comparison of serum levels of MDA and SOD among the three groups?","answer":"The result of the comparison of serum levels of MDA and SOD among the three groups was that the serum levels of MDA and SOD in groups A and B were slightly lower than those in group C, but there were no significant differences among the groups.","input_idx":[[2002,2167]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4472927,"edit_id":"9defba365b580c28d182d4c651fb21db","category":"concept","question":"What was the main goal of the study?","answer":"The main goal of the study was to understand how long-term alcohol intake relates to a specific stomach infection caused by a bacteria called H. pylori.","input_idx":[[185,344]],"output_idx":[[0,130]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4488551,"edit_id":"49dce926444ddf661f22d0dbfa4f5ab6","category":"omission","question":"What is the source of stress that is induced by physical activity?","answer":"The source of stress that is induced by physical activity is not specified in the simplification.","input_idx":[[4,51]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4488551,"edit_id":"c5a43302566fd806363e8c7ec30bbf4b","category":"omission","question":"What are the specific effects of physical activity on the body?","answer":"The specific effects of physical activity on the body are not specified in the simplification.","input_idx":[[97,146]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4488551,"edit_id":"4746a65ee7d40c619aa84414f9b0e0e1","category":"omission","question":"Under what condition was the increase in sIgA levels observed?","answer":"The increase in sIgA levels was observed at rest after 90 days of Asx supplementation.","input_idx":[[622,688]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4488551,"edit_id":"5fde494da45ae5223b76b7a54da58c86","category":"concept","question":"What does \"prooxidant-antioxidant balance\" mean?","answer":"\"Prooxidant-antioxidant balance\" refers to the balance between the production of reactive oxygen species (prooxidants) and the neutralization of these species by antioxidants in the body. A decrease in this balance can indicate an increase in oxidative stress.","input_idx":[[717,761]],"output_idx":[[808,855]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4488551,"edit_id":"3a530959c45063bf5563d920582ba217","category":"concept","question":"Where in the body are the muscle enzymes located?","answer":"The muscle enzymes are located in the muscles of the body.","input_idx":[[767,795]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4488551,"edit_id":"f8a4c64c6dfcad4e22627de78c75809f","category":"concept","question":"What do \"neutrophil count\" and \"hs-CRP level\" mean?","answer":"\"Neutrophil count\" refers to the number of neutrophils in the blood, which are a type of white blood cell that plays a role in the body's defense against infection. \"hs-CRP level\" refers to the level of C-reactive protein (CRP) in the blood, which is a marker of inflammation. A rise in both of these measures indicates an increase in the body's inflammatory response.","input_idx":[[875,920]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4493951,"edit_id":"8da74a635236232ee52227fd4d97a504","category":"omission","question":"What is the purpose of this study?","answer":"The purpose of this study was to identify which dose of haloperidol (1mg or 2mg) could be combined with dexamethasone without adverse effects in high-risk patients undergoing gynecological laparoscopic surgery.","input_idx":[[12,120]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4493951,"edit_id":"6af8ee2eaf653a3f49a96e02ee0906f6","category":"omission","question":"What were the criteria used to select the participants in this study?","answer":"The participants were selected based on three established PONV risk factors based on Apfel's score.","input_idx":[[471,558]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4493951,"edit_id":"136bb2ad969211e30798911de5426e67","category":"omission","question":"What drugs were given to the participants in this study?","answer":"The participants were given intravenous (IV) saline, haloperidol 1 mg, and haloperidol 2 mg, respectively.","input_idx":[[607,744]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4493951,"edit_id":"7df3adbe87001e9c75ad59901fd3b327","category":"concept","question":"What specific outcomes were measured in this study?","answer":"The study measured the overall early (0\u20132 h) and late (2\u201324 h) incidences of nausea, vomiting, rescue anti-emetic administration, pain, and adverse effects (cardiac arrhythmias and extrapyramidal effects).","input_idx":[[824,1009]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4493951,"edit_id":"ceffa40be9223e2b5dbc9c8f8ce0b457","category":"concept","question":"What tool was used to measure sedation in the study?","answer":"The sedation score was recorded in the postanesthesia care unit (PACU).","input_idx":[[1041,1111]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4517637,"edit_id":"3d5a2d05e9fdd8045cc3e2a1f5226ed5","category":"omission","question":"What is the risk of negative protein balance in infants undergoing cardiac surgery?","answer":"Infants undergoing cardiac surgery are at risk of a negative protein balance due to increased proteolysis in response to surgery and the cardiopulmonary bypass circuit, and limited intake.","input_idx":[[12,88]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4517637,"edit_id":"d667207f401b3a6449afb313832a9234","category":"omission","question":"What was the specific aim of the study?","answer":"The study aimed to quantify the effect on protein kinetics of a short-term high-protein diet in infants following cardiac surgery.","input_idx":[[202,345]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4517637,"edit_id":"ce82c050ade66a57ba18b26f84cd4f13","category":"concept","question":"How was the test done to measure the valine kinetics and fractional albumin synthesis rate?","answer":"The test was done using mass spectrometry with [1-13C]valine infusion. This is a technique that uses isotopes to track the movement of valine in the body and measure how much of it is being synthesized.","input_idx":[[625,753]],"output_idx":[[585,689]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4517637,"edit_id":"51088403dd65e38e0c9b7294249429d9","category":"concept","question":"What statistical method was used to compare the results between the two groups?","answer":"The Mann\u2013Whitney U test was used to investigate differences between group medians. This is a non-parametric test that is used to compare the medians of two groups and determine if there is a significant difference between them.","input_idx":[[755,836]],"output_idx":[[786,822]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4555141,"edit_id":"133d24ea7d47cc56da264d30d01d4390","category":"omission","question":"What was the main goal of this study?","answer":"The main goal of this study was to examine the long-term cognitive and social-emotional effects of multiple micronutrient supplementation compared with iron supplementation alone, administered during infancy.","input_idx":[[226,434]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4555141,"edit_id":"bac18ead2e97f8e1751f31dab479da05","category":"omission","question":"What tests were done on the children in the follow-up trial?","answer":"The children were assessed for intelligence, working memory, inhibition, and executive function.","input_idx":[[766,996]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4555141,"edit_id":"35ed76949a880ea066b497cb722371b3","category":"concept","question":"How long did the babies receive the supplements?","answer":"The babies received the supplements for six months.","input_idx":[[707,765]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4555141,"edit_id":"227f948755dd974ca994b1515ea54eb0","category":"concept","question":"What did the results show?","answer":"The results showed that the type of supplement they had as babies did not make a difference in these areas.","input_idx":null,"output_idx":[[716,822]],"annotator":"mistral-7b","prediction_errors":["invalid_input_localization"]},{"PMCID":4562579,"edit_id":"2863daa272e08d28e1f0cc0ae15832f4","category":"omission","question":"What is Myofibrillar FSR and what does it measure?","answer":"Myofibrillar FSR stands for Myofibrillar protein synthesis rate and it measures the rate at which muscle tissue produces new proteins after exercise.","input_idx":[[1438,1454]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4562579,"edit_id":"4384779c35cef4b5ef880c7b635401ba","category":"concept","question":"What is anabolic resistance and how does it affect muscles?","answer":"Anabolic resistance is a condition where the body's ability to build muscle tissue is reduced. This can be caused by a variety of factors, including aging, lack of physical activity, and certain medical conditions. In this study, the researchers found that older adults who took fewer steps (SR) had anabolic resistance, which led to weaker muscles.","input_idx":[[133,152]],"output_idx":[[96,110]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4574984,"edit_id":"5cfe2d62b6351a26166aad8d09debc55","category":"omission","question":"What was the intervention used in this study?","answer":"The intervention used in this study was patient empowerment through information booklet and diary keeping.","input_idx":[[548,613]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4574984,"edit_id":"201905c61cded2e4018ab88c26f9f8e3","category":"omission","question":"What was the primary outcome of this study?","answer":"The primary outcome of this study was postoperative length of hospital stay.","input_idx":[[785,828]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4574984,"edit_id":"b3a95aa5f280065c27269763287a7772","category":"omission","question":"What was the secondary outcome of this study?","answer":"The secondary outcome of this study was long-term global health-related quality of life one year postoperatively.","input_idx":[[836,916]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4574984,"edit_id":"b24a2588eed2fc316244f9ae85fd4ae4","category":"concept","question":"What exactly was the intervention used in this study?","answer":"The intervention used in this study was patient empowerment through information booklet and diary keeping.","input_idx":[[548,613]],"output_idx":[[538,569]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4574984,"edit_id":"eb53c9bc7b069be3fc8acce609ac6611","category":"concept","question":"What type of stress and complications were measured in this study?","answer":"The type of stress and complications that were measured in this study were not specified.","input_idx":[[1007,1045]],"output_idx":[[758,786]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4574984,"edit_id":"f2c1f09731f91afa624dded760c7d674","category":"concept","question":"What were the specific predictors of hospital stay and life quality after a year that were identified in this study?","answer":"The specific predictors of hospital stay and life quality after a year that were identified in this study were not specified.","input_idx":[[1075,1127]],"output_idx":[[1111,1156]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4577567,"edit_id":"b3935e3bca0e9ebb13b0e819b71c3c23","category":"omission","question":"What is the purpose of the study?","answer":"The purpose of the study is to investigate the effects of stride frequency manipulation during uphill training on stride length in race walking.","input_idx":[[0,86]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4577567,"edit_id":"46b30097f172656c625f4ac066f4947e","category":"omission","question":"What were the two training methods used in the study?","answer":"The two training methods used in the study were stride frequency manipulation (RWM) and free stride frequency (RWF).","input_idx":[[397,554]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4577567,"edit_id":"e6ef93afc7ec83cd2244a378d6a3e898","category":"concept","question":"What specific kinematic parameters were measured in the study and how were they affected by the training?","answer":"The specific kinematic parameters measured in the study were stride length and contact time. Stride length increased by 4.54% in the RWM group and decreased by 1.18% in the RWF group. Contact time increased by 4.58% in the RWM group and decreased by <1% in the RWF group. Stride frequency decreased by 4.44% in the RWM group and increased by 1.19% in the RWF group. Internal work decreased by 7.09% in the RWM group and increased by 7.09% in the RWF group.","input_idx":[[565,814]],"output_idx":[[414,555]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4577567,"edit_id":"ea7fefc75f10b9259a2745100fd17628","category":"concept","question":"What specific kinematic parameters were measured in the study and how were they affected by the training?","answer":"The specific kinematic parameters measured in the study were stride length and contact time. Stride length decreased by 1.18% in the RWF group and increased by 4.54% in the RWM group. Contact time decreased by <1% in the RWF group and increased by 4.58% in the RWM group. Stride frequency increased by 1.19% in the RWF group and decreased by 4.44% in the RWM group. Internal work decreased by 7.09% in the RWM group and increased by 7.09% in the RWF group.","input_idx":[[827,1054]],"output_idx":[[625,797]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4599047,"edit_id":"97e5af8900fcea4dbb3c422b3444a7cc","category":"omission","question":"What was the purpose of the study?","answer":"The purpose of the study was to evaluate the 3-year clinical outcomes of the Superion\u00ae device in the treatment of moderate degenerative lumbar spinal stenosis.","input_idx":[[0,255]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4599047,"edit_id":"dbdb65608b5cbf37ca0456fa58fdf7b1","category":"omission","question":"Who were the participants in the study?","answer":"The participants were people aged 45 years and above, suffering from moderate lower back spinal degeneration.","input_idx":[[256,1064]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4599047,"edit_id":"37dcfea80aec62ca77e6ae7d236e1b70","category":"omission","question":"What was the specific diagnosis and location of the spinal stenosis in the participants?","answer":"The participants were diagnosed with moderate degenerative lumbar spinal stenosis at one or two contiguous levels from L1 to L5.","input_idx":[[269,630]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4599047,"edit_id":"bb5e003da481d89d016956b268b326d3","category":"concept","question":"What were the four components of the primary endpoint?","answer":"The four components of the primary endpoint were improvement in two of three domains of the Zurich Claudication Questionnaire, no reoperations at the index level, no major implant\/procedure-related complications, and no clinically significant confounding treatments.","input_idx":[[771,1076]],"output_idx":[[644,861]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4609664,"edit_id":"5baa120e58845424e6fe02ceb7e1734c","category":"omission","question":"What was the purpose of this study?","answer":"The purpose of this study was to compare the formation of dentinal cracks and craze lines in the root dentin during root canal preparation with three different NiTi endodontic systems.","input_idx":[[14,251]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4609664,"edit_id":"c4959b9eb196a1355fddf36b99b1b45b","category":"omission","question":"What type of teeth were used in the study?","answer":"One hundred extracted mandibular premolars with single canals were used in the study.","input_idx":[[276,368]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4609664,"edit_id":"3fc44956c7320ad0c69bb8e39fb76f03","category":"omission","question":"How were the teeth prepared in each group?","answer":"In groups 1, 2 and 3 the teeth were prepared using Mtwo, PTU and RCP, respectively. While in group 4 (control group) the samples were left unprepared.","input_idx":[[369,587]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4609664,"edit_id":"1e70c6463a3b4e8ebdfb190d04d67187","category":"concept","question":"How were the teeth sectioned after preparation?","answer":"The teeth were sectioned perpendicular to the long axis of root at 3, 5 and 9-mm distances from the apex.","input_idx":[[588,716]],"output_idx":[[452,536]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4609664,"edit_id":"63ea734874cd9028df4efd8b4f721e42","category":"concept","question":"What statistical tests were used to analyze the data?","answer":"The data was analyzed using the chi-square and Fisher's exact tests.","input_idx":[[810,878]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4624894,"edit_id":"935ba6fd0dad7df2a3bbb1a653ca391f","category":"omission","question":"Why was this study conducted?","answer":"The study was conducted to determine the best treatment for a specific type of hepatitis C that is mainly found in certain geographic areas.","input_idx":[[12,128]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4624894,"edit_id":"a75900d37979ab5e46cb6532672a8a93","category":"omission","question":"Why was this study conducted?","answer":"The study was conducted to compare the effectiveness of two different treatment lengths in patients who had achieved an RVR.","input_idx":[[129,439]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4624894,"edit_id":"313dd3988079a38c03f6f1a683175dc8","category":"omission","question":"Who were the participants in the study?","answer":"The participants in the study were treatment-naive, non-cirrhotic patients with chronic hepatitis C genotype 6 in Southern China.","input_idx":[[463,659]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4624894,"edit_id":"0bb3aad11d6d4c14a59ca71008a1dd48","category":"omission","question":"What was the definition of RVR?","answer":"The definition of RVR was HCV RNA negativity at week 4 (<50 IU).","input_idx":[[660,875]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4624894,"edit_id":"3a1cdbf1b2be72e3246836159749773d","category":"omission","question":"What is the difference between intention-to-treat and per-protocol analysis?","answer":"The intention-to-treat analysis looks at the success rate of all patients who were originally assigned to a treatment group, regardless of whether they completed the full treatment course. The per-protocol analysis looks at the success rate of patients who completed the full treatment course.","input_idx":[[1062,1279]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4624894,"edit_id":"e8a2095b193429db6763d216c5f7486e","category":"omission","question":"What other adverse events were compared between the groups?","answer":"The other adverse events that were compared between the groups were not mentioned in the simplification.","input_idx":[[1280,1415]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4624894,"edit_id":"a75900d37979ab5e46cb6532672a8a93","category":"concept","question":"Why was this study conducted?","answer":"The study was conducted to compare the effectiveness of two different treatment lengths in patients who had achieved an RVR.","input_idx":[[129,439]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4624894,"edit_id":"313dd3988079a38c03f6f1a683175dc8","category":"concept","question":"Who were the participants in the study?","answer":"The participants in the study were treatment-naive, non-cirrhotic patients with chronic hepatitis C genotype 6 in Southern China.","input_idx":[[453,659]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4624894,"edit_id":"0bb3aad11d6d4c14a59ca71008a1dd48","category":"concept","question":"What was the definition of RVR?","answer":"The definition of RVR was HCV RNA negativity at week 4 (<50 IU).","input_idx":[[660,875]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4624894,"edit_id":"b4fedede6d68f2022559ca01b66825b5","category":"concept","question":"What is the difference between intention-to-treat and per-protocol analysis?","answer":"The intention-to-treat analysis looks at the success rate of all patients who were originally assigned to a treatment group, regardless of whether they completed the full treatment course","input_idx":[[1062,1279]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4687242,"edit_id":"d2e190aaef02680e0c7748344d6ba83e","category":"omission","question":"What herb was studied in this study?","answer":"The herb studied in this study is Ashwagandha.","input_idx":[[14,57]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4687242,"edit_id":"d8a384227fa11b5cd4743a4e0779cf21","category":"omission","question":"What specific areas of health did the study aim to prove the efficacy of Ashwagandha?","answer":"The study aimed to prove the efficacy of Ashwagandha in improving cardiovascular endurance and physical performance.","input_idx":[[238,374]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4687242,"edit_id":"4f75b627293132a56a89b7e5da18057f","category":"concept","question":"How was the cardiovascular fitness of the subjects measured?","answer":"The cardiovascular fitness of the subjects was measured by measuring the oxygen consumption at peak physical exertion (VO2 max) levels during a 20 m shuttle run test.","input_idx":[[656,807]],"output_idx":[[681,781]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4687242,"edit_id":"a1f79027573a2a10b6a3ea0e91da2613","category":"concept","question":"What specific questionnaire was used to measure the subjects' quality of life?","answer":"The study used the World Health Organization self-reported QOL questionnaire to measure the subjects' quality of life.","input_idx":[[808,986]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4704894,"edit_id":"7e19c79ab5d7ac4e3716bb8e5211edb6","category":"omission","question":"What is the main advantage of using social media for smoking cessation treatment?","answer":"Social media can be a great way to reach young adults who may be more likely to engage with online interventions.","input_idx":[[12,105]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4704894,"edit_id":"871e83c46d0ba23757cb074a7b08929c","category":"omission","question":"How many people were involved in the study and what were their characteristics?","answer":"The study involved 79 participants, 20% of whom were female, with an average age of 20.8 years old.","input_idx":[[695,741]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4704894,"edit_id":"37885fbc3b5f2f8b206b1bfd58260817","category":"omission","question":"How were participants assessed for their readiness to quit smoking and what were the groups they were assigned to?","answer":"Participants were assessed for their readiness to quit smoking and then assigned to one of 7 secret Facebook groups based on their stage of change.","input_idx":[[742,868]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4704894,"edit_id":"b030faf5699a89d5412f65622b9a18e8","category":"concept","question":"What kind of content was posted on Facebook and what was the goal of the posting?","answer":"The research staff posted content on Facebook based on the Transtheoretical Model of Behavior Change (TTM) Decisional Balance and the 10 processes of change, with the goal of increasing engagement among participants.","input_idx":[[869,1003]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4704894,"edit_id":"32ce3a705722ecbb27a166084bce8738","category":"concept","question":"How was engagement measured in the study?","answer":"Engagement was measured by the number of comments from participants in response to the daily posts.","input_idx":[[1004,1086]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4711101,"edit_id":"6b0e2eb7f7c3b1b1451301c8b5e5279e","category":"omission","question":"What is the current state of knowledge about the use of minimally invasive surgical technique (MIS) in total knee arthroplasty (TKA)?","answer":"There is still a lack of consensus in the literature about the use of MIS in TKA.","input_idx":[[12,191]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4711101,"edit_id":"3912a7f9dd4567d00a0b9711025485d3","category":"omission","question":"How many centers were involved in the study?","answer":"The study was conducted at three centers: Maastricht, Zwickau, and Adelaide.","input_idx":[[445,500]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4711101,"edit_id":"992482dafe277cd6a8805aaf62d60171","category":"omission","question":"How were the patients assigned to the MIS or conventional group?","answer":"Patients were randomly assigned to either the MIS group with dedicated instrumentation or the conventional group to receive cruciate retaining CAS-TKA without patella resurfacing.","input_idx":[[543,703]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4711101,"edit_id":"c55a8b2e7fa75c1fa49557048934877b","category":"concept","question":"How significant was the difference in pain levels between the two groups?","answer":"The difference in pain levels between the two groups was statistically significant.","input_idx":[[1012,1153]],"output_idx":[[834,979]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4711101,"edit_id":"eb237be7baff04a5102860a60c8293b9","category":"concept","question":"How significant was the difference in surgery time and blood loss between the two groups?","answer":"The difference in surgery time and blood loss between the two groups was statistically significant.","input_idx":[[1238,1402]],"output_idx":[[994,1072]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4711101,"edit_id":"a6d23931371feef1aec265a2ac57fbef","category":"concept","question":"How significant was the difference in component alignment between the two groups?","answer":"The difference in component alignment between the two groups was not statistically significant.","input_idx":[[1403,1550]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4717319,"edit_id":"bdd277e2e0f549f9186e6224b6114e65","category":"omission","question":"How many patients were included in the study?","answer":"A total of 676 patients enrolled in the open-label phase.","input_idx":[[566,622]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4717319,"edit_id":"67a94bcf0dbadedf13b05bdf469b4250","category":"omission","question":"By how much did the severity of symptoms decrease during the open-label phase?","answer":"During the open-label phase, the mean Positive and Negative Syndrome Scale total score decreased from 90.1 to 54.4 in patients who met clinical stability criteria and were randomized.","input_idx":[[736,914]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4717319,"edit_id":"e57628d03da9e1827c260dbad1244118","category":"omission","question":"By how much did lurasidone delay the time to relapse compared to placebo?","answer":"In the double-blind phase, lurasidone significantly delayed time to relapse compared with placebo, reflecting a 33.7% reduction in risk of relapse.","input_idx":[[916,1163]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4717319,"edit_id":"8718341bd59fe52cc61da25f3a2d715e","category":"omission","question":"What was the probability of relapse at the double-blind week 28 endpoint in the lurasidone group?","answer":"At the end of the 28 weeks, the probability of relapse was 42.2% in the lurasidone group.","input_idx":[[1164,1321]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4717613,"edit_id":"9b32d0a2d883ca4be525ed609d8f2d4f","category":"omission","question":"What type of surgery was performed on the patients in the nutrition program group?","answer":"The patients in the nutrition program group underwent anatomic resection, which was performed by thoracotomy in 20 patients and videothoracoscopy in 11 patients.","input_idx":[[1078,1224]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4717613,"edit_id":"3de1f23beda20bc2a3a87d2ec46aa898","category":"omission","question":"What were the specific values of the serum albumin levels in the control and nutrition program groups?","answer":"In the control group, the serum albumin levels decreased from 100% of the baseline to 25.71% on the postoperative third day. In the nutrition program group, the serum albumin levels decreased from 100% of the baseline to 14.69% on the postoperative third day.","input_idx":[[1357,1611]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4768925,"edit_id":"2637b26579e333f50fdfbd6e51aefaae","category":"omission","question":"What method was used to detect the hormone levels and NIHSS scores of the patients?","answer":"The hormone levels and NIHSS scores of the patients were detected using the radioimmunoassay method.","input_idx":[[711,916]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4768925,"edit_id":"62ade7afb10f96164b2c539ef0e393c6","category":"concept","question":"What software was used to analyze the data?","answer":"The data was analyzed using SPSS17.0 software.","input_idx":[[1260,1319]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4769147,"edit_id":"4fb50b1862ccef475fd5a7a7fc229127","category":"omission","question":"What are the benefits of breastfeeding for babies?","answer":"Breastfeeding can reduce the risk of infections and other health problems in babies, and it can also improve their overall well-being.","input_idx":[[12,84]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4769147,"edit_id":"0238b46a369fa735df8f425779ac115b","category":"omission","question":"Why are breastfeeding rates still low despite public health efforts?","answer":"There could be various reasons for this, such as lack of education or support for breastfeeding, cultural or societal barriers, or medical reasons.","input_idx":[[131,160]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4769147,"edit_id":"9af2114937b3436dd37617cace262d04","category":"omission","question":"What was the goal of the study?","answer":"The goal of the study was to investigate the effect of giving newborns a small amount of baby formula feed on breastfeeding rates.","input_idx":[[162,284]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4769147,"edit_id":"58ed7ffb33381350b7a54ab37c39228f","category":"concept","question":"What was the primary hypothesis of the study?","answer":"The primary hypothesis of the study was that giving newborns a small amount of baby formula feed would not negatively impact breastfeeding rates at discharge, 3 and 6 months of age.","input_idx":[[286,499]],"output_idx":[[113,237]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4769147,"edit_id":"716f887d54d999013fc0f0d1d49414e6","category":"concept","question":"What was the statistical significance of the results?","answer":"The results showed that there was no significant difference in breastfeeding rates between the two groups at discharge, 3 and 6 months of age. The p-values were 0.2, 0.12, and 0.45 respectively.","input_idx":[[1107,1372]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4784207,"edit_id":"0e0d2b98bfc13390073bfab3fcc26f9f","category":"omission","question":"How was the adequacy of consent determined?","answer":"The adequacy of consent was determined by generating a composite index from the responses of the patients and analyzing it.","input_idx":[[620,703]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4784207,"edit_id":"0001c41580339fdb1e8b938a55804a86","category":"concept","question":"How were the patients divided into the two groups?","answer":"The patients were randomly divided into two groups.","input_idx":[[267,319]],"output_idx":[[280,319]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4784207,"edit_id":"0465ed6f78c0d4c6626a0982e787b387","category":"concept","question":"What is the adequacy of consent index and how was it calculated?","answer":"The adequacy of consent index is a measure of how well the patients understood the anesthesia process, including common side effects and potential serious complications. It was calculated from the responses of the patients and analyzed.","input_idx":[[882,965]],"output_idx":[[856,947]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4796524,"edit_id":"d18cda62831c8ce841c6380443ddd319","category":"omission","question":"What are the specific complications that patients with ureteral stents may encounter?","answer":"Patients with ureteral stents may encounter complications such as encrustation, stent crustation, which can lead to loss of kidney, and complications related to stent extraction: pain and UTI increasing related to cystoscopy for stent extraction accompanying excess expenses.","input_idx":[[157,187]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4796524,"edit_id":"d95ae3471ae8e6fa09d0864efe5e70a2","category":"omission","question":"How were the complications compared between the two groups?","answer":"The study compared the rates of infection, how often the stent got blocked, and how bad any urinary symptoms were between the two groups.","input_idx":[[721,780]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4796524,"edit_id":"1737e7e99e645cf71325a7200161963e","category":"concept","question":"What was the specific technique used in the study group?","answer":"The study group had a stent attached to a Foley catheter.","input_idx":[[567,613]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4796524,"edit_id":"7be1da1d4c38bddb3ca9f37434a7905a","category":"concept","question":"What was the specific technique used in the control group?","answer":"The control group used the stent in the standard way, separate from the catheter.","input_idx":[[668,694]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4808872,"edit_id":"4c7862cc22230f16227a2be5adb5be2f","category":"omission","question":"What was the focus of the study?","answer":"The study examined the effects of creatine supplementation on explosive performance and the optimal individual PAP time during a set of complex training bouts.","input_idx":[[62,95]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4808872,"edit_id":"32b462ab59c4af05cbc7002b5a55d5ce","category":"omission","question":"What tests were done in the study?","answer":"The athletes performed tests of back squat for one repetition maximum (1RM) strength and complex training bouts for determining the individual optimal timing of PAP, height and peak power of a counter movement jump before and after the supplementation.","input_idx":[[387,652]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4808872,"edit_id":"1385eff292f392894d73c852e7cb1f53","category":"concept","question":"What is postactivation potentiation (PAP)?","answer":"Postactivation potentiation (PAP) is a phenomenon that can acutely increase muscle power, but it is an individualized process that is influenced by muscle fatigue. It is a test used to measure the effect of creatine on muscle power.","input_idx":[[62,95]],"output_idx":[[332,429]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4808872,"edit_id":"1c11465275d263f5c0a89d28ecbcd8df","category":"concept","question":"Who were the participants in the study?","answer":"Thirty explosive athletes participated in the study.","input_idx":[[387,412]],"output_idx":[[122,160]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4877819,"edit_id":"cc03a71b97723f4a3cec85e0664d56fe","category":"omission","question":"What is the medicinal plant used in the study?","answer":"The medicinal plant used in the study is Andrographis paniculata (A. paniculata).","input_idx":[[12,295]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4877819,"edit_id":"72cfabc2cbc864d05f3b777531f64886","category":"omission","question":"What is the most common and disabling symptom in MS?","answer":"In MS, fatigue is one of the most common and disabling symptoms.","input_idx":[[296,390]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4877819,"edit_id":"e2330ddeb62414e9817b5e4e99513744","category":"omission","question":"What type of MS was investigated in the trial?","answer":"The trial investigated the effect of A. paniculata on relapse rate and fatigue in relapsing-remitting MS (RRMS) patients receiving interferon beta.","input_idx":[[391,553]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4877819,"edit_id":"c0da009ce216ae372e8ee6e070a118af","category":"concept","question":"How was the study designed?","answer":"The study was designed as a randomized double-blind placebo-controlled trial, where patients were randomly assigned to receive either A. paniculata or a placebo, and the researchers were blinded to which group each patient was in.","input_idx":[[564,817]],"output_idx":[[372,523]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4877819,"edit_id":"f6ac83782625f15d162bb963f9fb92e6","category":"concept","question":"How much reduction in fatigue did the patients experience?","answer":"The patients who were given the A. paniculata extract experienced a significant decrease in fatigue, equivalent to a 44% reduction at 12 months.","input_idx":[[1085,1243]],"output_idx":[[1132,1279]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4877819,"edit_id":"cdeb4ff05b7cd3719b07eb228a98cdc3","category":"concept","question":"What trends were observed in the data?","answer":"The data showed a trend in reducing new lesions among the A. paniculata group, but there were no statistically significant differences in relapse rate, EDSS, or inflammatory parameters.","input_idx":[[1244,1417]],"output_idx":[[1341,1450]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4893758,"edit_id":"ef476bafc8929830a6e41e7159925eeb","category":"omission","question":"In which setting was the study conducted?","answer":"The study was conducted in emergency department (ED).","input_idx":[[14,113]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4893758,"edit_id":"d073f3201d1c813399a7b5f3dbc575e8","category":"omission","question":"What were the specific outcomes that were compared between the two pain relief methods?","answer":"The study compared procedural characteristics, patients' satisfaction as well as adverse events between fentanyl\/midazolam and remifentanil for PSA of 18\u201364 years old patients.","input_idx":[[414,584]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4893758,"edit_id":"27563f4517b58128ffa0ab79429b6132","category":"concept","question":"Who were the patients that were included in the study?","answer":"The study included patients aged between 18 and 64 years old.","input_idx":[[414,584]],"output_idx":[[31,157]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4893758,"edit_id":"0a550a53705a31078d741d6f12467c46","category":"concept","question":"What were the specific outcomes that were measured in the study?","answer":"The study compared procedural characteristics, patients' satisfaction as well as adverse events between fentanyl\/midazolam and remifentanil for PSA of 18\u201364 years old patients.","input_idx":[[414,584]],"output_idx":[[31,157]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4914313,"edit_id":"9af3c465233d75c32e5e75cb30ffb138","category":"omission","question":"What was the main conclusion of the study?","answer":"The main conclusion of the study was that the addition of cetuximab to chemo-radiotherapy following induction chemotherapy did not improve survival.","input_idx":[[1457,1544]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4914313,"edit_id":"3bfc09e84d60a8774d378f1348d1d31d","category":"omission","question":"What was the relationship between miR-21 levels and clinical outcome in patients with LAPC treated with induction chemotherapy followed by chemo-radiotherapy?","answer":"The study found that patients with high levels of miR-21 had worse progression-free survival and overall survival compared to patients with low levels of miR-21.","input_idx":[[1545,1710]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4914313,"edit_id":"72fa8845d099ec87bb7e51eb4331c7ac","category":"concept","question":"What was the specific combination of drugs used in the study?","answer":"The specific combination of drugs used in the study was gemcitabine and capecitabine (GEM-CAP) followed by capecitabine or UFT plus radiotherapy (A), or capecitabine or UFT plus cetuximab plus RT (B).","input_idx":[[1457,1544]],"output_idx":[[1498,1610]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4914313,"edit_id":"063cc9034c82dc9c9f27c8a8cf694954","category":"concept","question":"What was the specific clinical outcome that was measured in the study?","answer":"The specific clinical outcome that was measured in the study was progression-free survival and overall survival.","input_idx":[[1545,1710]],"output_idx":[[1618,1711]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4937273,"edit_id":"143a54a9de5154b4fb4032fb23229966","category":"omission","question":"How does alirocumab get removed from the body?","answer":"Alirocumab is removed from the body through a process called target\u2010mediated clearance, which involves binding to a protein called proprotein convertase subtilisin\/kexin type 9 (PCSK9).","input_idx":[[12,127]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4937273,"edit_id":"3730f0d478aa220afd01350b176e053e","category":"omission","question":"What other medications can increase PCSK9 levels?","answer":"Apart from statins, other medications that can increase PCSK9 levels include ezetimibe and fenofibrate.","input_idx":[[129,158]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4937273,"edit_id":"bc9d25d6a98ecb7794bcaa45948280d7","category":"omission","question":"Can the dosage of alirocumab be adjusted based on other medications a person is taking?","answer":"Yes, the dosage of alirocumab can be adjusted based on other medications a person is taking. For example, every 4 weeks dosing of alirocumab may be appropriate for some patients in absence of background statin.","input_idx":[[223,326]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4937273,"edit_id":"5554087eebee25e007f481953917e8aa","category":"concept","question":"What were the cholesterol levels of the participants in the study?","answer":"The participants in the study had LDL-C levels greater than 130 mg\/dL.","input_idx":[[374,504]],"output_idx":[[409,550]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4937273,"edit_id":"3a29cf08cf855f51f6f533f804d9fd29","category":"concept","question":"When did the maximal mean LDL-C reductions occur in the study?","answer":"The maximal mean LDL-C reductions occurred on day 71 in all groups.","input_idx":[[654,860]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4937273,"edit_id":"577c3d0db96fca9e3e943e696bd7b180","category":"concept","question":"What percentage of LDL-C reduction was sustained through day 85 in the study?","answer":"The effect of alirocumab in reducing cholesterol levels was sustained through day 85, but the duration of effect was slightly diminished when alirocumab was used with ezetimibe or fenofibrate.","input_idx":[[861,1076]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4941128,"edit_id":"d14a47c22543aae6c5fd454e34b79997","category":"omission","question":"What was the previous trial that showed the benefits of aDBS?","answer":"A recent acute trial of unilateral aDBS showed that aDBS can lead to substantial improvements in contralateral hemibody Unified Parkinson's Disease Rating Scale (UPDRS) motor scores and may be superior to conventional continuous DBS in Parkinson's disease (PD).","input_idx":[[121,381]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4941128,"edit_id":"1fa1ba5d1569de9fcb33f2fb95812598","category":"omission","question":"What was the purpose of this study?","answer":"The purpose of this study was to test whether the benefits of aDBS are retained with bilateral aDBS and in the face of concurrent medication.","input_idx":[[383,492]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4941128,"edit_id":"30afe00ef6bf6e57c8ec6163148156a1","category":"concept","question":"How was the aDBS delivered to the patients?","answer":"aDBS was delivered to both sides of the brain independently, depending on the level of brain activity. The stimulation was triggered according to the amplitude of \u03b2 activity at the corresponding electrode.","input_idx":[[594,740]],"output_idx":[[525,634]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4941128,"edit_id":"14a3d668149de9a8b0713823e7912393","category":"concept","question":"What was the exact mean stimulation voltage used in the study?","answer":"The exact mean stimulation voltage used in the study was 3.0\u00b10.1 volts.","input_idx":[[741,784]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4967511,"edit_id":"3002cff034d7459deaa5c738facf0dc4","category":"omission","question":"What is the Health Promoting Schools framework (HPS)?","answer":"The Health Promoting Schools framework (HPS) is a model from the World Health Organization that aims to improve the health and well-being of students in schools.","input_idx":[[12,104]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4967511,"edit_id":"4582bd8f767c6547cdf356a60c70387a","category":"omission","question":"How was the study designed?","answer":"The study was a cluster randomized controlled trial, meaning that the units of randomization were primary school classes and the participants were randomly assigned to either an intervention group or a control group.","input_idx":[[273,324]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4967511,"edit_id":"df330377be3a0a58cbc7251022adb47e","category":"omission","question":"When was the final assessment conducted?","answer":"The final assessment was conducted in April 2012.","input_idx":[[1520,1566]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4967511,"edit_id":"8ca67fd70fedff3c9a6db6ad6e66b395","category":"concept","question":"What specific measures were used to assess each outcome?","answer":"The specific measures used to assess each outcome are not mentioned in the simplification, but they are described in the original text. For example, for the outcome \"Emotional and Social Experience in School\", validated and standardized questionnaires were used, and for the outcome \"Motor Skills\", validated and standardized motoric and coordination tests were used in the school gym.","input_idx":[[1090,1402]],"output_idx":[[786,978]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4967511,"edit_id":"46b0714c0da87ecdac4c8443fefd068f","category":"concept","question":"What was the primary outcome of the study?","answer":"The primary outcome of the study was Classroom Climate, which is a measure of the quality of the classroom environment and the relationships between students and teachers. It is part of the outcome category \"Emotional and Social Experience in School\".","input_idx":[[1403,1519]],"output_idx":[[993,1062]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4972969,"edit_id":"7a3b44ff9cd99cecbc0bbf53f31090cc","category":"omission","question":"What was the purpose of this study?","answer":"The purpose of this study was to evaluate the effectiveness of two different training approaches for health workers in managing infectious diseases.","input_idx":[[12,159]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4972969,"edit_id":"2fbc730a164eac8e49ac9f94e083a9de","category":"omission","question":"How many health facilities participated in the study?","answer":"Thirty-six health facilities participated in the study.","input_idx":[[695,807]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4972969,"edit_id":"17760e3fc3b689e5283f8aa4aa60d7ea","category":"omission","question":"How many health workers received the IMID training?","answer":"Two health workers in both arms received the IMID training.","input_idx":[[809,843]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4972969,"edit_id":"071f52c3c5c4ee146e6822b00450be05","category":"omission","question":"How long did the OSS visits last?","answer":"The OSS visits lasted from April to December 2010.","input_idx":[[845,939]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4972969,"edit_id":"70c5b6c284280974d1404ce927931579","category":"omission","question":"How many outpatient visits were analyzed?","answer":"777,667 outpatient visits were analyzed.","input_idx":[[961,1032]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4972969,"edit_id":"c52b88b439eb41f480216d1974ed9513","category":"omission","question":"What percentage of outpatient visits were analyzed?","answer":"86.1% of outpatient visits were analyzed.","input_idx":[[1034,1115]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4972969,"edit_id":"61d0e64f99247bddcf6ef3dce5988b0f","category":"omission","question":"How many providers provided treatment?","answer":"64 IMID-MLP and 1,515 No-IMID providers provided treatment.","input_idx":[[1117,1182]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4972969,"edit_id":"49b4744fc10a1ae55bdb6367e66097c6","category":"omission","question":"How was the effect of OSS measured?","answer":"The effect of OSS was measured by the difference in pre\/post changes across arms after controlling for covariates (adjusted ratio of relative risks = a RRR).","input_idx":[[1184,1340]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4972969,"edit_id":"91782921b711a08c8944baaa592690a0","category":"concept","question":"What type of training did the health workers receive?","answer":"The health workers received training on integrated management of infectious diseases (IMID).","input_idx":[[809,843]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4972969,"edit_id":"d829a849d08d95473dcb3f0493063b46","category":"concept","question":"What was the purpose of the hands-on guidance?","answer":"The purpose of the hands-on guidance was to support health workers in managing emergency patients and applying IMID knowledge.","input_idx":[[845,939]],"output_idx":[[775,835]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4972969,"edit_id":"081c4419c72be1c8ea524e40409f0073","category":"concept","question":"When were the outpatient visits analyzed?","answer":"The outpatient visits were analyzed from November 2009 to December 2010.","input_idx":[[961,1032]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4972969,"edit_id":"c52b88b439eb41f480216d1974ed9513","category":"concept","question":"What percentage of outpatient visits were analyzed?","answer":"86.1% of outpatient visits were analyzed.","input_idx":[[1034,1115]],"output_idx":[[867,921]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4972969,"edit_id":"91782921b711a08c8944baaa592690a0","category":"concept","question":"What type of training did the health workers receive?","answer":"The health workers received training on integrated management of infectious diseases (IMID).","input_idx":[[1117,1182]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4972969,"edit_id":"308b213cd64b9f4fcbe807bc602b4fe8","category":"concept","question":"How were the covariates controlled for?","answer":"The covariates were controlled for by using an adjusted ratio of relative risks (RRR).","input_idx":[[1184,1340]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4984916,"edit_id":"aae27c5b7e86c908ef1a67b8f327477e","category":"omission","question":"What type of trial was this?","answer":"This was a phase II, randomized, open trial.","input_idx":[[430,515]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4984916,"edit_id":"2f0e1c2b39acf21aa8ad01d08ac1ae08","category":"omission","question":"What was the main goal of the trial?","answer":"The main goal of the trial was to see how many problems arose overall.","input_idx":[[516,568]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4984916,"edit_id":"a263f1d377606562259c5ae238a6f031","category":"omission","question":"What were the other goals of the trial?","answer":"The other goals of the trial were to see individual complication rates, how long it took for the first problem to happen and how patients\u2019 quality of life was affected.","input_idx":[[569,677]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4984916,"edit_id":"f5db8b94ab2f5533770a427506aaeb16","category":"omission","question":"How was the data analyzed in the trial?","answer":"The data was analyzed by intention to treat.","input_idx":[[678,713]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4984916,"edit_id":"2e09dd33f182a8b6f6b228e0389fa268","category":"omission","question":"What else was looked at in the trial besides the problems that arose?","answer":"Besides the problems that arose, the costs of each treatment were also looked at.","input_idx":[[714,758]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":4984916,"edit_id":"aae27c5b7e86c908ef1a67b8f327477e","category":"concept","question":"What type of trial was this?","answer":"This was a phase II, randomized, open trial.","input_idx":[[430,515]],"output_idx":[[484,532]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4984916,"edit_id":"2f0e1c2b39acf21aa8ad01d08ac1ae08","category":"concept","question":"What was the main goal of the trial?","answer":"The main goal of the trial was to see how many problems arose overall.","input_idx":[[516,568]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4984916,"edit_id":"a263f1d377606562259c5ae238a6f031","category":"concept","question":"What were the other goals of the trial?","answer":"The other goals of the trial were to see individual complication rates, how long it took for the first problem to happen and how patients\u2019 quality of life was affected.","input_idx":[[569,677]],"output_idx":[[659,780]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4984916,"edit_id":"f5db8b94ab2f5533770a427506aaeb16","category":"concept","question":"How was the data analyzed in the trial?","answer":"The data was analyzed by intention to treat.","input_idx":[[678,713]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4984916,"edit_id":"2e09dd33f182a8b6f6b228e0389fa268","category":"concept","question":"What else was looked at in the trial besides the problems that arose?","answer":"Besides the problems that arose, the costs of each treatment were also looked at.","input_idx":[[714,758]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":4994121,"edit_id":"79f4342963919fdb26b58b79d817c695","category":"omission","question":"What was the goal of this study?","answer":"The goal of this study was to research the effects of levosimendan (LS) and sodium nitroprusside (SNP) combination on systolic and diastolic ventricular function after coronary artery bypass grafting (CABG) who required endoventricular patch repair (EVPR).","input_idx":[[0,9]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4994121,"edit_id":"0c4701858a3f4a2da68e3be4ed7eb3f5","category":"omission","question":"How was the study conducted?","answer":"The study was conducted on 70 patients with ischemic dilated cardiomyopathy. Levosimendan (LS) and sodium nitroprusside (SNP) combination was administered in 35 patients (study group, SG). In the remaining patients, normal saline solution was given (placebo group, PG). Levosimendan (10\u03bcgr\/kg) started 4 h prior to operation and we stopped LS before the initiation of extracorporeal circulation (ECC). During the rewarming period, we started again levosimendan (10\u03bcgr\/kg) in combination with SNP (0.1-0.2 \u03bcgr\/kg\/min). If mean blood pressure decreased by more than 25% compared with pre-infusion values, for corrected of mean arterial pressure, the volume loading was performed using a 500 ml ringer lactate. Hemodynamic variables, inotrophyc requirement, and laboratory values were recorded.","input_idx":[[267,287]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4994121,"edit_id":"0043c0ef3ba80d099138a335906382ac","category":"omission","question":"What were the findings of the study?","answer":"The study showed that LS and SNP combination impressive increase in left ventricular systolic and diastolic functions including LVEF. The use of this combination achieved more less inotrophics and IABP requirement.","input_idx":[[1028,1035]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":4994121,"edit_id":"980be8406acf535b3bccbc7cee3f3adc","category":"omission","question":"What was the main conclusion of the study?","answer":"The study shows that the LS and SNP combination really improved heart function during and after surgery. Using these drugs led to less need for other supporting drugs or equipment. Thus, we suggest using this drug combination before and during surgery.","input_idx":[[1902,1912]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5002324,"edit_id":"0322c90925840856db64663f74cfcce5","category":"omission","question":"What was the goal of the study?","answer":"The goal of the study was to examine the effects of a balance-based exergaming intervention using the Kinect sensor on postural stability and balance in people with Parkinson's disease.","input_idx":[[12,191]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5002324,"edit_id":"e7fbadc4dce00f04e105f914891b62cf","category":"omission","question":"How was the study conducted?","answer":"The study was conducted as a subject-blinded, randomized controlled study.","input_idx":[[203,263]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5002324,"edit_id":"b43673336ccc63054bde84deb9cfa3b6","category":"omission","question":"Who were the participants in the study?","answer":"The participants in the study were twenty people with Parkinson's disease at Hoehn and Yahr stages I through III.","input_idx":[[264,323]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5002324,"edit_id":"ffd1461d7f4b029de24449d38819c025","category":"concept","question":"What tests were used to measure balance and stability?","answer":"The tests used to measure balance and stability were the limits of stability (LOS) and one-leg stance (OLS) tests, as well as the Berg Balance Scale (BBS) and the timed up and go (TUG) test.","input_idx":[[489,588]],"output_idx":[[636,751]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5002324,"edit_id":"3c0a2bdda0cfd128c28fd98dc3de8462","category":"concept","question":"What tests were used to assess balance?","answer":"The tests used to assess balance were the Berg Balance Scale (BBS) and the timed up and go (TUG) test.","input_idx":[[589,680]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5002324,"edit_id":"7fe274c1359d01c3f7ce0daf4d637b33","category":"concept","question":"When were the tests administered?","answer":"The tests were administered before and after the training.","input_idx":[[681,731]],"output_idx":[[636,751]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5018291,"edit_id":"a426276ed40d2b49a70dc37a6ae9ddc4","category":"omission","question":"How was the ketamine and bupivacaine administered in the study?","answer":"The ketamine and bupivacaine were infiltrated into the nephrostomy tract.","input_idx":[[259,313]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5018291,"edit_id":"f45a8b6d0dada8885ca6fca1d994f9b3","category":"omission","question":"How was the saline solution administered in the study?","answer":"The saline solution was infiltrated into the nephrostomy tract.","input_idx":[[547,614]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5018291,"edit_id":"aeec34fa9814018a6c175cd8bf00087e","category":"concept","question":"How was the ketamine and bupivacaine combined in the study?","answer":"The ketamine and bupivacaine were mixed together and infiltrated into the nephrostomy tract.","input_idx":[[259,313]],"output_idx":[[717,748]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5018291,"edit_id":"a374ff6de83cac9113ed2bbfad64ba41","category":"concept","question":"What was the concentration of ketamine in the saline solution that was administered?","answer":"The saline solution contained 0.5 mg\/kg ketamine.","input_idx":[[917,1002]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5019463,"edit_id":"5e9b15b0759c3b512428b5072daab851","category":"omission","question":"Where were the patients diagnosed and where was the study conducted?","answer":"The patients were diagnosed with a glaucoma-related condition following a comprehensive eye examination at 43 community sites in Philadelphia, PA, USA.","input_idx":[[352,494]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5019463,"edit_id":"6419c180aed7d19afed423f572db39ab","category":"omission","question":"How long was the study and what were the three groups that were randomized?","answer":"The study lasted for one year and the three groups were: Group 1 (G1) received follow-up eye care in a community-based setting with assistance from a patient navigator; Group 2 (G2) received follow-up eye care in an office-based setting with assistance from a patient navigator; and Group 3 (G3) received follow-up eye care in an office-based setting without a patient navigator (usual care).","input_idx":[[560,623]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5019463,"edit_id":"cd20deb432479d6e4183cb8e88be77a2","category":"omission","question":"What statistical method was used to compare the adherence rates among the three groups?","answer":"The adherence rates were compared among the three groups using a chi-squared test at a significance level of 0.05.","input_idx":[[960,1072]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5019463,"edit_id":"298797243a615ae92db3c87f06f8eb41","category":"concept","question":"What was the purpose of randomizing the patients into the three groups?","answer":"The purpose of randomizing the patients into the three groups was to ensure that the groups were comparable and that the results were not biased.","input_idx":[[560,623]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5019463,"edit_id":"342c60b5fbbba1d14134456ab5853c3f","category":"concept","question":"What statistical method was used to compare the adherence rates among the three groups?","answer":"The adherence rates were compared among the three groups using a chi-squared test.","input_idx":[[960,1072]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["missing_output_localization"]},{"PMCID":5019971,"edit_id":"e3d218825306d85539be02f82796e5ac","category":"omission","question":"What is the background of this study?","answer":"The study is looking at the effects of a drug called Maraviroc on HIV patients who are also taking the drug Abacavir, which some believe may increase their risk of heart disease.","input_idx":[[0,123]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5019971,"edit_id":"1ae40ea0b21b1a7683c1f6b9f8d1e691","category":"omission","question":"What type of experiments were done to show the effects of Maraviroc?","answer":"The effects of Maraviroc were shown in murine experiments, which are experiments done on mice.","input_idx":[[124,271]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5019971,"edit_id":"25fedc32ff026bed09ac36055a4fd522","category":"omission","question":"What specific parameters were measured in the study?","answer":"The study measured FMD (flow-mediated dilatation), immunological and inflammatory parameters.","input_idx":[[272,471]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5019971,"edit_id":"c056813488313d3bb8283bf788fca7a8","category":"concept","question":"How much did blood flow improve after maraviroc intensification?","answer":"Blood flow improved by 0.73% after maraviroc intensification.","input_idx":[[1210,1396]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5019971,"edit_id":"c88ad8aebcfd18c4bd3ff121d97b8b00","category":"concept","question":"How was the relationship between blood flow and inflammation\/immune activation measured?","answer":"The relationship between blood flow and inflammation\/immune activation was measured using linear regression modeling and the specific values of the coefficients (\u03b2) and the confidence intervals (CI) were provided.","input_idx":[[1397,1602]],"output_idx":[[1026,1177]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5043523,"edit_id":"9482e3194e84f1e41cfb269c3ae1d752","category":"omission","question":"What is the hypothesis being tested in this study?","answer":"The hypothesis being tested is that individuals with knowledge of their genetic risk are more likely to make health-promoting dietary and lifestyle changes.","input_idx":[[157,238]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5043523,"edit_id":"714fd4fb3eb5652a18f10660b713ef62","category":"omission","question":"How was the data analyzed to determine the changes in folate intake?","answer":"General linear model analysis was used to assess changes in folate intake between the MTHFR risk, MTHFR non-risk and control groups from baseline to month 6 of the intervention.","input_idx":[[758,935]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5043523,"edit_id":"3fbf85033624d3f9f98e853dade128e6","category":"concept","question":"How was the study conducted?","answer":"The study was conducted online across seven locations in Europe, with participants receiving either general healthy eating advice or varying levels of personalised nutrition advice.","input_idx":[[220,341]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5043523,"edit_id":"d8c21ce2329aa50475fc1ba3ec838abb","category":"concept","question":"What specific gene and its variants were being tested in the study?","answer":"The specific gene being tested was the methylenetetrahydrofolate reductase (MTHFR) gene, and the two variants being tested were CT\/TT and CC. The relationship between these variants and cardiovascular health was also being examined.","input_idx":[[458,757]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5054596,"edit_id":"bf2de141291c20b3b928420dbc876b36","category":"omission","question":"What was the purpose of this study?","answer":"The study aimed to understand how practicing basic tasks with a body-powered prosthetic device can help users get better at real-world tasks, and how this learning changes over time in new users of such devices.","input_idx":[[12,133]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5054596,"edit_id":"b551b44cb6aa2b4095e0f2f1e6fb385c","category":"omission","question":"How did the type of training affect the improvements in the SHAP score?","answer":"The type of training had a small but significant influence on the improvements in the SHAP score.","input_idx":[[1235,1328]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5054596,"edit_id":"798b0261f97b14cdb9a6199c5ef01527","category":"concept","question":"How does the prosthetic device provide feedback to the user?","answer":"The prosthetic device is controlled by a harness and cable, and provides limited feedback to the user about limb position.","input_idx":[[134,267]],"output_idx":[[91,205]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5054596,"edit_id":"68908b3d956c4ede816633ff4f226dd0","category":"concept","question":"How was performance measured in the study?","answer":"Performance was measured with the Southampton Hand Assessment Procedure (SHAP) prior to and after the training sessions, and after 2 weeks and 3 months retention.","input_idx":[[901,1074]],"output_idx":[[775,903]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5117579,"edit_id":"106e67bdcef4f6984327d8626e6986f8","category":"omission","question":"What are the effects of the drug Dexmedetomidine?","answer":"Dexmedetomidine is a drug that helps to reduce pain, anxiety, and causes sleepiness without affecting breathing.","input_idx":[[12,137]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5117579,"edit_id":"653b3049ed5a92781bd040c9cd61aaee","category":"omission","question":"What is a common complication of spinal anesthesia?","answer":"Hypotension is a common complication of spinal anesthesia.","input_idx":[[235,293]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5117579,"edit_id":"cff372e78ea5976ae62d6f3cf89472fd","category":"omission","question":"Why is it important to decrease anxiety before a procedure?","answer":"Decreasing anxiety of patients before procedure is important for high quality of procedure.","input_idx":[[294,385]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5117579,"edit_id":"aaa5f02d1461fb9e52adf74554bc6b4e","category":"concept","question":"What kind of changes in blood pressure can Dexmedetomidine cause?","answer":"Dexmedetomidine can cause a biphasic cardiovascular response, and induce transient hypertension.","input_idx":[[138,234]],"output_idx":[[134,173]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5117579,"edit_id":"fd25adddc49288fc87ffd035733dad5d","category":"concept","question":"How much lower was the incidence of hypotension in Group A compared to Group B?","answer":"The incidence of hypotension was significantly lower in Group A (16.1%) than in Group B (48.4%) during infusion of dexmedetomidine (p = 0.01).","input_idx":[[1302,1444]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5117579,"edit_id":"758b9cd08f650daffa15a81986b3537f","category":"concept","question":"How much did the incidence of bradycardia and desaturation differ between the two groups?","answer":"The incidence of bradycardia and desaturation did not significantly differ between the two groups.","input_idx":[[1529,1627]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5122106,"edit_id":"2b991ffbbbd65bea6d344d274feef81d","category":"omission","question":"What is the global health problem that the study is investigating?","answer":"The study is investigating the effectiveness of a cream in reducing abdominal fat thickness and waist circumference, which are complications of obesity.","input_idx":[[12,97]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5122106,"edit_id":"e76d58bbcd8a3484abbfa5dfbc89ca8f","category":"omission","question":"What other methods have been used to reduce abdominal fat thickness?","answer":"There are other methods to reduce abdominal fat thickness, such as liposuction.","input_idx":[[229,308]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5122106,"edit_id":"4d66a9a08c8a906f92b0dbf79ba35ad4","category":"omission","question":"What type of cream was used in the study?","answer":"The type of cream used in the study was Arnebia Euchroma (AE) ointment.","input_idx":[[353,466]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5122106,"edit_id":"dd845cdbcc191b39376343d28dd9b8b1","category":"concept","question":"What type of study was conducted in the medical clinic in Iran in 2014?","answer":"The study was a double-blind clinical trial.","input_idx":[[492,624]],"output_idx":[[499,555]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5122106,"edit_id":"69d6f16343f5e28ec54e44db1274e089","category":"concept","question":"What statistical methods were used to compare the results?","answer":"The statistical methods used in the study were t-test for comparing parametric variables between groups, paired t-test for changes from baseline to final, and repeated measure ANOVA for changes at different steps.","input_idx":[[1061,1234]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["missing_output_localization"]},{"PMCID":5122238,"edit_id":"ea62d0ac2aa30e599393ecdd5be783c2","category":"omission","question":"What specific type of shivering was the study looking at?","answer":"The study was looking at shivering that occurs both during and after surgery.","input_idx":[[12,47]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5122238,"edit_id":"2706ed1fd4e6b9992a469bb8ee275088","category":"omission","question":"What type of study was this?","answer":"This was a clinical trial study.","input_idx":[[411,433]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5122238,"edit_id":"c4328f5ae4911640aeef5b3ffd73b946","category":"concept","question":"How were the patients selected for the study?","answer":"The patients were selected for the study if they were candidates for surgery that required spinal anesthesia.","input_idx":[[408,553]],"output_idx":[[228,344]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5122238,"edit_id":"984767a77882058cf84a4ef2238a0d7d","category":"concept","question":"What doses of hydrocortisone were given to the patients in the study?","answer":"The first group received 1 mg\/kg hydrocortisone, the second group received 2 mg\/kg hydrocortisone, and the third group received normal saline.","input_idx":[[554,760]],"output_idx":[[345,648]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5125190,"edit_id":"dc203918bdc79cc5ee26a591478fcd08","category":"omission","question":"What was the conclusion of the study?","answer":"The study found that pre-treatment with intravenous methylprednisolone was as effective as lignocaine in reducing propofol injection-induced pain.","input_idx":[[1250,1387]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5125190,"edit_id":"24b224af829f1a91a3a525f9daf9186a","category":"concept","question":"How was the effectiveness of the drugs determined?","answer":"The effectiveness of the drugs was determined through statistical tests, specifically Student's t-test and Chi-square test\/Fisher's exact test.","input_idx":[[1250,1387]],"output_idx":[[1225,1363]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5125721,"edit_id":"6536e89663756d02b3656a3a07f4313e","category":"omission","question":"What is the relationship between type 2 diabetes and diabetic kidney disease?","answer":"Type 2 diabetes can increase the risk of developing diabetic kidney disease (DKD).","input_idx":[[120,199]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5125721,"edit_id":"7fd1084b0e1fc900e7e5956bac945246","category":"omission","question":"How was the study designed?","answer":"The study was a parallel, randomized, open-label controlled trial.","input_idx":[[397,451]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5125721,"edit_id":"10ca92c76529c1d7b08b451ea810a48d","category":"omission","question":"When were the blood samples and dietary information collected?","answer":"Blood samples and dietary information were collected at the start and end of the 4-week study.","input_idx":[[669,765]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5125721,"edit_id":"97d43200960a658d7003c77457475cff","category":"concept","question":"What were the specific changes in the markers and how statistically significant were they?","answer":"The specific changes in the markers were a decrease in the urinary albumin to creatinine ratio (UACR) and urea nitrogen (UN) in the TB intervention group compared to the diet control group. The results were statistically significant at 4 weeks (P<0.05).","input_idx":[[798,1009]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5125721,"edit_id":"db19e0dfbbf9e50948725f2a97ea24d9","category":"concept","question":"What were the specific subgroups and how statistically significant were the results?","answer":"The specific subgroups were T2DM patients with normoalbuminuria and microalbuminuria. The results showed a significant reduction in UACR and UN for these subgroups (P<0.05).","input_idx":[[1075,1260]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5125808,"edit_id":"64fe1894bade4d38b06e87e5f4284025","category":"omission","question":"What was the main goal of this study?","answer":"The main goal of this study was to compare the blood pressure lowering efficacy of the combination therapy (CKD-828 2.5\/40 mg and CKD-828 2.5\/80 mg) to that of S-amlodipine monotherapy.","input_idx":[[629,819]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5125808,"edit_id":"6fbc8cd87b499eaa7eaa85aaccb5681c","category":"omission","question":"How was the safety of the treatments evaluated in this study?","answer":"The safety of the treatments was evaluated based on adverse events, vital signs, and physical examination findings.","input_idx":[[820,916]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5125808,"edit_id":"86a420b21ea74cb951f01fc4e964592a","category":"concept","question":"Who were the participants in this study?","answer":"The participants were patients who had high blood pressure despite taking S-amlodipine for 4 weeks.","input_idx":[[377,522]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5125808,"edit_id":"64fe1894bade4d38b06e87e5f4284025","category":"concept","question":"What was the main goal of this study?","answer":"The main goal of this study was to compare the blood pressure lowering efficacy of the combination therapy (CKD-828 2.5\/40 mg and CKD-828 2.5\/80 mg) to that of S-amlodipine monotherapy.","input_idx":[[629,819]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5129820,"edit_id":"7336f0f81f788389c1295b04c3b280ee","category":"omission","question":"Why is it important to evaluate the effect of olaparib on HRQoL during maintenance therapy?","answer":"It is important to evaluate the effect of olaparib on HRQoL during maintenance therapy because it is a crucial aspect of patient care and can help to improve the overall well-being of patients.","input_idx":[[294,388]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5129820,"edit_id":"852e3f0cc0549270478ac91a139b43af","category":"omission","question":"What was the primary measure used to evaluate the effect of olaparib on HRQoL?","answer":"The primary measure used to evaluate the effect of olaparib on HRQoL was the TOI of the FACT-O questionnaire.","input_idx":[[827,868]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5129820,"edit_id":"5df1f470c2e50f78a3676ed3ae6820aa","category":"concept","question":"What was the specific dosage of olaparib that patients took and for how long were they followed?","answer":"Patients received olaparib 400 mg b.i.d. (twice a day) and were followed for a total of 28 days.","input_idx":[[493,573]],"output_idx":[[314,406]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5129820,"edit_id":"ffe50dfbf1507b3f2b0abf816f5bc468","category":"concept","question":"What was the specific measure used to evaluate the best response of patients in the study?","answer":"The specific measure used to evaluate the best response of patients in the study was the TOI of the FACT-O questionnaire.","input_idx":[[1026,1099]],"output_idx":[[716,787]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5223669,"edit_id":"11b83c46ff6215c547b1b20f7fa6d696","category":"omission","question":"What type of study is being analyzed?","answer":"The type of study being analyzed is a 2-arm randomized controlled trial (RCT) with a baseline outcome followed by a few assessments at fixed follow-up times.","input_idx":[[11,279]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5223669,"edit_id":"6567adbecb6c05411e5294a74693f1a7","category":"omission","question":"What is cLDA and how does it work?","answer":"cLDA is a statistical method that constrains the means of baseline measurements to be equal between arms in a randomized controlled trial. It is used to estimate treatment effects and inferential statistics.","input_idx":[[322,434]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5223669,"edit_id":"d811e98b4b37a28848a02a5dc5093ea6","category":"concept","question":"What methods were used to analyze the data from the study conducted at Group Medical Clinics (GMC)?","answer":"Linear mixed models were used to analyze the data from the study conducted at Group Medical Clinics (GMC).","input_idx":[[712,888]],"output_idx":[[638,782]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5223669,"edit_id":"b4bb5be40b242f548be414589ceeacfe","category":"concept","question":"What does \"significantly more\" mean in this context?","answer":"\"Significantly more\" means that the difference between the GMC treatment and usual care was statistically significant, meaning that it is unlikely to have occurred by chance.","input_idx":[[899,1124]],"output_idx":[[957,1139]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5244020,"edit_id":"bd7c98622976f61daa826dd827e74ed9","category":"omission","question":"How common are pain and urinary symptoms after CRC surgery?","answer":"Pain and urinary symptoms are common and can have a poor recovery after CRC surgery.","input_idx":[[0,106]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5244020,"edit_id":"a50a779d4ff0077bb7860e15638dfcf4","category":"omission","question":"How was the study designed?","answer":"The study was a randomized control study, meaning that the participants were randomly assigned to one of the three groups and the results were compared between them.","input_idx":[[360,511]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5244020,"edit_id":"10da2b4d757a85e851dd115becb9822f","category":"omission","question":"How long did the patients inhale the substances?","answer":"The patients inhaled the substances for 20 minutes.","input_idx":[[513,604]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5244020,"edit_id":"3f03702898c1c99333afe1197050a0d1","category":"concept","question":"What specific measures were used to measure the different parameters?","answer":"The specific measures used to measure the different parameters were not mentioned in the simplification.","input_idx":[[606,805]],"output_idx":[[674,863]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5244020,"edit_id":"b62982ab0726bea13bbdf50d9ba121d0","category":"concept","question":"What were the specific results of the measurements?","answer":"The specific results of the measurements were not mentioned in the simplification.","input_idx":[[807,927]],"output_idx":[[864,1000]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5244020,"edit_id":"f0515b19ec46a32fb68715a486abde6f","category":"concept","question":"How statistically significant were the differences observed?","answer":"The differences observed were statistically significant, with inhalation of linalyl acetate being significantly more effective than inhalation of lavender or vehicle.","input_idx":[[929,1168]],"output_idx":[[1068,1203]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5301061,"edit_id":"527989c45a0f39aa5ade0abfca9242c8","category":"omission","question":"What specific aspect of spiritual wellbeing was measured in the study?","answer":"The study measured the religious dimension of spiritual wellbeing.","input_idx":[[1174,1193]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5301061,"edit_id":"3743265ba9c5ddb0ad88557e8a13a79f","category":"omission","question":"What specific aspect of spiritual wellbeing was measured in the study?","answer":"The study measured the existential aspect of spiritual wellbeing.","input_idx":[[1203,1244]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5301061,"edit_id":"b636e55fbc6fb4bc1b049cd6e6a52fd8","category":"concept","question":"What type of religious program was implemented in the study?","answer":"The religious program implemented in the study was based on Islam.","input_idx":[[327,360]],"output_idx":[[611,642]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5301061,"edit_id":"527989c45a0f39aa5ade0abfca9242c8","category":"concept","question":"What specific aspect of spiritual wellbeing was measured in the study?","answer":"The study measured the religious dimension of spiritual wellbeing.","input_idx":[[1174,1193]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5301061,"edit_id":"3743265ba9c5ddb0ad88557e8a13a79f","category":"concept","question":"What specific aspect of spiritual wellbeing was measured in the study?","answer":"The study measured the existential aspect of spiritual wellbeing.","input_idx":[[1203,1244]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5313491,"edit_id":"ba17642391a30095087391ea1a79a659","category":"omission","question":"What was the goal of the study?","answer":"The goal of the study was to evaluate the effect of a GDFR strategy on the postoperative outcome of high-risk patients undergoing brain surgery.","input_idx":[[133,326]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5313491,"edit_id":"0f8b5adef163ac3af879580d10980ddf","category":"omission","question":"What were the specific outcomes that were studied in the study?","answer":"The specific outcomes that were studied in the study were ICU length of stay, lactates at the end of surgery, postoperative complications, hospital length of stay, mortality at day 30, and costs.","input_idx":[[691,889]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5313491,"edit_id":"9790deeafa7dae4ba991e5ff29b39747","category":"concept","question":"Who were the patients in the study?","answer":"The patients in the study were high-risk patients undergoing brain surgery.","input_idx":[[282,325]],"output_idx":[[415,448]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5313491,"edit_id":"eb4d67cdf0579b6ea898464e748a9c58","category":"concept","question":"What was the specific association between intraoperative GDFR and the outcomes?","answer":"The specific association between intraoperative GDFR and the outcomes was a reduction in ICU length of stay and costs, and a decrease in postoperative morbidity.","input_idx":[[1697,1824]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5350209,"edit_id":"55452d6824c1ae31c434afb78b6badce","category":"omission","question":"What previous research did the study build upon?","answer":"The study built upon previous research that showed that strong visual health-warning messages can increase perceived health risks and intentions to reduce alcohol consumption.","input_idx":[[5,185]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5350209,"edit_id":"f67495978b1add2adff1f47d8e67af11","category":"omission","question":"How many participants were in the study and what were the conditions they were in?","answer":"There were 45 female participants in the study. They consumed an alcoholic beverage in a relaxed environment in one of three conditions: no health-warning label, a text-only health-warning label or a pictorial health-warning label with text.","input_idx":[[527,766]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5350209,"edit_id":"dad64d63be5dbef7e53f1be17c47cdf4","category":"concept","question":"How did the researchers measure the speed of alcohol consumption?","answer":"The researchers measured the speed of alcohol consumption by the time it took for the participants to finish their drink.","input_idx":[[777,959]],"output_idx":[[753,887]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5350209,"edit_id":"5a9d60b8c2238e536f8ab5b166518732","category":"concept","question":"How did the researchers measure product acceptability?","answer":"The researchers measured product acceptability by asking the participants to rate on a scale how much they liked the drink.","input_idx":[[960,1065]],"output_idx":[[966,1049]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5379203,"edit_id":"78ce97e90db1c8efa4ee14f47286c654","category":"omission","question":"How was the study designed?","answer":"The study was a prospective, controlled CPAP parallel study of new referrals with suspected OSAS randomized into group A) home-based or B) hospital-based approach.","input_idx":[[134,283]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5379203,"edit_id":"2758aed7a77749828935d596279f1f30","category":"omission","question":"What was the treatment for both groups?","answer":"Both groups received CPAP, a machine used for treating sleep apnea, for three months.","input_idx":[[284,493]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5379203,"edit_id":"e8040adf484cb6fd20423cad3a942e93","category":"omission","question":"What was the primary endpoint of the study?","answer":"The primary endpoint of the study was the Epworth sleepiness score.","input_idx":[[494,579]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5379203,"edit_id":"432fa5aec956889abf6f0c77c6ab3288","category":"concept","question":"What is the difference between the two groups?","answer":"The study was a prospective, controlled CPAP parallel study of new referrals with suspected OSAS randomized into group A) home-based or B) hospital-based approach.","input_idx":[[134,283]],"output_idx":[[0,111]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5379203,"edit_id":"7fbf90ad620017f733b0247acb39bdef","category":"concept","question":"What is CPAP?","answer":"CPAP is a machine used for treating sleep apnea, it delivers pressurized air through a mask to keep the airways open during sleep.","input_idx":[[284,493]],"output_idx":[[333,432]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5379203,"edit_id":"cc3429485178e2501e54c32ef1408fe1","category":"concept","question":"What is the Epworth sleepiness score?","answer":"The Epworth sleepiness score is a measure of daytime sleepiness, it is calculated by asking patients to rate on a scale of 0 to 24 how likely they are to fall asleep during eight different situations during the day.","input_idx":[[494,579]],"output_idx":[[435,527]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5416724,"edit_id":"5ca533baad6a60ae3d6cb42785bd055e","category":"omission","question":"What was the purpose of this study?","answer":"The study aimed to compare the performance of three different types of tools used for placing breathing tubes in patients who have limited neck movement.","input_idx":[[21,313]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5416724,"edit_id":"6c479af14d8c994e55a3f01fd464b50b","category":"omission","question":"Who were the participants in the study?","answer":"The study included 90 adults who were relatively healthy and undergoing surgeries that required breathing tubes.","input_idx":[[324,665]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5416724,"edit_id":"3cefb87d540837d676c186dae2a99275","category":"omission","question":"What were the specific measurements taken in the study?","answer":"The study measured the ease of intubation, the view of the throat area, any additional maneuvers used to make intubation successful, and the impact on the patients' heart rates and blood pressure levels.","input_idx":[[666,853]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5416724,"edit_id":"efbf5e0a903961e9922c497ba875b686","category":"concept","question":"What was the specific technique used in the study?","answer":"The study used manual inline axial cervical spine stabilisation (MIAS) technique.","input_idx":[[21,313]],"output_idx":[[21,158]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5416724,"edit_id":"4e887eddd927321796ec8bafb6525541","category":"concept","question":"What were the specific criteria used to select the participants in the study?","answer":"The study included 90 adults who were relatively healthy and undergoing surgeries that required breathing tubes.","input_idx":[[324,665]],"output_idx":[[275,398]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5416724,"edit_id":"2ab9bd8e80193acc28540e2b1448e7de","category":"concept","question":"What were the specific parameters used to measure the ease of intubation?","answer":"The study measured the ease of intubation based on the Intubation difficulty scale (IDS) score, Cormack-Lehane grade of glottic view, optimisation manoeuvres and impact on haemodynamic parameters.","input_idx":[[666,853]],"output_idx":[[507,728]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5433398,"edit_id":"9a4da53e105a4ff92b2357fdf3373236","category":"omission","question":"What is the challenge with managing the health of people with multiple sclerosis?","answer":"People with multiple sclerosis often require care from many different doctors, which can create a complex system for managing their health.","input_idx":[[12,147]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5433398,"edit_id":"d242bcb988be154fd4cc9e4b179ebe0a","category":"omission","question":"What is the purpose of this study?","answer":"The purpose of this study is to evaluate the effectiveness of an integrated multidisciplinary approach versus usual care in MS patients.","input_idx":[[148,236]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5433398,"edit_id":"b020adb67b678f037ce68899de4f91da","category":"concept","question":"What was the IMD approach in the study?","answer":"The IMD approach was a half-day individually tailored comprehensive assessment in the MS clinic.","input_idx":[[489,696]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5433398,"edit_id":"cc8fda8d77d8f601be9a7fb5d6fae1b6","category":"concept","question":"What tool was used to measure the quality of life of the patients?","answer":"The quality of life of the patients was measured using the MSIS-29 scale.","input_idx":[[697,840]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5440036,"edit_id":"c96d63fcfc9e3b35dbbbe24f31128437","category":"omission","question":"What condition is the study investigating?","answer":"The study investigates the condition of postoperative nausea and vomiting (PONV) which is commonly observed after eye enucleation and orbital hydroxyapatite implant surgery.","input_idx":[[11,51]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5440036,"edit_id":"5b5d4603986edb718db5d431986cce43","category":"omission","question":"Who were the participants in the study?","answer":"The participants in the study were adults, aged 18 to 70, that are categorised as healthy or having mild illness by the American Society of Anesthesiologists.","input_idx":[[543,597]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5440036,"edit_id":"982ea2ff57304593aac96472c4ca1038","category":"omission","question":"How long was the assessment period for the severity of nausea and vomiting?","answer":"The severity of nausea and vomiting was assessed for 72 hours after surgery.","input_idx":[[1081,1108]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5440036,"edit_id":"562bbd20ee9107c91be49667e9ce24f1","category":"concept","question":"How was the study designed?","answer":"The study was designed as a prospective, randomized, double-blind trial.","input_idx":[[144,187]],"output_idx":[[295,300]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5440036,"edit_id":"e0bcbf154db8289e2153de48abeb0f9f","category":"concept","question":"What does a complete response mean in this context?","answer":"A complete response means that the patient did not experience any nausea or vomiting during the 72-h postoperative period.","input_idx":[[1046,1068]],"output_idx":[[999,1020]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5440738,"edit_id":"880056993e01821acd7e25f4d861df6e","category":"omission","question":"How many patients were included in the study?","answer":"There were 40 patients in the control group and 45 patients in the text messaging adjunct group.","input_idx":[[1075,1278]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5440738,"edit_id":"b7f14f840f7f8754f35649a856dc7ecf","category":"omission","question":"What kind of messages were sent in the text messaging adjunct?","answer":"The text messaging adjunct included daily mood monitoring messages, daily messages reiterating the theme of that week's content, and medication and appointment reminders.","input_idx":[[1279,1440]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5440738,"edit_id":"1c69b865aa8515e5f175ee067acf4c3b","category":"concept","question":"How were the texts used in the therapy process?","answer":"The therapist could access the texts and used them as a tool for teaching CBT skills. The mood data and qualitative responses were sent to a web-based platform for review by the therapist and displayed in session as a tool for teaching CBT skills.","input_idx":[[1441,1611]],"output_idx":[[1195,1269]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5442667,"edit_id":"d59bdaeefbe636aba47c57e150afc906","category":"omission","question":"What previous research has shown about the effectiveness of MTM interventions?","answer":"Previous research has shown that MTM interventions can be effective in addressing inappropriate medication use in older adults.","input_idx":[[388,495]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5442667,"edit_id":"182e8f02d4004fc89ebe138a3c0b6290","category":"omission","question":"What specific measures were used to evaluate the effectiveness of the intervention?","answer":"The study evaluated the effectiveness of the intervention using changes in the medication appropriateness index (MAI) targeting anticholinergic medications and in the anticholinergic drug scale (ADS) score from baseline to the end of study.","input_idx":[[1008,1201]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5442667,"edit_id":"b0be3fa7a23688a3cbb74ee04e607542","category":"concept","question":"What are anticholinergic properties?","answer":"Anticholinergic properties are certain characteristics of certain medications that can have negative effects on the body, such as increased anticholinergic burden and negatively impacting cognition.","input_idx":[[135,172]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5442667,"edit_id":"9a0cb9f4c9be703b19b10eb7b085e5bb","category":"concept","question":"What are MTM interventions?","answer":"MTM interventions are a type of coordinated care between doctors and pharmacists that aims to improve medication use and reduce the risk of adverse effects.","input_idx":[[388,437]],"output_idx":[[291,339]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5442667,"edit_id":"6684081469587c46262d7b42af578b21","category":"concept","question":"What is a targeted patient-centered pharmacist\u2013physician team MTM intervention?","answer":"A targeted patient-centered pharmacist\u2013physician team MTM intervention is a type of coordinated care between doctors and pharmacists that is tailored to the specific needs of individual patients and aims to improve medication use and reduce the risk of adverse effects.","input_idx":[[740,808]],"output_idx":[[275,307]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5448649,"edit_id":"d27384ac1b62c33b2e026e239c92d335","category":"omission","question":"Who were the participants in the study?","answer":"The participants were patients with advanced biliary tract cancer (aBTC) who had failed to respond to at least one regimen of chemotherapies.","input_idx":[[437,508]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5448649,"edit_id":"e2adda732f7047b3a1afa12999681c71","category":"omission","question":"How were the peptides selected for the vaccination?","answer":"The peptides were selected based on the pre\u2010existing peptide\u2010specific IgG responses of the patients. HLA\u2010matched peptides were chosen to increase the likelihood of an immune response.","input_idx":[[651,758]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5448649,"edit_id":"12c1cc002c929af0fd67e1e50cd26b5d","category":"omission","question":"What were the results of the T cell responses in the two arms of the study?","answer":"The T cell responses to the vaccinated peptides in the PPV\/CPA arm tended to be greater than those in the PPV alone arm.","input_idx":[[801,917]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5448649,"edit_id":"79b949118cba67a62809c0aac1abbdcf","category":"concept","question":"What is the definition of advanced biliary tract cancer (aBTC)?","answer":"Advanced biliary tract cancer (aBTC) is a type of liver cancer that has spread to other parts of the body and is resistant to chemotherapy.","input_idx":[[437,508]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5448649,"edit_id":"e2adda732f7047b3a1afa12999681c71","category":"concept","question":"How were the peptides selected for the vaccination?","answer":"The peptides were selected based on the pre\u2010existing peptide\u2010specific IgG responses of the patients. HLA\u2010matched peptides were chosen to increase the likelihood of an immune response.","input_idx":[[649,758]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5448649,"edit_id":"12c1cc002c929af0fd67e1e50cd26b5d","category":"concept","question":"What were the results of the T cell responses in the two arms of the study?","answer":"The T cell responses to the vaccinated peptides in the PPV\/CPA arm tended to be greater than those in the PPV alone arm.","input_idx":[[801,917]],"output_idx":[[634,695]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5491994,"edit_id":"d3e557dfc51c399483cb365fd28d238b","category":"omission","question":"Why is it important for patients to understand their diagnosis and treatment plan?","answer":"Understanding your diagnosis and treatment plan is important because it helps you follow the treatment plan and make informed decisions about your health.","input_idx":[[202,287]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5491994,"edit_id":"127632cba814d8da8dacd0b5e31d2733","category":"omission","question":"How was the study designed?","answer":"The study was a randomized, prospective study, meaning that participants were randomly assigned to either the treatment group or a control group, and the study was conducted over a set period of time.","input_idx":[[767,841]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5491994,"edit_id":"193374a04dc88376fdbef82a89f5293a","category":"concept","question":"What specific conditions were the study participants suffering from?","answer":"The study participants were suffering from conditions like a deviated septum or a blocked sinus passage.","input_idx":[[157,200]],"output_idx":[[123,179]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5491994,"edit_id":"87dc29a38f2f2bee0bfd0fd3d810eda5","category":"concept","question":"What kind of data was used to create the 3D model?","answer":"The 3D model was created based on clinical X-ray data.","input_idx":[[498,555]],"output_idx":[[418,446]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5491994,"edit_id":"97dd257e1ea8e43b0c84b2db93af8026","category":"concept","question":"What was the design of the study?","answer":"The study was a two-arm, single-center, randomized, prospective study, meaning that participants were randomly assigned to either the treatment group or a control group, and the study was conducted over a set period of time at a single center.","input_idx":[[767,822]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5498715,"edit_id":"8a7e2e14f56a9667a25435bf989fbbf3","category":"omission","question":"What type of fitness test was used to measure physical fitness?","answer":"The specific type of fitness test used to measure physical fitness was not mentioned in the simplification.","input_idx":[[496,517]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5498715,"edit_id":"ed144215aba515fa05811ac8492f4b60","category":"omission","question":"What type of questionnaire was used to measure physical activity?","answer":"The specific type of questionnaire used to measure physical activity was not mentioned in the simplification.","input_idx":[[528,573]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5498715,"edit_id":"29e685cc70fbf322fa1ce82c6bc38ad4","category":"concept","question":"What is Self-determination theory (SDT) and how does it help understand people's motivations for exercise?","answer":"Self-determination theory (SDT) is a psychological theory that explains how people make decisions and take action. It suggests that people are more likely to engage in a behavior if they feel autonomous, competent, and have a sense of control over it. In the context of exercise, SDT helps understand the motivations and barriers to exercise, and how to increase motivation.","input_idx":[[62,93]],"output_idx":[[128,200]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5498715,"edit_id":"db60234ec36a5ff2c8f447a331382598","category":"concept","question":"What is motivational interviewing (MI) and how does it work to increase motivation for exercise?","answer":"Motivational interviewing (MI) is a counseling technique that helps people explore and resolve ambivalence about a behavior, such as exercise. It works by helping people identify their own motivations and barriers to the behavior, and then working with them to develop a plan to overcome those barriers and increase motivation.","input_idx":[[150,180]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5506592,"edit_id":"d4d49b44011d9373163a7b445d331d27","category":"omission","question":"Where was the study conducted?","answer":"The study was conducted in Mexico and Nicaragua.","input_idx":[[347,469]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5506592,"edit_id":"9d1ad1ece80e10044db4c2556a7330ab","category":"omission","question":"How was social vulnerability related to expenditures on anti-mosquito products?","answer":"The study examined how households that were more vulnerable socially spent less on anti-mosquito products.","input_idx":[[1104,1202]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5506592,"edit_id":"6e514c671c28a6de21fb9924ef58934e","category":"concept","question":"What specific questions were asked in the survey?","answer":"The survey included questions about socio-economic status, self-reported dengue illness, and purchase of and expenditure on insecticide anti-mosquito products in the previous month.","input_idx":[[741,1103]],"output_idx":[[529,749]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5506592,"edit_id":"9a3c6e4ea7f8a50c2e687aed76cdc7a5","category":"concept","question":"What percentage of households used anti-mosquito products in 2010?","answer":"In 2010, nearly half of the households used anti-mosquito products.","input_idx":[[1322,1468]],"output_idx":[[972,1076]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5506592,"edit_id":"a0ecd6c1a5acde5c31bf7009bdf0500f","category":"concept","question":"What was the statistical significance of the difference in product use and spending between the households that received the intervention and those that did not in 2012?","answer":"The difference in product use and spending between the households that received the intervention and those that did not in 2012 was statistically significant.","input_idx":[[1528,1803]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5506697,"edit_id":"d6168c76643202d2acab6e851ae0db67","category":"omission","question":"What were the specific criteria that patients had to meet in order to be included in the study?","answer":"Patients had to be aged 10-17, have bipolar I disorder, be in a depressive phase, have a CDRS-R total score of 40 or higher, a YMRS total score of 15 or lower, and a YMRS-item 1 score of 2 or lower.","input_idx":[[208,424]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5506697,"edit_id":"5f20f8d88f146fc0642f4f405c4b298c","category":"omission","question":"What questionnaire was used to measure QoL in the study?","answer":"The revised KINDL questionnaire for measuring health-related QoL in children and adolescents (KINDL-R) was used.","input_idx":[[564,722]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5506697,"edit_id":"49fff9ed5bb6b0a40a1fd9297371fba8","category":"concept","question":"What was the purpose of the questionnaire that patients and parents filled out?","answer":"The purpose of the questionnaire was to measure health-related QoL in children and adolescents with bipolar depression.","input_idx":[[564,722]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5513842,"edit_id":"701b8ecab9262ed6789e0acc37206036","category":"omission","question":"What specific measures were used to evaluate the effectiveness of the paravertebral block?","answer":"The specific outcome measures used were the severity of pain measured on a numeric pain rating scale, total opioid consumption, and the first analgesic request time during the first postoperative 24 hours.","input_idx":[[626,811]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5513842,"edit_id":"97a855990feaacb0fa83a8d2f8c96b7b","category":"omission","question":"What were the specific results of the study?","answer":"The specific results of the study were that 24 hours after surgery, the paravertebral block group had a lower pain score at rest and at movement compared to the control group. The difference between the groups was statistically significant.","input_idx":[[1006,1156]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5513842,"edit_id":"0cc596fa58023b7f8b07bda6ddc9054e","category":"concept","question":"What is a numeric pain rating scale?","answer":"A numeric pain rating scale is a tool used to measure the intensity of pain on a scale from 0 to 10, where 0 is no pain and 10 is the worst pain possible.","input_idx":[[626,811]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5513842,"edit_id":"adb3d3ac01a066a26aecf56a7627a57a","category":"concept","question":"What is cumulative opioid consumption?","answer":"Cumulative opioid consumption refers to the total amount of opioid medication that a person takes over a period of time. In this study, it was measured in milligrams (mg) and was used to evaluate the effectiveness of the paravertebral block in managing pain after cholecystectomy.","input_idx":[[1265,1546]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5514258,"edit_id":"0b2dfb0c48d0bdd58046c5c6d70013fe","category":"omission","question":"What is the source of the data used in this study?","answer":"The data used in this study came from the National Cancer Database (NCDB).","input_idx":[[139,170]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5514258,"edit_id":"fe26b19ab6fb0134889a924be1f51f7f","category":"omission","question":"What were the specific criteria for the high risk group?","answer":"Patients were considered high risk if they had extracapsular extension and\/or positive margin after resection.","input_idx":[[612,721]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5514258,"edit_id":"8f117c5c0b9b36cbb21c75347771d8ab","category":"omission","question":"What were the specific criteria for the intermediate risk group?","answer":"Patients were considered intermediate risk if they did not meet the criteria for high risk but had pT3-T4 disease, pN+ disease, lymphovascular space invasion, adenoid cystic histology, or grade 2-3 disease.","input_idx":[[723,929]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5514258,"edit_id":"914591d81d196cce8e90495b5ee7d97e","category":"omission","question":"What were the specific criteria for the low risk group?","answer":"Patients who did not meet criteria for high or intermediate risk were considered low risk.","input_idx":[[930,1020]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5514258,"edit_id":"ac3691cff5ea5e41a705f37a73e5323a","category":"concept","question":"What were the specific features that were used to risk-stratify the patients?","answer":"Patients were risk-stratified based on certain features of their disease, such as how far it had spread, cancer type, and so on.","input_idx":[[517,566]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5514258,"edit_id":"214f51464b49a69a7e32fed04ec4969a","category":"concept","question":"What specific statistical methods were used to analyze the data?","answer":"The data was summarized with descriptive statistics and analyzed with STATA, which is a statistical software package.","input_idx":[[1021,1176]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5518918,"edit_id":"5631665f4272f4841e5aa0c061093bd9","category":"omission","question":"Why is it important to improve participation rates and long-term effectiveness of cardiac rehabilitation?","answer":"Improving participation rates and long-term effectiveness of cardiac rehabilitation is important because it can lead to better health outcomes for patients who have had a cardiac event.","input_idx":[[5,242]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5518918,"edit_id":"8da08cdd7a54430f89d9a17dd3234606","category":"omission","question":"How were the patients selected for the study?","answer":"The patients were selected based on their cardiac risk level and were randomly assigned to either home-based training with telemonitoring guidance or center-based training.","input_idx":[[385,572]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5518918,"edit_id":"6ca42e4d197b2a1ce8f162d11abe5e0c","category":"omission","question":"How satisfied were the patients in each group?","answer":"The patients in the home-based group were more satisfied with their training than the patients in the center-based group.","input_idx":[[573,688]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5518918,"edit_id":"0736f28d4a90fd32cb8b6e27e5bf5c22","category":"concept","question":"What were the specific results of the study in terms of physical fitness?","answer":"The study found that both groups improved their physical fitness after rehab and kept it up after one year, but there were no significant differences between the two groups.","input_idx":[[689,875]],"output_idx":[[607,735]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5518918,"edit_id":"b91bd09bc584641dc98547ffb704c23d","category":"concept","question":"What were the specific results of the study in terms of exercise levels?","answer":"The study found that exercise levels did not change during the one-year study period for both groups.","input_idx":[[876,994]],"output_idx":[[738,784]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5518918,"edit_id":"9a603a1d2a325de17f5f4c4546ac8fe5","category":"concept","question":"What were the specific results of the study in terms of healthcare costs?","answer":"The study found that healthcare costs were statistically non-significantly lower in the home-based group, by an average of \u20ac437 per patient. Additionally, from a societal perspective, the home-based group was found to be more cost-effective, with a statistically non-significant difference of \u20ac3160 per patient. The probability that it was more cost-effective varied between 97% and 75% depending on the willingness-to-pay.","input_idx":[[995,1498]],"output_idx":[[785,939]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5529957,"edit_id":"feb9480112a567ee212db77fe778b1d3","category":"omission","question":"What was the name of the study that this research was a part of?","answer":"The research was a part of the Chronic Thromboembolic Pulmonary Hypertension Soluble Guanylate Cyclase\u2013Stimulator Trial 1 study.","input_idx":[[211,307]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5529957,"edit_id":"4e261a000df4c02b988b5da1018bea44","category":"omission","question":"What type of chronic lung disease did the patients have?","answer":"The patients had chronic thromboembolic pulmonary hypertension (CTEPH) or persistent\/recurrent CTEPH after pulmonary endarterectomy.","input_idx":[[319,418]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5529957,"edit_id":"3c1281afbfb9a4f2c0b7d620609e9fe3","category":"concept","question":"How often and in what dosage were the patients given riociguat?","answer":"Patients were given up to 2.5 mg of riociguat three times daily.","input_idx":[[419,492]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5529957,"edit_id":"3520bd706ccc00525c1ae7070f6bae3e","category":"concept","question":"What specific indicators of heart and lung function were tested and what do they measure?","answer":"The specific indicators tested were pulmonary vascular resistance (PVR), cardiac index, mean pulmonary artery pressure, and 6-minute walk distance. These indicators measure the resistance to blood flow in the lungs, the heart's ability to pump blood, the pressure in the lungs, and the distance a person can walk in 6 minutes, respectively.","input_idx":[[493,554]],"output_idx":[[360,465]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5545112,"edit_id":"69953faed885b7ffd4eaed7e9d645c4f","category":"omission","question":"How was the study conducted?","answer":"The study was conducted as a prospective double-blinded, randomized trial.","input_idx":[[167,227]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5545112,"edit_id":"6664fbd39000859cd1cd92803feae248","category":"omission","question":"What disease did the patients have that made them eligible for the study?","answer":"The patients had ulcerative colitis (UC).","input_idx":[[303,383]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5545112,"edit_id":"077de0d5dbcff284980825bcdcf0a02a","category":"omission","question":"How long was the study conducted for?","answer":"The study was conducted for 90 days.","input_idx":[[385,505]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5545112,"edit_id":"d3d8dbaf7dab0a7ee18d75351f0db54c","category":"omission","question":"What specific tools were used to measure quality of life and disease severity?","answer":"The Short Inflammatory Bowel Disease Questionnaire (SIBDQ) was used to measure quality of life and the Partial Mayo Score was used to measure disease severity.","input_idx":[[507,677]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5545112,"edit_id":"17056d1636f9b3b966a177cc8e0f9db4","category":"concept","question":"How much did the vitamin D levels increase in both groups?","answer":"The vitamin D levels increased by an average of 5.00\u00a0\u00b1\u00a03.12 ng\/ml in the 2,000 IU group and 16.80\u00a0\u00b1\u00a09.15 ng\/ml in the 4,000 IU group.","input_idx":[[990,1069]],"output_idx":[[833,872]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5545112,"edit_id":"238be192f051a19a67807529fbeaa447","category":"concept","question":"What is considered \"healthy\" vitamin D levels?","answer":"Normal vitamin D levels are considered to be greater than 30 ng\/dl.","input_idx":[[1288,1468]],"output_idx":[[923,1079]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5545112,"edit_id":"7708a678ea2918465d3dc0ed464b7045","category":"concept","question":"How much did the quality of life scores improve in both groups?","answer":"The quality of life scores improved by an average of 1.0\u00a0\u00b1\u00a01.0 in the 4,000 IU group and 0.1\u00a0\u00b1\u00a01.0 in the 2,000 IU group.","input_idx":[[1520,1663]],"output_idx":[[1081,1188]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5545112,"edit_id":"9e12748e93a137eea454e59db3b7f7b2","category":"concept","question":"How much did the severity scores change in both groups?","answer":"The severity scores decreased by an average of \u22120.5\u00a0\u00b1\u00a01.5 in the 2,000 IU group and \u22121.3\u00a0\u00b1\u00a02.9 in the 4,000 IU group, but this change was not statistically significant.","input_idx":[[1701,1883]],"output_idx":[[1190,1269]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5555437,"edit_id":"c59799f6083ca191c4981fdd81e1be69","category":"omission","question":"What type of trial was this study?","answer":"This study was an open-label, phase 3, randomised superiority trial.","input_idx":[[313,387]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5555437,"edit_id":"7449c499b1976a29e8f6befcfe9af076","category":"omission","question":"What was the specific radiotherapy schedule for each group?","answer":"Patients in the twice-daily group received 45 Gy radiotherapy in 30 twice-daily fractions of 1\u00b75 Gy over 19 days, while patients in the once-daily group received 66 Gy in 33 once-daily fractions of 2 Gy over 45 days, starting on day 22 after commencing cisplatin\u2013etoposide chemotherapy (given as four to six cycles every 3 weeks in both groups).","input_idx":[[676,982]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5555437,"edit_id":"70d494924906b8d5fe39db85570bb09b","category":"omission","question":"How were patients assigned to the two groups?","answer":"Patients were randomly assigned to one of two groups using a method called minimisation with a random element, stratified by institution, planned number of chemotherapy cycles, and performance status.","input_idx":[[984,1139]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5555437,"edit_id":"c59799f6083ca191c4981fdd81e1be69","category":"concept","question":"What type of trial was this study?","answer":"This study was an open-label, phase 3, randomised superiority trial.","input_idx":[[313,387]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5555437,"edit_id":"7449c499b1976a29e8f6befcfe9af076","category":"concept","question":"What was the specific radiotherapy schedule for each group?","answer":"Patients in the twice-daily group received 45 Gy radiotherapy in 30 twice-daily fractions of 1\u00b75 Gy over 19 days, while patients in the once-daily group received 66 Gy in 33 once-daily fractions of 2 Gy over 45 days, starting on day 22 after commencing cisplatin\u2013etoposide chemotherapy (given as four to six cycles every 3 weeks in both groups).","input_idx":[[676,982]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5555437,"edit_id":"70d494924906b8d5fe39db85570bb09b","category":"concept","question":"How were patients assigned to the two groups?","answer":"Patients were randomly assigned to one of two groups using a method called minimisation with a random element, stratified by institution, planned number of chemotherapy cycles, and performance status.","input_idx":[[984,1139]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5571493,"edit_id":"99348e649b8893f0ad7c5542e6b102d4","category":"omission","question":"How were the experiments conducted?","answer":"The experiments were conducted in a random order.","input_idx":[[320,379]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5571493,"edit_id":"d4a908e9f38b87be0ac476371633eadb","category":"omission","question":"How often were blood glucose levels checked during the experiments?","answer":"Blood glucose levels were checked every 15 minutes for 4 hours.","input_idx":[[407,453]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5571493,"edit_id":"f5f618f2e78ae2436beacacdea0eda9e","category":"omission","question":"What was the purpose of the ECG?","answer":"The ECG was performed to measure the electrical activity of the heartbeat before and after quinine infusion.","input_idx":[[517,599]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5571493,"edit_id":"f9acff085645cef1f66051a74db4e3ea","category":"concept","question":"How significant was the difference in blood sugar levels between the quinine and non-quinine groups?","answer":"The difference in blood sugar levels between the quinine and non-quinine groups was statistically significant (p < 0.001).","input_idx":[[610,879]],"output_idx":[[696,835]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5571493,"edit_id":"2469c97bca3b84eb88a77eabbe54565c","category":"concept","question":"How significant was the drop in blood sugar levels at the 60th minute?","answer":"The drop in blood sugar levels at the 60th minute was statistically significant (p < 0.001).","input_idx":[[880,1113]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5588713,"edit_id":"8d122e102d23aea0ede7ada743674444","category":"omission","question":"What is the link between inhaling tiny particles in the air and health risks?","answer":"Inhaling tiny particles in the air, or air pollution, is linked with greater risks of illness and death.","input_idx":[[12,125]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5588713,"edit_id":"630eb84110906e67d306a1f346591cd6","category":"omission","question":"What type of particles were used in the study?","answer":"The particles used in the study were nanoparticles, which are particles that are less than 100 nanometers in size.","input_idx":[[126,150]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5588713,"edit_id":"70e7c165947e2e5ca16bae49728497c7","category":"omission","question":"How were the carbon nanoparticles administered in the study?","answer":"The carbon nanoparticles were purposely put in certain areas of the lungs of healthy men.","input_idx":[[352,408]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5588713,"edit_id":"7b30f168a645242f3d26966a2b15dbb7","category":"concept","question":"How was the study designed and conducted?","answer":"The study was designed as an investigator-initiated, randomized controlled, dose-escalation study in 26 healthy males. The participants received saline (control) in one lung segment and saline (placebo) or carbon nanoparticles 10 \u03bcg, 50 \u03bcg, or 100 \u03bcg in the contra-lateral lung. Six hours later, blood and bronchoalveolar lavage fluid (BALF) was collected for inflammation and coagulation parameters.","input_idx":[[505,606]],"output_idx":[[469,565]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5588713,"edit_id":"82881fd96495eaff11c6e2dcbc61df36","category":"concept","question":"What does the \"p-value\" of 0.046 mean?","answer":"The \"p-value\" of 0.046 indicates that the increase in blood neutrophils after challenge with carbon nanoparticles was statistically significant at a 5% significance level.","input_idx":[[895,1018]],"output_idx":[[898,1037]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5588713,"edit_id":"91c36da7550b93bc40b49421a328e955","category":"concept","question":"What does the \"p-value\" of 0.05 mean?","answer":"The \"p-value\" of 0.05 indicates that the increase in blood neutrophils after challenge with the highest dose of carbon nanoparticles was statistically significant at a 5% significance level.","input_idx":[[1019,1161]],"output_idx":[[1052,1169]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5626376,"edit_id":"124074e5f921afa6def25cc47d4b0d3d","category":"omission","question":"What were the treatments that were tested in the study?","answer":"The treatments tested were viscosupplementation (injection of a gel-like substance into the knee) or platelet-rich plasma (concentrated blood cells that might help healing), and standard care.","input_idx":[[40,90]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5626376,"edit_id":"fb2410146a1e8dc8c333e9ac19bbdce8","category":"omission","question":"What were the conditions under which the study was conducted?","answer":"The study was conducted under normal clinical practice conditions.","input_idx":[[232,273]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5626376,"edit_id":"7bbc94ca31c8b256545ad51c1a315148","category":"concept","question":"How were the 50 patients selected for the study?","answer":"The 50 patients were selected based on their meniscal lesions occurring concomitantly with osteoarthritis.","input_idx":[[930,958]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5626376,"edit_id":"9d6e692cf77be82813a6d2fb753b28e2","category":"concept","question":"What were the clinical outcomes that were evaluated in the study and how were they measured?","answer":"The clinical outcomes that were evaluated were pain and function, and they were measured using the Western Ontario and McMaster Universities Arthritis Index (WOMAC) at 3, 6, 12, and 18 months.","input_idx":[[662,798]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5626376,"edit_id":"795db3a820103b701c22775852155f2f","category":"concept","question":"What was the criteria used to determine the minimum clinically important improvement (MCII)?","answer":"The minimum clinically important improvement (MCII) was determined as a relative improvement of 20 or more for pain and function.","input_idx":[[799,907]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5682159,"edit_id":"d7fa52be13dd1a4196fa3c4a80fd4819","category":"omission","question":"Why are patient-reported outcomes important when assessing the efficacy of aesthetic procedures?","answer":"Patient-reported outcomes are important because they give insight into how patients perceive the results of a treatment, which is a key factor in determining whether a treatment is effective.","input_idx":[[12,113]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5682159,"edit_id":"e79bb2a7d85de258810ff2dacf6fe7b7","category":"omission","question":"How was the filler applied to the face?","answer":"The same injection technique and volume of the filler was applied to both sides of the face.","input_idx":[[425,515]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5682159,"edit_id":"10b1d924954b0f0865ea2d22806720ee","category":"omission","question":"Were there any restrictions on the use of anesthetics, overcorrection, and touch-ups during the treatment?","answer":"No, anesthetics, overcorrection, and touch-ups were not permitted during the treatment.","input_idx":[[516,578]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5682159,"edit_id":"c3e2602643d439798f8c735fa21a76a8","category":"concept","question":"How severe was the volume loss in the cheeks of the participants?","answer":"The participants had moderate-to-severe volume loss in the cheeks.","input_idx":[[216,274]],"output_idx":[[294,347]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5682159,"edit_id":"f24a3c86179918a939657c4edb422dd7","category":"concept","question":"What tool was used to measure the aesthetic improvements in the participants?","answer":"The Global Aesthetic Improvement Scale was used to measure the aesthetic improvements in the participants.","input_idx":[[638,672]],"output_idx":[[601,660]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5682159,"edit_id":"6ccf577129f38d6d65431e96c231914e","category":"concept","question":"How was treatment satisfaction measured in the participants?","answer":"Treatment satisfaction was measured by confirming the participants' willingness to repeat the treatment or recommend it to friends.","input_idx":[[677,778]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5702778,"edit_id":"ec17b7c9de6e2b520fcb4dc41e95309a","category":"omission","question":"How was the fizzy water made?","answer":"The fizzy water was made by a soda carbonator.","input_idx":[[192,280]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5702778,"edit_id":"c86fc65b04fbdaade8ca15e05ec02201","category":"omission","question":"How were the teeth selected for the study?","answer":"Seventy-five premolar teeth were randomly selected and divided into a control group and 4 experimental groups based on the carbonation level and the presence of calcium ions in the test solutions.","input_idx":[[282,475]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5702778,"edit_id":"e8eb07e915dd1fca90a7205095fa9262","category":"omission","question":"What was the procedure for testing the teeth?","answer":"The teeth were prepared and then submerged in each test solution for 15 minutes three times a day for 7 days.","input_idx":[[476,660]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5702778,"edit_id":"fb4b98b2da96973530ce2b54b6f456bc","category":"concept","question":"What type of test was used to measure the hardness of the enamel and how many specimens were tested?","answer":"Microhardness tests were used to measure the hardness of the enamel and 10 specimens were tested from each group.","input_idx":[[661,775]],"output_idx":[[764,800]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5702778,"edit_id":"2a2b9ee17fb0c4a9724ce7346d31b692","category":"concept","question":"What type of microscope was used to look at the enamel and how many specimens were tested?","answer":"Scanning electron microscopy (SEM) tests were used to look at the enamel and 5 specimens were tested from each group.","input_idx":[[776,919]],"output_idx":[[805,858]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5702778,"edit_id":"49815198817cf106458a891aae1d919c","category":"concept","question":"Which statistical tests were used to compare the changes in hardness between the groups?","answer":"Microhardness changes in different groups were statistically compared using paired t-tests, the Wilcoxon signed rank test, and the Kruskal-Wallis test.","input_idx":[[920,1071]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5730627,"edit_id":"032f0cbfeb3c3182bd685492d55ccb4f","category":"omission","question":"What rating scale was used to measure ADHD symptoms in the study?","answer":"The Attention-Deficit\/Hyperactivity Disorder Rating Scale IV (ADHD-RS-IV) was used to measure ADHD symptoms in the study.","input_idx":[[956,1025]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5730627,"edit_id":"b44c11a996d65c8d4ee693ae1e335775","category":"omission","question":"What statistical measure was used to compare the mean changes in ADHD symptoms between groups?","answer":"The statistical measure used to compare the mean changes in ADHD symptoms between groups was the least squares (LS) mean \u00b1 standard error of the mean (SEM).","input_idx":[[1495,1553]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5730627,"edit_id":"c49c72761d12e86d5d64d5ec8e1dc69d","category":"omission","question":"What statistical test was used to determine if one treatment was significantly better than the other?","answer":"The statistical test used to determine if one treatment was significantly better than the other was a t-test.","input_idx":[[1857,1946]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5730627,"edit_id":"749aff9962c63928b625a6125b295e23","category":"concept","question":"What were the specific doses of LDX and OROS-MPH given in the study?","answer":"LDX was given in doses of 30-70mg\/day and OROS-MPH was given in doses of 18-72mg\/day.","input_idx":[[705,815]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5730627,"edit_id":"f8ac1075672f13bc1a9cc349a27dee12","category":"concept","question":"What were the specific doses of LDX and OROS-MPH given in the study?","answer":"LDX was given in doses of 70mg\/day and OROS-MPH was given in doses of 72mg\/day.","input_idx":[[848,953]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5771057,"edit_id":"2bb95c3974d4cc9b68d9d43792cfc51f","category":"omission","question":"What was the first dual task condition?","answer":"The first dual task condition was auditory word recognition plus visual processing.","input_idx":[[800,845]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5771057,"edit_id":"acb900ec51dfbafdb9a81c099665da40","category":"omission","question":"What was the second dual task condition?","answer":"The second dual task condition was auditory working memory (word) plus visual processing.","input_idx":[[851,901]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5771057,"edit_id":"acc9b3b11661a616487f664dcadb9483","category":"omission","question":"What was the third dual task condition?","answer":"The third dual task condition was auditory working memory (sentence) plus visual processing in noise.","input_idx":[[911,974]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5771057,"edit_id":"4a90fcb8604eb41d81754403adb13db5","category":"concept","question":"How was the relationship between task complexity and performance measures determined?","answer":"A repeated measures analysis of variance was performed to determine the relationship between task complexity and performance measures.","input_idx":[[986,1165]],"output_idx":[[805,1002]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5771057,"edit_id":"1b7e9955f14249223f370779d68a39e4","category":"concept","question":"How was it determined that the cognitive subtests of the WCJ-III test could predict performance?","answer":"Linear regression was used to determine that the cognitive subtests of the WCJ-III test could predict performance across dependent variable measures.","input_idx":[[1166,1312]],"output_idx":[[1003,1149]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5805261,"edit_id":"bcf2e12fdcfbe70a7cf44d3cd2cd4ee9","category":"omission","question":"What was the main goal of this study?","answer":"The main goal of this study was to compare the effectiveness of two different methods of radiofrequency ablation (RFA) for people with liver cancer.","input_idx":[[35,330]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5805261,"edit_id":"f149eb7cbb95d3871d4e185a64769d98","category":"omission","question":"Was this study approved by an institutional review board?","answer":"Yes, this study was approved by an institutional review board.","input_idx":[[344,414]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5805261,"edit_id":"7170be2b0a839ceb30eee438b2f90204","category":"omission","question":"How were the patients selected for this study?","answer":"The patients were selected randomly from April 2014 to January 2015 and the criteria for inclusion were not specified.","input_idx":[[415,641]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5805261,"edit_id":"b0f593299165750e68acf717012752d3","category":"concept","question":"What specific technical parameters were evaluated in the study?","answer":"The specific technical parameters that were evaluated in the study were the number of ablations, ablation time, volume, energy delivery, and complications.","input_idx":[[642,771]],"output_idx":[[508,679]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5805261,"edit_id":"e43d3aa5752a56d3bd50bd852d1512ec","category":"concept","question":"How was the ablation volume measured and what was the statistical significance of the difference between the two groups?","answer":"The ablation volume was measured in cubic centimeters (cm3) and the difference between the two groups was not statistically significant (p = 0.229).","input_idx":[[1187,1308]],"output_idx":[[939,1026]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5805261,"edit_id":"b74d165e68e3334e45ec5aa1b94b3cac","category":"concept","question":"What was the nature of the technical issue and major complication in each group?","answer":"The nature of the technical issue in the SM-RFA method was not specified, but there was one major complication in each group. The major complication in the SB-RFA group was not specified, but in the SM-RFA group it was a major side effect.","input_idx":null,"output_idx":[[1027,1131]],"annotator":"mistral-7b","prediction_errors":["invalid_input_localization"]},{"PMCID":5808396,"edit_id":"f26240ce761c87a66265d85489f6d16d","category":"omission","question":"What are the negative outcomes associated with sexual violence?","answer":"Sexual violence can cause major physical, emotional, and social problems.","input_idx":[[12,107]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5808396,"edit_id":"23ce001577e16acc328c5a81dad62e4b","category":"omission","question":"What is stigma and how does it affect survivors of sexual violence?","answer":"Stigma refers to negative attitudes, beliefs, and behaviors towards a particular group of people, in this case survivors of sexual violence. It can affect their mental health, social interactions, and overall well-being.","input_idx":[[109,274]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5808396,"edit_id":"b03ce77d59ec44f233922745c86dde0c","category":"omission","question":"What was the aim of this study?","answer":"The aim of this study was to assess the effect of group Cognitive Processing Therapy (CPT) on stigma and the extent to which stigma might moderate the effectiveness of CPT in treating mental health problems among survivors of sexual violence in the Democratic Republic of Congo.","input_idx":[[275,537]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5808396,"edit_id":"4047f1ab7355fd36edf520b27493ad91","category":"concept","question":"How significant was the difference in felt stigma between the two groups?","answer":"The difference in felt stigma between the two groups was statistically significant at the end of treatment (Cohen's D = 0.44, p = 0.02), but it was no longer significant six months later (Cohen's D = 0.45, p = 0.12).","input_idx":[[1299,1585]],"output_idx":[[1014,1130]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5808396,"edit_id":"22796a23d91b0484273c96b8525f2edb","category":"concept","question":"Did feeling stigmatized or discriminated affect the effectiveness of CPT on mental health symptoms and functional impairment?","answer":"No, feeling stigmatized or discriminated did not significantly moderate the effect of CPT on mental health symptoms or functional impairment.","input_idx":[[1586,1711]],"output_idx":[[349,431]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5809707,"edit_id":"10721cb87bf546482ca401b9b8ef9143","category":"omission","question":"How long did it take for patients to be ready to go home?","answer":"It took significantly longer for patients in the ketamine group to be ready to go home compared to the other two groups.","input_idx":[[715,781]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5809707,"edit_id":"c3a4f30da8dcb25432b643491b0ecafc","category":"concept","question":"How were the patients divided into the three groups?","answer":"The patients were randomly assigned to one of the three groups.","input_idx":[[356,398]],"output_idx":[[441,474]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5809707,"edit_id":"321ab45e1883402c17837ef751ea4408","category":"concept","question":"What was the dosage of the medications given to the patients in each group?","answer":"Group 1 received a normal saline solution, Group 2 received 50 \u00b5g of fentanyl, and Group 3 received 0.5 mg\/kg of ketamine.","input_idx":[[400,532]],"output_idx":[[476,627]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5827507,"edit_id":"0b03f9071264319a588959cc55e2a224","category":"omission","question":"What is the name of the disorder that the study is about?","answer":"The disorder is called dentinal hypersensitivity (DH).","input_idx":[[9,39]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5827507,"edit_id":"7f04f179da5594c45f353d4c8edb88ee","category":"omission","question":"Is there a standardized treatment for dentinal hypersensitivity (DH)?","answer":"No, there is no standardized treatment for dentinal hypersensitivity (DH).","input_idx":[[144,191]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5827507,"edit_id":"39cd6ae878a253fa3348851a77e58b91","category":"omission","question":"Are there any alternative treatments for dentinal hypersensitivity (DH)?","answer":"Yes, there are alternative treatments for dentinal hypersensitivity (DH), including laser therapies.","input_idx":[[200,259]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5827507,"edit_id":"4838b7e987db8f92d22e06fdbba82d6e","category":"concept","question":"What was the concentration of potassium nitrate used in the study?","answer":"The concentration of potassium nitrate used in the study was 5%.","input_idx":[[534,561]],"output_idx":[[706,723]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5827507,"edit_id":"ec19669cd5e3fe1b5eeed340f96eb1d9","category":"concept","question":"What type of laser was used in the study and what were its parameters?","answer":"The specific type of laser used in the study was a gallium-aluminum-arsenide diode laser, with a power wattage of 0.5 W, a wavelength of 980 nm, and a non-contact pulse mode.","input_idx":[[578,699]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5827507,"edit_id":"7d84f8757b412498a78b92017e613db2","category":"concept","question":"What statistical test was used to compare the mean VAS scores at different intervals of time?","answer":"The statistical test used to compare the mean VAS scores at different intervals of time was one-way ANOVA and Bonferroni correction post hoc test.","input_idx":[[1288,1341]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5852865,"edit_id":"6c68a704b5c93ae40acfbb81adcc69f4","category":"omission","question":"What was the purpose of this study?","answer":"The purpose of this study was to investigate the effects of supplementation with carotenoids on macular pigment.","input_idx":[[0,232]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5852865,"edit_id":"2f3ac63d422ca59bc72406c951366fdc","category":"omission","question":"Where can these supplements be found?","answer":"These supplements can be found in many health food stores or online.","input_idx":[[233,351]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5852865,"edit_id":"938963f0ed87d4f39ee53b368017b64d","category":"omission","question":"What were the two types of supplements given to the participants?","answer":"The two types of supplements given to the participants were 20 mg\/day of lutein and 20 mg equivalent free carotenoids of a combination of diacetate esters of the macular carotenoids.","input_idx":[[352,655]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5852865,"edit_id":"dc418569192950c697c6638b58153afb","category":"concept","question":"How statistically significant was the difference between the two groups?","answer":"The difference was statistically significant at a p-value of 0.0287.","input_idx":[[838,894]],"output_idx":[[608,791]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5852865,"edit_id":"a6763fbdb9b2e694e770adc3681bfa50","category":"concept","question":"What was the trend towards smaller increases in macular pigment for subjects with higher baseline values?","answer":"The trend was that participants who had higher levels of the macular substance at the start of the study had a smaller increase in levels.","input_idx":[[895,1015]],"output_idx":[[792,926]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5852865,"edit_id":"bf79a69275a1d92ff95d8d2ddb324344","category":"concept","question":"Was the trend towards smaller increases in macular pigment for subjects in the diacetate group significant?","answer":"The trend was only significant for subjects in the diacetate group.","input_idx":[[1016,1103]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["missing_output_localization"]},{"PMCID":5853038,"edit_id":"594d8e8fd520b799f4306368dd44c446","category":"omission","question":"How many people were included in the study?","answer":"25 people were included in the study.","input_idx":[[325,401]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5853038,"edit_id":"4ddcee64a3935c607815e5bc69c1e284","category":"omission","question":"What happened to the participants after the first day of the study?","answer":"After the first day, the participants went back to using their regular toothpaste for two weeks.","input_idx":[[498,597]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5853038,"edit_id":"fe666a4396ef392affb4e614e9f18066","category":"concept","question":"How were the participants examined for plaque?","answer":"The participants were examined for plaque and given a plaque score.","input_idx":[[325,401]],"output_idx":[[290,364]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5853038,"edit_id":"4ddcee64a3935c607815e5bc69c1e284","category":"concept","question":"What happened to the participants after the first day of the study?","answer":"After the first day, the participants went back to using their regular toothpaste for two weeks.","input_idx":[[498,597]],"output_idx":[[520,632]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5861369,"edit_id":"ded513204eb0cfbb7111b3a3c683b535","category":"omission","question":"What were the specific metabolic risk markers that were measured in the study?","answer":"The study measured insulin sensitivity, insulin secretion, fasting lipids, and cortisol levels as metabolic risk markers.","input_idx":[[1522,1544]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5861369,"edit_id":"6a86fdc50cf75ddedbbf9ed7e3ae0620","category":"omission","question":"What specific aspects of mental health were measured in the study?","answer":"The study measured mental health using the WHO Well-Being Index (WHO-5), Major Depression Inventory (MDI), Short Form 36 (SF-36) and PCOS questionnaire.","input_idx":[[125,138]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5861369,"edit_id":"89a12110d163c168e09a3e1742f6863e","category":"concept","question":"What is the ACTH test and how is it used to measure stress hormone levels?","answer":"The ACTH test is a hormone test that measures the levels of adrenocorticotroph hormone (ACTH) in the blood. ACTH is a hormone that stimulates the production of cortisol, a stress hormone. The test is used to diagnose and monitor conditions that affect the adrenal gland, such as Cushing's syndrome.","input_idx":[[525,563]],"output_idx":[[810,834]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5861369,"edit_id":"a4a11b4024c650c539847ee1c4fe2397","category":"concept","question":"What do the different cortisol levels mean and how were they measured?","answer":"The different cortisol levels refer to the levels of cortisol in the blood at different times during the ACTH test. The cortisol 0 refers to the baseline level of cortisol before the ACTH test, cortisol 60 refers to the level of cortisol 60 minutes after the ACTH test, peak cortisol refers to the highest level of cortisol during the ACTH test, and area under the curve for cortisol during ACTH test refers to the total amount of cortisol released in response to the ACTH test. These levels are used to diagnose and monitor conditions that affect the adrenal gland, such as Cushing's syndrome.","input_idx":[[1099,1192]],"output_idx":[[1100,1115]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5863413,"edit_id":"297bbad61955c4b7f887be4ce10e2d52","category":"omission","question":"What is the disease that the study is about?","answer":"The study is about lichen planus, a chronic inflammatory, autoimmune, mucocutaneous disease of unknown etiology.","input_idx":[[21,114]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5863413,"edit_id":"ab2784696e6c970bed9fedf7080fdb34","category":"omission","question":"What is the current treatment for oral lichen planus?","answer":"The current treatment for oral lichen planus is corticosteroids.","input_idx":[[115,185]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5863413,"edit_id":"238a64604c9935cd4db7e54bacc8cdc8","category":"omission","question":"What treatment did the control group receive?","answer":"The control group received a topical application of triamcinolone acetonide 0.1%.","input_idx":[[620,713]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5863413,"edit_id":"419195ce93e1fea9c7621f3edf08ced5","category":"concept","question":"What was the specific treatment that the control group received?","answer":"The control group received a topical application of triamcinolone acetonide 0.1%.","input_idx":[[620,713]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5863413,"edit_id":"1f84958587f5a81db274a6a3649d63c0","category":"concept","question":"What type of propolis was used in the study?","answer":"The propolis used in the study was a gel.","input_idx":[[720,773]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5863413,"edit_id":"9b592aaaef303a8a904364d0fd2a4917","category":"concept","question":"How significant was the reduction in pain and erythema scores for both groups?","answer":"The reduction in pain and erythema scores for both groups was statistically significant.","input_idx":[[986,1217]],"output_idx":[[846,936]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5866486,"edit_id":"ca2917457d10afa86bf78f5e2cc60044","category":"omission","question":"What tool was used to measure the effectiveness of the interventions?","answer":"The effectiveness of the interventions was measured using the Dizziness Handicap Inventory (DHI) which is a questionnaire that measures the impact of dizziness and balance problems on a person's life.","input_idx":[[909,1001]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5866486,"edit_id":"592f1fe8fa1cc4d9a8157502bb9e4ef7","category":"omission","question":"What were the initial conditions of the patients before the treatment?","answer":"The physical conditions and DHI scores of patients in both groups were similar at baseline, meaning that both groups had similar symptoms and levels of disability before the treatment started.","input_idx":[[1065,1155]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5866486,"edit_id":"69d9630de3b3230acc0e3ec8db5d02aa","category":"concept","question":"How was the vestibular rehabilitation program designed and verified?","answer":"The program was designed by a team of experts and then reviewed and approved by a joint committee of vestibular rehabilitation groups. The program was tailored to each individual patient and included a variety of exercises and treatments to help improve balance and dizziness.","input_idx":[[751,907]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5866486,"edit_id":"e0c76d3560a29e0aa67566c266bfb5fc","category":"concept","question":"What specific tool was used to measure the effectiveness of the interventions?","answer":"The effectiveness of the interventions was measured using the Dizziness Handicap Inventory (DHI) which is a questionnaire that measures the impact of dizziness and balance problems on a person's life.","input_idx":[[909,1001]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5891985,"edit_id":"dde7fcae72344291b3cebc1378c2f5ac","category":"omission","question":"What is the potential impact of liraglutide on glucose and lipid metabolism disorder and adhesion molecule activation?","answer":"Liraglutide has been suggested to have an impact on glucose and lipid metabolism disorder and adhesion molecule activation, which may play important roles in the vascular damage of diabetes.","input_idx":[[12,213]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5891985,"edit_id":"5d7c6d31e40d228cd71da0d1fde4e1b1","category":"omission","question":"What were the inclusion criteria for the study?","answer":"The study included 60 patients who were newly diagnosed with type 2 diabetes mellitus and had a mean age of 33.97\u2009\u00b1\u20095.67\u00a0years.","input_idx":[[445,636]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5891985,"edit_id":"ec9a5b5a1d1850c71ea5b3a5bd8bfccc","category":"omission","question":"What was the specifics of the glucose tolerance test used in the study?","answer":"The study used a 75\u00a0g oral glucose tolerance test, which involves consuming a standard amount of glucose and then having blood samples taken at specific time points to measure glucose levels.","input_idx":[[637,742]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5891985,"edit_id":"c2c302c135e3b728195c2899bba71a1d","category":"concept","question":"How might liraglutide help with type 2 diabetes?","answer":"Liraglutide has been suggested to have an impact on glucose and lipid metabolism disorder and adhesion molecule activation, which may play important roles in the vascular damage of diabetes.","input_idx":[[12,213]],"output_idx":[[50,95]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5891985,"edit_id":"e634ac4b69c6a4f88b796a9eb468781e","category":"concept","question":"How was the study designed?","answer":"The study was designed as a randomized, double-blind, placebo-controlled trial, where 60 patients with type 2 diabetes were randomly assigned to receive either liraglutide or metformin.","input_idx":[[445,636]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5923799,"edit_id":"66dc6b9aaa080d7a2d899cfd85af33f6","category":"omission","question":"What was the purpose of this study?","answer":"The purpose of this study was to investigate the effects of regular Taekwondo (TKD) training on physical fitness, mood, sociability, and cognitive functions in children from multicultural families in South Korea.","input_idx":[[0,195]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5923799,"edit_id":"1669fce49b274232f3ea20253f5e6a0a","category":"omission","question":"How many children were included in the study and how were they divided into the two groups?","answer":"The study included 30 children from multicultural families in South Korea. The children were randomly divided into two groups: 15 children attended Taekwondo sessions once a week for 16 weeks, and the other 15 children didn't.","input_idx":[[372,613]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5923799,"edit_id":"a87465d42c69e954d7f72f643557b20a","category":"omission","question":"What specific sub-variables of sociability were measured in the study?","answer":"The study measured sociability and 'being left out' score, a sub-variable of sociability. The results showed that the 'being left out' score was significantly lower after the intervention, while the sociability score was significantly higher.","input_idx":[[1256,1458]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5966460,"edit_id":"986c24dc34dc3d3e2d16c3e9515ef183","category":"omission","question":"Did the gel cause any significant changes to protein levels?","answer":"No, the gel did not cause any significant changes to protein levels.","input_idx":[[683,809]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5966460,"edit_id":"6dd3f60006f2355a26ee823639a46494","category":"omission","question":"Did the placebo cause any changes to proteins and immune response?","answer":"Yes, the placebo caused changes to proteins involved in proteolysis, activation of the immune response and inflammation after 2 hours.","input_idx":[[938,1133]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5966460,"edit_id":"38cc90573ecf1238d0716020c4514181","category":"concept","question":"What specific techniques were used to analyze the samples?","answer":"The samples were analyzed using label-free tandem MS\/MS for proteomics and 16 S rRNA gene amplicon sequencing for microbiome analyses.","input_idx":[[519,682]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5966460,"edit_id":"c942ed43cf21972a51b07fdd10d1dd3f","category":"concept","question":"What does FDR < 5% mean?","answer":"FDR < 5% means that the results are statistically significant at a 5% level of confidence.","input_idx":[[683,809]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5976307,"edit_id":"a428ca4bafdc3df3be7e82702b4e229f","category":"omission","question":"What was the purpose of this study?","answer":"The purpose of this study was to investigate whether using etomidate with another sedative, midazolam, might lead to fewer heart and lung-related side effects compared to using propofol and midazolam during a colonoscopy in elderly patients.","input_idx":[[19,40]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5976307,"edit_id":"0129c3a2afd58bfee7e757ac95a22ae9","category":"omission","question":"How was this study conducted?","answer":"This study was conducted as a clinical trial at a single center. It was double-blinded, meaning that neither the researcher nor the participants knew which treatment each participant received, and it was randomized, meaning the participants were randomly assigned one of the treatments.","input_idx":[[395,483]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5976307,"edit_id":"0dba54aa211932801805cb641dddb24d","category":"concept","question":"What was the purpose of the colonoscopy for these patients?","answer":"The purpose of the colonoscopy for these patients was to screen for any potential issues with their colon.","input_idx":[[484,639]],"output_idx":[[430,608]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5976307,"edit_id":"aec5ee7015ad32c3eec7a7ce3f3b9a8b","category":"concept","question":"What were the researchers looking for in this study?","answer":"The researchers were looking for any heart and lung-related side effects that might occur during the colonoscopy.","input_idx":[[640,699]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5976501,"edit_id":"8cd7494b4632b47616a98a1e6a1c7020","category":"omission","question":"What is the most effective way to prevent diabetes in prediabetic adults?","answer":"The most effective way to prevent diabetes in prediabetic adults is through lifestyle modification.","input_idx":[[127,220]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5976501,"edit_id":"2a03153424c88148fbce304436b6cff8","category":"omission","question":"Why is the prevalence of diabetes increasing despite the benefits of lifestyle change?","answer":"Despite the benefits of lifestyle change, diabetes prevalence continues to increase due to various factors such as sedentary lifestyle, poor diet, and genetic predisposition.","input_idx":[[231,314]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5976501,"edit_id":"d904878372c58b60539ce118a4b96e2d","category":"omission","question":"What questionnaires were used to examine the effect of 5-ALA on mood and coping ability?","answer":"The study used the Psychosocial Depressive Symptoms Questionnaire (PDS) and the Perceived Stress Scale (PSS) to examine the effect of two doses of 5-ALA (15 mg and 50 mg) on various components of mood (i.e., hopefulness, loneliness, and motivation) and coping ability.","input_idx":[[933,1195]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5976501,"edit_id":"e264e489c24abf806b274ebb5a24233f","category":"concept","question":"How was the study conducted?","answer":"The study was conducted as a double-blind, randomized parallel-group study, where participants were randomly assigned to one of three groups: control, 15 mg dose, or 50 mg dose. The study was double-blind, meaning that neither the researcher nor the participants knew which treatment each participant received, and it was randomized, meaning the participants were randomly assigned one of the treatments.","input_idx":[[863,931]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5976501,"edit_id":"d8930f0855085e79c51dd0821154b510","category":"concept","question":"What did the literature review find?","answer":"The literature review found zero published articles on the relationship between 5-ALA administration and mood and coping ability.","input_idx":[[1424,1582]],"output_idx":[[733,776]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5976501,"edit_id":"a50db6c5a87c9e326948bc6b9dd2a741","category":"concept","question":"How statistically significant were the results?","answer":"The results were statistically significant, with p-values of 0.004 for improved coping ability and 0.002 for improved self-perception of effort spent.","input_idx":[[1649,1809]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5976501,"edit_id":"a4e1cad8a74873ea80412f45945fde1e","category":"concept","question":"How statistically significant was the dose-dependent relationship?","answer":"The dose-dependent relationship was statistically significant, with p-values of 0.003 for measures of effort, 0.006 for loneliness, and 0.003 for coping ability.","input_idx":[[1820,1996]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5985618,"edit_id":"a9f805f68b829a058a527d7e0c3aeb65","category":"omission","question":"What was the goal of this study?","answer":"The goal of this study was to compare the effectiveness and safety of two different treatments for bad breath caused by a chronic condition called tonsillitis with cheesy substance in the throat.","input_idx":[[128,348]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5985618,"edit_id":"776af587c1022af1e5815ad49937fa96","category":"omission","question":"How many people were included in the study?","answer":"Sixty-two patients were included in the study and were randomly assigned into two groups.","input_idx":[[373,560]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5985618,"edit_id":"497ed26d815c946a1d2a4cc0e759bc3b","category":"omission","question":"What treatments did the two groups receive?","answer":"Group A received temperature-controlled radiofrequency tonsil ablation and Group B received CO2-laser cryptolysis.","input_idx":[[561,629]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5985618,"edit_id":"8080795ae28028b8354be0173ac0717e","category":"omission","question":"When were the severity of symptoms evaluated after the procedure?","answer":"The severity of symptoms including halitosis and foreign body sensation was evaluated 7 days, 1 month, and 6 months after the procedure.","input_idx":[[630,765]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5985618,"edit_id":"b864ffd185d4b98a5d3fc0e896f6c900","category":"omission","question":"What were the safety outcome measures that were evaluated?","answer":"Patient pain levels and amount of bleeding were evaluated as safety outcome measures.","input_idx":[[766,851]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5985618,"edit_id":"1b2251e46096ccdbeacb67612d8be05f","category":"omission","question":"How were pain levels evaluated?","answer":"Pain levels were evaluated during the intervention and at Day 1, 3, and 7 following the procedure using a visual analog scale (VAS).","input_idx":[[852,985]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5985618,"edit_id":"598e753184a319d76dd09479bc6f05ec","category":"concept","question":"At which time points were the pain scores measured?","answer":"The pain scores were measured at 7 days, 1 month, and 6 months after the procedure.","input_idx":[[996,1151]],"output_idx":[[898,1017]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5985618,"edit_id":"132ceeba4f9146527b4f3a72de0bbdd4","category":"concept","question":"What was the significance level of the difference in bleeding between the two groups?","answer":"The difference in bleeding between the two groups was significant at the 5% level.","input_idx":[[1152,1256]],"output_idx":[[1018,1104]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5985618,"edit_id":"13e30c1b26099ef40ebe25b901dc6f7e","category":"concept","question":"What was the significance level of the difference in duration of procedure between the two groups?","answer":"The difference in duration of procedure between the two groups was not significant at the 5% level.","input_idx":[[1257,1354]],"output_idx":[[1114,1186]],"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5986443,"edit_id":"cd5cce90914df2ddf99a8985e14a8cb2","category":"omission","question":"What are sarcopenia and dynapenia?","answer":"Sarcopenia is the loss of muscle mass and strength in older adults, while dynapenia is the decline in muscle strength in older adults.","input_idx":[[25,49]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5986443,"edit_id":"386a185719fa068a8670142b205616d5","category":"omission","question":"What are the strategies that may contribute to health improvements in older adults?","answer":"Resistance training (RT) and increased protein intake are strategies that may contribute to health improvements in older adults.","input_idx":[[140,193]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["spurious_output_localization"]},{"PMCID":5986443,"edit_id":"6ba87d29a8b5fc979c390efccb26c970","category":"omission","question":"What specific measurements were taken before and after the intervention?","answer":"Body composition, muscular strength, functional capacity, and dietary intake were assessed before and after the intervention.","input_idx":[[913,1030]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":5986443,"edit_id":"72755712ce376f1ea032438fc67d9713","category":"concept","question":"What statistical method was used to analyze the data?","answer":"Two-way analysis of covariance (ANCOVA) for repeated measures, with baseline scores as covariates was used to analyze the data.","input_idx":[[1032,1129]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":5986443,"edit_id":"8cb8ff9db442de6b19904225613e70ba","category":"concept","question":"What statistical test was used to determine the significance of the results?","answer":"A time vs. group interaction (p < 0.05) was used to determine the significance of the results.","input_idx":[[1161,1198]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":65514,"edit_id":"e075cbdbb4869eaf943ff70d6504f69f","category":"omission","question":"What is the common agreement about the risk of coronary artery disease and high LDL-cholesterol?","answer":"It is commonly agreed that people with a high blood LDL-cholesterol will have a higher risk of coronary artery disease (CAD) than people with low blood LDL-cholesterol.","input_idx":[[12,180]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":65514,"edit_id":"6ecf7c6f63a1d99857fc5bebfd81dad4","category":"omission","question":"Why was this study conducted?","answer":"The study was conducted because of the increasingly high costs of medication in Thailand, and the government set up several measures to combat the problem.","input_idx":[[181,308]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":65514,"edit_id":"fbc4b464f51b97c5f7244697835acfb3","category":"omission","question":"What is the drug that was tested in the study?","answer":"The drug that was tested in the study is Simvastatin, which is an HMG-CoA reductase inhibitor and is listed as an essential drug for the treatment of hypercholesterolemia.","input_idx":[[455,573]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":[]},{"PMCID":65514,"edit_id":"a69ca07c79f060bee055acf0e0daaf61","category":"concept","question":"How were the drugs given to the participants?","answer":"The drugs were given to the participants as 10-mg single oral doses in a two-period crossover design.","input_idx":[[912,1007]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":65514,"edit_id":"519ebcf8aaa266d4fcc03395b734d4eb","category":"concept","question":"When were the blood samples collected?","answer":"Blood samples were collected every 4 weeks for 16 weeks after the drugs were given.","input_idx":[[1008,1098]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]},{"PMCID":65514,"edit_id":"459b45a6ecd51b3ec3daa229aa1a12ff","category":"concept","question":"What was the main parameter that was checked in the study?","answer":"The main parameter that was checked in the study was blood LDL-cholesterol.","input_idx":[[1099,1169]],"output_idx":null,"annotator":"mistral-7b","prediction_errors":["invalid_output_localization"]}]